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Abstract 
An understanding of the mechanisms underlying the various stages of 
transcription is crucial to find solutions to the problems caused by mis-expression of 
genes that may give rise to a host of human diseases. My thesis research focusses on an 
analysis of the RNA Polymerase II elongation factor Ell1/Eaf1 in S. pombe.  Eleven-
nineteen lysine-rich in leukemia (ELL) is encoded by a gene involved in translocations 
with MLL in leukemia and forms a tight complex with ELL-associated factors (EAF). 
ELL/EAF is an RNA polymerase II elongation factor that in metazoa can assemble into a 
larger assembly that also includes P-TEFb and other proteins encoded by genes involved 
in MLL translocations.  This larger assembly, sometimes called SEC, binds to a specific 
"docking site" in the metazoan Mediator complex.  Distantly related ELL- and EAF-like 
genes were identified in S. pombe that encode Ell1/Eaf1 and can stimulate Pol II 
elongation in vitro.  My thesis addresses two distinct projects, with overlapping 
motivations:  
First, to see whether S. pombe might provide a good model for functional studies 
of the Mediator and ELL/EAF interaction, I carried out a thorough proteomic analysis of S. 
pombe Mediator and defined several new subunits.  My results were recently published 
as part of a collaborative structural analysis of S. pombe Mediator.   
Second, I used a combination of biochemical, genetic, and genomic approaches to 
characterize Ell1/Eaf1 function in fission yeast. Using mass spectrometry, I identified an 
uncharacterized sequence orphan, SPAC6G9.15c, that associates with both Ell1 and Eaf1 
to form a ternary complex that, based on ChIP-seq localizes at genes with high RNA Pol II 
occupancy.  I also performed an SGA screen for genes that genetically interact with ell1, 
eaf1, and SPAC6G9.15c and identified a set of overlapping genes that interact with all 
three, as well as others that interact only with ell1. 
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CHAPTER 1: Introduction  
1.1 Regulation of gene expression 
Cells need to perform various functions at various times to survive.  To do so, cells 
need to alter the kinds and amounts of proteins they contain in response to growth 
conditions.  The amount of a protein present in a cell can be controlled by regulating 
many steps of gene expression, including RNA synthesis, the processing of primary 
transcripts into mature mRNA, transport of mRNA from the nucleus to cytoplasm, 
translation or turnover of mRNAs, and, ultimately, protein degradation.  
Protein coding genes are transcribed into mRNA precursors by RNA polymerase II 
(Pol II). Synthesis of RNA transcripts by Pol II is the first step in gene expression and is a 
major point of gene regulation. Transcription can be divided into 3 major steps; initiation, 
elongation and termination. This introduction will examine the functions and regulation 
of Pol II, discuss a key transcriptional coregulator called the Mediator complex and the 
transcription elongation factor ELL, and introduce S. pombe as a model system for 
answering questions about the functions of ELL in cells.   
 
1.2 RNA Pol II transcription 
In eukaryotic cells the synthesis of ribonucleic acid (RNA) from the DNA is 
achieved by the three types of RNA Polymerases present. Pol I is responsible for synthesis 
of the large ribosomal RNAs (rRNAs), and Pol III for 5S and 5.8S RNAs, tRNAs, and several 
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other small non-coding RNAs. Pol II is responsible for the synthesis of protein coding 
mRNAs along with other non-coding RNAs, including snRNAs, which have key roles in 
RNA splicing, and long non-coding RNAs, miRNAs, and others, many of which regulators 
of gene expression.   
 This section of the introduction examines the basic properties of Pol II and its 
function in basal transcription and the various stages of transcriptional regulation. 
 
RNA Polymerase II 
 RNA Polymerase II on its own it cannot recognize and bind promoter or unwind 
DNA template around a transcription start site.  However, Pol II can bind to and initiate 
transcription on single stranded DNA.  In addition, once it is initiated, it can transcribe 
double stranded DNA without help from additional proteins. In cells, however, the DNA is 
not naked and bound by histone complexes and the various mechanisms that exist for 
providing the polymerase access to the template are discussed later. Sequence specific 
factor also help to activate specific genes. 
Pol II consists of 12 polypeptides, designated Rpb1 through Rpb12. The largest Pol 
II subunit, Rpb1, contains a largely unstructured C-terminal domain (CTD) that constitutes 
a unique feature of Pol II and distinguishes it from all other polymerases. The CTD, 
composed of tandem heptad repeats, is conserved from fungi to humans, although the 
number of repeats and the consensus sequence vary in different organisms. For example, 
vertebrate CTDs contain 52 tandem heptapeptide repeats (most having a consensus 
Y1S2P3T4S5P6S7), and the fission yeast contains 29 heptads, 24 of which are all-consensus, 
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whereas the CTD of budding yeast consists of 26 heptads, 19 of which are perfect 
consensus. 
 Several kinases have been implicated in phosphorylation of the CTD. The CTD is 
phosphorylated on Ser5 by a protein kinase, CDK7/Cyclin H, that is associated with the 
general initiation factor TFIIH.  CDK7 also appears to phosphorylate the CTD on Ser7 
(Akhtar et al., 2009). CDK9/cyclin T (also called P-TEFb in mammals), phosphorylates the 
CTD on Ser2 (Meinhart and Cramer, 2004) and is required for phosphorylation of Thr4 
(Hsin et al., 2011). Another PIC component, CDK8/Cyclin C, a subunit of the Mediator 
complex, can also phosphorylate the CTD on both Ser2 and Ser5 in vitro (Liao et al., 
1995). Serine 5 phosphorylation usually occurs at or near the promoter, while serine 2 
phosphorylation is seen primarily on polymerase molecules that have moved away from 
the promoter region and are engaged in transcript elongation (Komarnitsky et al., 2000). 
  
1.2.A Transcription initiation 
 Pol II can bind to and initiate transcription on single stranded DNA.  In addition, 
once it has initiated, it can transcribe double stranded DNA without help from additional 
proteins.  On its own, however, it cannot recognize and bind promoter DNA, nor can it 
unwind the DNA template around the transcription site.  Accordingly, promoter-specific 
transcription by RNA Polymerase II depends on assistance from a set of evolutionarily 
conserved general initiation factors. 
Transcription initiation is a complex process involving the action of a large 
number of general and gene-specific transcription factors. Five evolutionarily conserved 
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general initiation factors, TFIIB, TFIID, TFIIE, TFIIF and TFIIH are necessary for promoter-
specific transcription initiation to take place in vitro. These factors, along with Pol II, are 
recruited to the promoter to form the pre-initiation complex (PIC) (Conaway and 
Conaway, 1997; Roeder, 1996).  A sixth factor, TFIIA, can stimulate transcription in vitro 
but is not essential. 
 TFIID, containing the TATA binding protein (TBP), binds to and bends the DNA at 
the promoter of the gene. TFIIA (Roeder, 1996) stabilizes the interaction between TBP 
and DNA. TFIIB promotes the selective binding of preformed Pol II/ TFIIF to TBP and in 
yeast has been shown to direct transcription to begin at a defined start site downstream 
of the TATA box. TFIIF performs dual roles in assembly of the preinitiation complex by 
binding to and strongly stabilizing the Pol II-containing intermediate and by supporting 
recruitment of TFIIE and TFIIH into the complex. Following the full assembly of the 
preinitiation complex, an ATP dependent DNA helicase activity associated with the XPB 
subunit of TFIIH helps to unwind the DNA surrounding the transcriptional start site (TSS) 
to form the open complex prior to initiation by Pol II.  
 Then initiation takes place, leading to formation of the first phosphodiester bond. 
The initial transcribing complex is fairly unstable.  This instability can result in the 
formation of short transcripts as the initiation complex disassociates from the DNA, a 
process known as abortive initiation.  Abortive initiation has been proposed to be due at 
least in part to interference between the growing RNA and the TFIIB B-finger (Kostrewa 
et al., 2009).  
 Once transcripts longer than 10-15 have been made, the polymerase goes into 
productive elongation. 
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Figure 1.1 A transcribing ternary complex.   
Figure is from  (Klug, 2001)   Roger Kornberg reprinted with permission.   
Cross sectional diagram showing some structural features of the elongating RNA polymerase II. As Pol II 
transcribes from left to right, the downstream DNA is  unwound and the template strand shown in blue is 
positioned near the 3’ end of the growing RNA chain (red) and the active site magnesium ions (pink). 
Polymerisation of the RNA chain occurs in a template dependent manner as nucleotides access the active 
site via the “funnel” and “pore”. As each nucleotide is added, a change in conformation of the bridge helix 
causes a translocation of the enzyme with respect to the DNA / RNA positioning the new 3’ end of the RNA 
chain at the active site ready for further nucleotide addition. The RNA chain is separated from the template 
by the rudder and guided towards the exit channel. During transcript elongation the enzyme remains stably 
associated with the DNA and RNA; downstream DNA is gripped by a pair of “jaws” (only one of which is 
shown here) and nucleic acids are also restrained by a “clamp” which swings towards the active site during 
elongation (Gnatt et al., 2001). 
 
 
1.2.B Early elongation 
CTD phosphorylation: The phosphorylation state of the CTD is critical in 
determining its activity and plays a central role in coordinating pre-mRNA processing by 
recruiting many of the enzymes and proteins critical for proper capping, splicing, and 
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polyadenylation of pre-mRNA, as well as for proper nuclear export and localization of 
mature mRNAs (Buratowski, 2009; Perales and Bentley, 2009; Yoh et al., 2008). 
Promoter escape occurs as the nascent RNA binds stably to Pol II and triggers the 
release the of TFIIB, after which the ternary transcription complex is referred to as the 
early elongation complex and energy from ATP hydrolysis is no longer required for 
transcript elongation (Dvir et al., 2001; Kostrewa et al., 2009).  This complex is not as 
stable as a fully functional ternary complex and is susceptible to transcript slippage or 
backtracking (until about +30), resulting in transcriptional arrest of Pol II as its active site 
becomes misaligned with the 3’ end of the transcript. The transcription factor TFIIS (SII) 
can induce Pol II catalyzed transcript cleavage to form a new 3’ end properly aligned at 
the active site, allowing elongation to continue (Pal and Luse, 2003; Wang et al., 2009). 
Transcriptionally engaged polymerase is also susceptible to controlled promoter 
proximal pausing in the region +20 to +40. The duration of pausing or arrest during early 
elongation can be controlled by multiple transcription elongation factors that influence the 
elongation competence of Pol II. Pausing is exacerbated by two negatively acting 
transcription factors, 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB)-sensitive 
inducing factor (DSIF) and negative elongation factor (NELF), which usually function 
together to promote Pol II arrest, possibly through binding of NELF to RNA. Release of Pol 
II from some of the pausing sites to start productive elongation is triggered by positive 
transcription elongation factor b (P-TEFb)(Peterlin and Price, 2006). 
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1.2.C Regulation during transcription elongation 
Transcriptional elongation is a highly regulated step during gene expression. Efforts 
to identify activities that stimulate the rate of elongation by RNA Polymerase II led to the 
discovery of numerous transcription factors, that can interact directly with elongating 
Polymerase and increase its elongation rate by suppressing transient pausing by the 
enzyme. These elongation factors include TFIIF and members of the ELL and Elongin 
families (Shilatifard et al., 1997c; Uptain et al., 1997). DSIF (Spt4/5) can also stimulate 
elongation via suppression of transient pausing under some conditions. Additional 
elongation factors, including TFIIS and the PAF1c can stimulate elongation by other 
mechanisms.  Below I summarize properties of IIF, Elongin, DSIF, TFIIS, and PAF1c.  ELL will 
be discussed in section 4. 
TFIIF participates in suppression of arrest of very early Pol II elongation 
intermediates at least in part by functioning as an adaptor that links TFIIE and TFIIH to 
the transcribing Polymerase. It also has an elongation activity capable of increasing the 
rate of synthesis of the first few phosphodiester bonds of nascent transcripts, ensuring 
that growing transcripts reach a sufficient length (>6 to 8 nucleotides) to be relatively 
resistant to abortion (Yan et al., 1999). TFIIF dissociates from early RNA Polymerase II 
elongation complexes shortly after Polymerase has synthesized 9 or 10 nucleotide long 
transcripts (Yudkovsky et al., 2000). 
Elongin was originally purified from rat liver nuclei by its ability to stimulate the 
rate of elongation by RNA polymerase II in vitro (Bradsher et al., 1993). Elongin is a 
heterotrimeric protein composed of a transcriptionally active Elongin A subunit and two 
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smaller Elongin B and Elongin C subunits. Elongin A can also act as the substrate 
recognition subunit of a Cullin-RING E3 ubiquitin ligase that has been shown to target Pol 
II stalled at sites of DNA damage (Harreman et al., 2009; Ribar et al., 2007; Yasukawa et 
al., 2008). 
ELL and its function will be discussed in the fourth section of this introduction. 
Polymerase associated factor complex (Paf1C) is another transcription elongation 
factor that coordinates the movement of Pol II through chromatin and the 
cotranscriptional processing and fate of nascent transcripts. It is composed of the 
proteins Paf1, Ctr9, Cdc73, Rtf1, and Leo1 (Wade et al., 1996). The Paf1C has been linked 
to a large and growing list of transcription related processes including: communication 
with transcriptional activators; recruitment and activation of histone modification factors 
(H2B ubiquitylation, H3K4/h3K36 methylation); facilitation of elongation on chromatin 
templates; and the recruitment of 3' end-processing factors necessary for accurate 
termination of transcription. It also acts as a regulator of promoter proximal pausing 
(Chen et al., 2016). 
 
1.2.D Termination and RNA processing 
Pol II transcripts are synthesized as precursors that are processed by capping, 
splicing, and 3’-end processing, which results in formation of 3’- polyadenylated transcripts 
(most mRNAs, some non-coding RNAs) or non-polyadenylated transcripts (Richard and 
Manley, 2009). In eukaryotes, the terminator signals are recognized by protein factors 
(cleavage and polyadenylation specificity factor (CPSF) and cleavage stimulation factor 
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(CstF)) which trigger the termination process. Once signals directing polyadenylation are 
transcribed, these factors recruit other proteins to the site to cleave the transcript, freeing 
the mRNA from the transcription complex, and add a string of about 200 A-residues to the 
3' end of the mRNA in a process known as polyadenylation. During these processing steps, 
the RNA polymerase continues to transcribe for several hundred to a few thousand bases 
and eventually dissociates from the DNA and downstream transcript.  
pre-mRNA transcripts synthesized are processed by addition of a 7-
methylguanosine cap at the 5’ end and splicing out of introns prior to transcription 
termination and export of the transcript from the nucleus. 
RNA capping of nascent transcripts takes place shortly after transcription 
initiation and is crucial for mRNA stability, splicing, polyadenylation, export and 
translation efficiency. In metazoans, a bifunctional capping enzyme with RNA 
triphosphatase and RNA guanylyltransferase activities binds to the phosphorylated CTD 
through the guanylyltransferase domain. This domain has two binding sites for 
phosphorylated CTD: one specific for the Ser2 phosphorylated CTD and the other, an 
allosteric activator site, for the Ser5 phosphorylated CTD (Ho and Shuman, 1999). In 
fission yeast it was shown that that recruitment of capping enzymes is the sole essential 
function of Ser5 as substitution of all Ser5 residues with Ala is lethal in S. pombe, but 
viability can be restored simply by tethering capping enzymes to the CTD (Schwer and 
Shuman, 2011). Capping enzyme can also bind to Spt5 (a subunit of DSIF) and Cdk9 (a 
component of P-TEFb) suggesting coordination between capping and control of early 
elongation, which may prevent productive elongation of uncapped transcripts (Pei et al., 
2003; Rasmussen and Lis, 1993). 
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Splicing of the pre-mRNA containing introns and transcription is coupled in cells. 
The spliceosome complex consists of snRNPs (small nuclear ribonucleoproteins) and 
other proteins (non-snRNPs) including members of the SR family. Hyperphosphorylated 
Pol II coimmunoprecipitates with both snRNPs and SR proteins suggesting a physical 
interaction between Pol II and the spliceosome (Kim et al., 1997).   
3’ end processing of RNA Pol II transcripts is also mediated by CTD 
phosphorylation. Polyadenylation of the 3’ end is a simple two-step reaction consisting of 
an endonucleolytic cleavage catalyzed by CPSF, followed by poly(A) tail synthesis on the 
cleaved transcript by polyadenylate polymerase, which binds CPSF. Polyadenylation 
serves to protect the 3’ end of the transcript from degradation and aids RNA export and 
translation.  Impairment of Ser2 phosphorylation by deletion of CTK1 in yeast (Ahn et al., 
2004) or treatment with the P-TEFb inhibitor flavopiridol in metazoan cells (Ni et al., 
2004) impairs recruitment of processing factors at the 3′ ends of genes and subsequent 
polyadenylation. The Polymerase continues to transcribe even after transcript cleavage 
until directed to terminate, but the resulting RNA is unmodified and quickly degraded. 
 
1.3 The Mediator complex 
A pivotal role is played by the multi-protein Mediator, which acts as a 
coregulatory complex for RNA Pol II (Myers and Kornberg, 2000). First isolated from 
Saccharomyces cerevisiae (Kelleher et al., 1990), Mediator is essential for the regulated 
basal transcription of all genes by Pol II (Takagi and Kornberg, 2006; Thompson and 
Young, 1995). Subsequent investigation to understand the mechanism of action of 
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Mediator has revealed that Mediator promotes activation of Pol II transcription via direct 
interactions with both DNA binding transcription factors and the Pol II preinitiation 
complex. Further studies have identified an array of Mediator surfaces capable of binding 
specifically to the transcription activation domains (TADs) of a large number of DNA 
binding transcription factors and to Pol II and several of the general factors (Conaway and 
Conaway, 2013). Mediator plays a role (i) in overcoming the activities of factors that 
negatively regulate elongation (Jishage et al., 2012; Malik et al., 2007), (ii) in recruiting 
Pol II transcription elongation factors and pre-mRNA processing factors (Donner et al., 
2010; Takahashi et al., 2011) and (iii) in controlling phosphorylation of the heptapeptide 
repeats in the Pol II C-terminal domain (CTD) (Boeing et al., 2010; Kim et al., 1994). 
 
1.3.A Mediator structure and function 
Whereas Mediator has some 30 subunits in humans (Sato et al., 2004), there are 
only 20 subunits in S. cerevisiae (Kim et al., 1994). Biochemical studies and 3D structure 
of budding yeast Mediator reveals that it consists of 3 submodules, referred to as the 
“Head”, “Middle”, and “Tail”. A fraction of the mediator in cells can also associate with an 
additional Kinase module having 4 subunits (MED12, MED13, Cyclin dependent kinase 
CDK8 and Cyclin C) (Asturias et al., 1999; Dotson et al., 2000).  Another fraction of 
Mediator that is free of the Kinase module can associate with Pol II to form what is called 
the “holoenzyme”. It has been suggested that the Kinase module must be displaced for 
the Mediator to interact with the Pol II  (Elmlund et al., 2006; Knuesel et al., 2009). 
Proteomic analysis helped to define a complete set of human Mediator subunits and 
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found that the metazoan holoenzyme includes an additional subunit known as MED26 
(Sato et al., 2004). A small population of mammalian mediator also contains both Kinase 
module and Med26. 
 
Figure 1.2 Mediator complex architecture. 
Figure is from (Robinson et al., 2015) Copyright © 2015, Robinson et al.   
S. cerevisiae Mediator subunit localization density map colored by individual subunit. 
 
 
Mediator can act both as a transcription activator and repressor. Experiments in 
both yeast and humans suggested that Mediator containing Kinase module contributes 
to the repression of Pol II transcription (Green and Johnson, 2004). The Mediator lacking 
the Kinase but containing the MED26 acts as an activator of transcription in mammalian 
cells and support activation of transcription in vitro. More recent studies, however, 
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reveal that cdk8 kinase activity is required for activation of a number of genes (Donner et 
al., 2007; Furumoto et al., 2007). 
 
1.3.B Role of Mediator in transcription elongation 
An early report showing the recruitment of Mediator to Drosophila heat shock 
genes only upon heat shock coinciding with the release of constitutively paused Pol II 
(Park et al., 2001), suggested that Mediator may have roles in transcription elongation. It 
was later observed in mouse ES cells that deletion of Med 23 interfered with the 
recruitment of Mediator and resulted in a failure to release paused pol II (Wang et al., 
2005). Also, Mediator subunits can be detected by ChIP not only at promoters but also 
within the transcribed regions of genes in both yeast and human cells (Takahashi et al., 
2011; Zhu et al., 2006). 
A role of Mediator in the regulation of transcript elongation has emerged as it 
helps in overcoming promoter proximal pausing caused by factors like DSIF and NELF 
(Wada et al., 1998; Yamaguchi et al., 1999), by recruiting the elongation factors to the 
genes and controlling the phosphorylation state of the C- terminal domain of the largest 
Pol II subunit (Donner et al., 2010; Takahashi et al., 2011).  
Studies suggest an interaction between P-TEFb and the Kinase module, and 
depletion of CDK8 reduced both P-TEFb recruitment and Pol II CTD phosphorylation 
(Donner et al., 2010). Mediator subunit MED23 also regulates basal transcription in vivo 
via an interaction with P-TEFb (Wang et al., 2013). 
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In metazoa, the MED26 subunit of Mediator acts as a docking site for elongation 
factors and super elongation complexes (SEC) (Takahashi et al., 2011). N-terminal domain 
(NTD) of Med 26 can bind directly to the SEC via its EAF subunit, hence Mediator 
supports activator dependent recruitment of ELL-EAF-containing complexes, including 
SEC, to promoter DNA in vitro (Takahashi et al., 2011). TFIIS, Elongin A and IWS1 all have 
a domain closely resembling the Med 26 NTD and have roles in Pol II elongation. MED26 
NTD also interacts with general transcription factor TFIID during initiation and hence may 
contribute to the switch of Pol II from initiation to productive elongation (Takahashi et 
al., 2011). 
 
1.4 ELL protein 
ELL stimulates transcription elongation in vitro and has been shown to interact 
physically with Pol II (Shilatifard et al., 1997c). ELL was first purified from rat liver nuclear 
extracts as an ~80kDa single polypeptide that can increase the rate of transcription by Pol 
II in vitro by suppressing transient pausing by Polymerase at multiple places along the 
DNA (Shilatifard et al., 1996). Two homologues of ELL have since been identified in 
humans, ELL2 (Shilatifard et al., 1997b) and ELL3 (Miller et al., 2000). 
How ELL stimulates elongation by Pol II has not been unequivocally determined. 
Based in part on the observation that ELL and other transcription factors with similar 
activities, including Elongin and TFIIF, can inhibit TFIIS induced nascent transcript 
cleavage by non-arrested RNA Polymerase II elongation intermediates (Elmendorf et al., 
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2001), it has been proposed that such factors suppress pausing by preventing 
displacement of the 3'-end of the nascent transcript from the polymerase catalytic site. 
 
 
 
Figure 1.3 The human ELL protein. 
The locations of the regions indicated in the figure are described: ELL full length gene, lysine rich region and 
translocation breakpoint (Thirman et al., 1994), regions required for stimulation of transcription elongation  
(Shilatifard et al., 1997c), occludin like domain  (Shilatifard, 1998a), regions involved in EAF1 and EAF2 
binding (Simone et al., 2003). 
 
Structure-function studies have defined a number of functional domains in ELL 
(Figure 1.3), including regions needed for stimulation of elongation and a small N-
terminal region that is dispensable for elongation activity but can interfere with 
promoter-specific transcription initiation by Pol II (Shilatifard et al., 1997a).  In humans 
and other metazoan organisms, ELL protein has a C-terminal domain similar to occludin, a 
membrane protein which localizes to tight junctions. The occludin-like domain is not 
required for ELL elongation activity in vitro (Shilatifard, 1998b). Other regions have been 
mapped including regions required for binding to ELL-associated factors (EAFs) and 
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regions that have found to inhibit transcription initiation or stimulate transcription 
elongation.  
The earliest information about in vivo functions of ELL came from studies in 
Drosophila.  The Drosophila gene encoding the ELL homolog Suppressor of Triplo-lethal 
(Su(Tpl)) is essential for viability in flies.  Loss of ELL gives rise to embryonic segmentation 
defects (Eissenberg et al., 2002).  Some alleles of Su(Tpl) suppress lethality resulting from 
overexpression of the Tpl gene, perhaps by impairing synthesis of Tpl mRNA (Eissenberg 
et al., 2002). Drosophila ELL colocalizes with Pol II at transcriptionally active sites on 
polytene chromosomes, and it was proposed that mutations in Su(Tpl) might 
preferentially affect synthesis of some long transcripts (Gerber et al., 2001). Although the 
Pol II CTD is not required for Pol II binding or function of ELL in vitro, reduced 
phosphorylation after knockdown of the cdk9 subunit of P-TEFb in Drosophila resulted in 
decreased binding of dELL, suggesting CTD phosphorylation could contribute to ELL 
recruitment (Eissenberg et al., 2007). Like the Cdk9 subunit of P-TEFb and the Spt5 
subunit of DSIF, a substantial amount of dELL colocalizes with phosphorylated Pol II on 
polytene chromosomes at transcriptionally active puff sites and relocalizes to heat shock 
genes upon heat shock (Thirman et al., 1997), consistent with the idea that ELL functions 
as elongation factor in vivo.  
In C. elegans ELL and EAF proteins play important roles in fertility, survival and 
body size regulation, in part by regulating the cuticle synthesis, suggesting ELL-EAF may 
help in the regulation if the extracellular matrix components (Cai et al., 2011). In Xenopus 
laevis, EAF2 protein functions during eye development to activate transcription of the 
gene encoding the essential Rx homeodomain transcription factor (Maurus et al., 2005). 
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ELL2 also plays an important role in immunoglobin secretion in plasma cells. It 
directs efficient alternative mRNA processing, influencing both proximal poly(A) site 
choice and exon skipping with genes encoding immunoglobulin heavy chain complex 
(IgH) (Martincic et al., 2009). Reducing ELL2 by siRNA, which reduced processing to the 
secretion-specific poly(A) site, also influenced the methylations of histone H3K4 and 
H3K79 on the IgH gene and impacted positive transcription factor b (P-TEFb), Ser-2 
carboxyl-terminal phosphorylation, and polyadenylation factor additions to RNA 
Polymerase II (Milcarek et al., 2011). 
 
 
1.4.A The MLL-ELL chimera in leukemia  
The human ELL gene was initially identified as a gene that undergoes fusion to the 
MLL gene in t(11;19)(q23;p13.1) translocations in acute myeloid leukemia (Thirman et al., 
1994). It was named ELL for eleven-nineteen lysine-rich in leukemia. A highly basic, 
lysine-rich motif of the ELL protein is homologous to similar regions of several proteins, 
including the DNA-binding domain of poly(ADP-ribose) polymerase.  
Chromosomal translocations involving the MLL and ELL genes generate a chimeric 
MLL-ELL gene that encodes a fusion protein that contains the entire ELL elongation 
activation domain and the occludin-like domain, but that lacks the first 45 N-terminal 
amino acids of the ELL protein. ELL can inhibit transcription initiation in vitro as it 
contains a Pol II interacting domain capable of negatively regulating polymerase activity 
in promoter-specific manner. In MLL-ELL translocation a portion of this functional domain 
is deleted, and ELL mutants lacking sequences deleted by the translocation bind RNA 
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polymerase II and are fully active in elongation, but fail to inhibit initiation (Shilatifard et 
al., 1997c) 
MLL family of proteins are H3K4 methyltransferases. The H3K4 methyl mark is 
widely associated with gene activation. MLL proteins have N-terminal AT-hooks and a 
catalytic SET domain at the C-terminal (Tkachuk et al., 1992). Apart from H3 K4 
methyltransferases in mammals, several (hSET1 MLL1, MLL2) have been found in large 
complexes. While sharing some subunits (e.g., Ash2L and WDR5), these complexes 
nevertheless contain unique sets of proteins that suggest nonoverlapping functions 
(Vedadi et al., 2017). The MLL gene is a recurrent site of genetic rearrangements 
associated with childhood hematological malignancies (Mohan et al., 2010). 
Translocations involving MLL can generate in-frame fusions of MLL with over 50 different 
partner genes, among which are the MLL fusion partners, AF9 family members AF9 and 
ENL, and the AF4/FMR2 family members AFF1 and AFF4. The critical feature of these 
chromosomal rearrangements is the generation of a chimeric transcript consisting of 5′ 
MLL and 3′ sequences of the gene on the partner chromosome (Luo et al., 2012). No 
consistent homologies or motifs among the partner gene sequences have been identified 
that might explain how their fusion to MLL results in leukemia. EAF1 contains a limited 
region of homology with the AF4, LAF4, and AF5q31 proteins that fuse to MLL in 11q23 
chromosome translocations. This domain is rich in serine, aspartic acid, and glutamic acid 
residues and has been shown to activate transcription. 
 
The MLL-ELL chimera causes immortalization when introduced into hematopoietic 
progenitor cells, which in turn causes acute myeloid leukemia when the cells are 
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transplanted into mice (Lavau et al., 2000). The chimeric MLL-ELL protein that results 
from the (11;19)(q23;p13.1) translocation contains the amino-terminal region of MLL, 
including its AT hooks, methyltransferase domain, and repression domain, fused to 
amino acids 46 to 621 of ELL, including its elongation domain, lysine-rich region, and 
occludin homology domain. Structure -function analyses of MLL-ELL chimera indicate that 
although the ELL Occludin-like CTD is sufficient for immortalization of hematopoietic 
precursors in vitro, both the ELL elongation activation domain near the N-terminus of the 
protein and Occludin-like C-terminus appear to contribute to oncogenesis induced by the 
MLL-ELL fusion protein in mice (DiMartino et al., 2000; Luo et al., 2001). 
 
1.4.B ELL-associated Factors (EAF) 
Two homologous proteins, EAF1 and EAF2, have been identified that interact 
directly with human ELL and positively regulate ELL elongation activity in vitro (Kong et 
al., 2005; Simone et al., 2001; Simone et al., 2003). EAF 1 and 2 bind directly to ELL and 
are positive regulators of ELL elongation activity (Kong et al., 2005).  
Binding to the EAF proteins protein is achieved through regions in both N and C 
termini of ELL (for EAF1) or through the C terminus only (for EAF2). Upregulation of ELL 
elongation activity in vitro requires only the N terminal region of EAF1 (Conaway lab 
(Charles Banks) unpublished data).  In addition to stimulating ELL activity, the C terminus 
of EAF1 contains an acidic transactivation domain which, when fused to a GAL4 DNA 
binding domain, will stimulate transcription from template containing GAL4 binding sites 
in whole cell extracts (Simone et al., 2001).   
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In mammalian cells, EAF1, EAF2, and ELL are colocalized in Cajal bodies, nuclear 
structures that are enriched in factors involved in transcription and mRNA processing 
(Gall et al., 1999). 
 
1.4.C ELL as a part of SEC 
A number of labs found the association of ELL family members with other 
elongation factors. Using sequential affinity-purification it was shown that human 
transcription factors/coactivators AFF4, ENL, AF9, and elongation factor ELL2 are 
components of the Tat-P-TEFb complex (He et al., 2010). A related study found that HIV-1 
Tat assembles a multifunctional transcription elongation complex consisting of core 
active P-TEFb, MLL-fusion partners involved in leukemia (AF9, AFF4, AFF1, ENL, and ELL), 
and PAF1 complex (Sobhian et al., 2010). Detailed biochemical purifications of some of 
the most frequently occurring MLL chimaeras resulted in the isolation of the super 
elongation complex (SEC) (Lin et al., 2010). The SEC contains the ELL family members 
ELL1, ELL2 and ELL3, along with ELL associated factors EAF1 or EAF2, the MLL 
translocation partners AF4/FMR2 family member 1 (AFF1; also known as AF4), AFF4, 
eleven-nineteen leukemia (ENL) and ALL1-fused gene from chromosome 9 (AF9), and the 
Pol II elongation factor P-TEFb (Lin et al., 2010). The SEC was also independently 
identified as a complex that binds Mediator through the Mediator subunit Med26 
(Takahashi et al., 2011). 
P-TEFb is a kinase composed of cyclin-dependent kinase 9 (CDK9) as a catalytic 
subunit and cyclin T1 (CYCT1) or CYCT2 as a regulatory subunit. P-TEFb phosphorylates 
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the Pol II CTD, NELF and the Spt5 subunit of DSIF and hence stimulates the dissociation of 
NELF from Pol II. NELF dissociation allows Pol II to enter the phase of productive 
elongation (Lis et al., 2000; Marshall et al., 1996; Peterlin and Price, 2006; Wei et al., 
1998). Most P-TEFb in cells is sequestered in an inactive complex with the 7SK snRNA and 
the proteins HEXIM1 or HEXIM2, LARP7 and MEPCE (Zhou et al., 2012). Upon receipt of 
cellular signals, P-TEFb is released from the 7SK snRNP complex, allowing it to interact 
with bromodomain-containing protein 4 (BRD4) or to incorporate into the SEC. 
AFF4 is required for SEC stability and proper transcription by poised RNA 
polymerase II in metazoans. Knockdown of AFF4 in leukemic cells leads to a reduction in 
MLL chimera target gene expression, suggesting that AFF4/SEC could be a key regulator 
in the pathogenesis of leukemia through many of the MLL partners (Lin et al., 2010). AFF4 
is known to act as a scaffolding protein which uses separate domains to bind different 
SEC subunits. It promotes the interaction between ELL2 and P-TEFb and helps maintain 
the integrity of SEC. AFF1 has been shown to interact with AFF4 (Yokoyama et al., 2010), 
though it is not clear whether the interaction between these two paralogous proteins can 
exist in a single SEC complex. AF9, AF10, and ENL have been shown to act as positive 
regulators of P-TEFb activity. They also interact directly with the histone 
methyltransferase Dot1, leading to the suggestion that Dot1-mediated methylation of 
H3K79 could be central to leukemogenesis in patients with MLL translocations (Bitoun et 
al., 2007; Mueller et al., 2007; Mueller et al., 2009). The AF9 YEATS domain binds strongly 
to histone H3K9 acetylation and, to a lesser extent, H3K27 and H3K18 acetylation, which 
is important for the chromatin recruitment of the H3K79 methyltransferase DOT1L. 
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However, how H3K79 methylation by Dot1 could lead to gene activation is not known. 
Dot1 neither resides in nor associate with SEC.  
Reports suggest that ELL facilitates Pol II pause site entry and release, as loss of 
ELL destabilizes the pre-initiation complexes and results in disruption of early elongation 
and promoter proximal chromatin structure before recruitment of AFF4 and other super 
elongation complex components. These changes result in significantly reduced 
transcriptional activation of rapidly induced genes (Byun et al., 2012). 
Recently, in both D. melanogaster and mammals ELL was found to be part of a 
second complex named LEC (little elongation complex), which contains ICE1 (interacts 
with the C terminus ELL subunit 1; also known as KIAA0947) and ICE2 (also known as 
NARG2) (Smith et al., 2011; Takahashi et al., 2011). LEC plays a role in the expression of 
Pol II- transcribed snRNA genes (Hu et al., 2013; Smith et al., 2011; Takahashi et al., 
2015). LEC also has been implicated in the resumption of transcription after DNA repair 
(Mourgues et al., 2013a).  ELL, EAF1, ICE, and ICE2 were all identified in a proteomic 
screen for proteins that interact with the transcription / DNA repair factor TFIIH.  ELL was 
shown to be recruited to UV-damaged chromatin dependent on the TFIIH-associated 
protein kinase Cdk7.  In this study, ELL depletion was seen to hinder Pol II transcription 
resumption after lesion removal and DNA gap filling and increase Pol II retention to the 
chromatin. 
 
43 
 
1.4.D Recruitment of SEC 
SEC can be recruited to genes it regulates by a variety of mechanisms. In HIV-1-
infected cells, Tat activates HIV-1 transcription by recruiting P-TEFb, ELL/EAF, and SEC 
family members through interactions with the TAR sequence in the 5′ end of the nascent 
HIV-1 transcript (Peterlin and Price, 2006; Sobhian et al., 2010). Tat also promotes SEC 
formation, which in turn stabilizes ELL2, an otherwise short-lived protein rapidly 
degraded by the proteasome. MLL–SEC is formed following translocation of MLL to any of 
the genes encoding SEC components. DNA binding domain of MLL help deliver the SEC to 
the MLL-target genes and hence achieve aberrant activation of MLL chimaera target 
genes through misregulation of transcriptional elongation checkpoint control (TECC) 
(Mueller et al., 2009). 
In Human cells, MED26 functions in part by recruiting ELL/EAF- and P-TEFb-containing 
complexes, including the SEC to promoters of a subset of genes via a direct interaction 
with the N-terminal domain (NTD) of MED26. EAF1 and EAF2 can bind directly to the NTD 
of Med26. The MED26 NTD also binds TFIID, and TFIID and elongation complexes interact 
with MED26 through overlapping binding sites suggesting that MED26 NTD may function 
as a molecular switch that contributes to the transition of Pol II into productive 
elongation (Takahashi et al., 2011). 
The YEATS domain of ENL/AF9 can also help target SEC to Pol II on chromatin 
through contacting the human Polymerase-Associated Factor complex (PAFc) complex 
(He et al., 2011). 
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The metazoan-specific Mediator subunit MED23 also helps in the recruitment of 
elongation factor P-TEFb, via an interaction with its CDK9 subunit (Wang et al., 2013). 
Whether this interaction can help in recruitment of SEC to genes is not known.  
 
Figure 1.4 Cartoon showing mechanisms of Transcriptional Regulation by SEC. 
The metazoan Super Elongation Complex can be recruited to genes by the Mediator through interaction 
with its subunits Med 26and Med23. SEC can help the paused polymerase to go into productive elongation 
 
1.4.E Other functions of ELL 
ELL can specifically interact with the p53 tumor suppressor protein by 
mechanisms that remain unclear. ELL acts as a negative regulator of p53 in transcription. 
p53 also inhibits the transcription elongation activity of ELL, suggesting the existence of a 
mutually inhibitory interaction between p53 and ELL. Elevated levels of ELL in cells 
resulted in the inhibition of p53-dependent induction of endogenous p21 and 
substantially protected cells from p53-mediated apoptosis that is induced by genotoxic 
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stress (Shinobu et al., 1999). ELL may also serve as a transcriptional factor to directly 
induce transcription of the thrombospondin-1 (TSP-1) gene, which encodes for an anti-
angiogenic protein (Zhou et al., 2009). 
 ELL has been proposed to also function as an E3 ubiquitin ligase and target c-Myc 
for proteasomal degradation. UbcH8 serves as a ubiquitin-conjugating enzyme in this 
pathway. ELL-mediated c-Myc degradation inhibits c-Myc-dependent transcriptional 
activity and cell proliferation, and also suppresses c-Myc-dependent xenograft tumor 
growth (Chen et al., 2016).  
 
1.5 S. pombe as a model system  
S. pombe, often known simply as “fission yeast,” is an ascomycete yeast. As 
eukaryotes, these yeasts can be used to study processes that are conserved from yeast to 
humans but absent from bacteria, such as organelle biogenesis and cytoskeletal 
organization, or to study mechanisms such as transcription, translation, and DNA 
replication, in which the eukaryotic components and processes are significantly different 
from those of their bacterial counterparts (Hoffman et al., 2015). Both 
Schizosaccharomyces pombe and its distant cousin Saccharomyces cerevisiae have been 
studied extensively and have led to the discovery of various genes involved in 
fundamental mechanisms of cellular processes. S. pombe and S. cerevisiae share 
substantial gene content, with ~75% of S. pombe genes having one or more recognizable 
orthologs in S. cerevisiae. Nevertheless, these species are separated by as much as 1 
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billion years of evolution (Hedges, 2002) and therefore, not surprisingly, the biology of 
these two organisms is dissimilar in several important ways. For example, S. pombe cells 
divide by medial fission, a process analogous to the division of cells in many metazoan 
organisms, whereas S. cerevisiae cells divide by budding. Furthermore, in S. pombe, 
mating and meiosis are tightly coupled, such that only the zygote is ever a diploid, and 
even here only transiently. By contrast, in S. cerevisisae, mating and meiosis are not 
coupled, and this organism prefers the diploid state. Species-specific gene gains and 
losses are also apparent. Specifically, genes required for functional complexes involved in 
pre-mRNA splicing, RNAi-mediated heterochromatin silencing, and signalosome function 
are present in S. pombe (and other metazoan organisms, including humans) but lost in S. 
cerevisiae (Aravind et al., 2000; Clarke, 1990). The structure of the centromeres in S. 
pombe is also considerably more complex and metazoan-like in comparison to the 
relatively simple centromeres of S. cerevisiae (Clarke, 1990). Genome-wide microarray, 
protein localization, and proteomic analyses suggest moderate conservation between the 
expression, accumulation, and subcellular localization of orthologous gene products and 
proteins in these two yeasts (Matsuyama et al., 2006). Since the divergence of the two 
species approximately 350 million years ago, S. pombe appears to have evolved less 
rapidly than S. cerevisiae so that it retains more characteristics of the common ancient 
yeast ancestor, causing it to share more features with metazoan cells. S. pombe also uses 
some enzyme systems or components of systems that are not present in S. cerevisiae, for 
example RNA interference and parts of the spliceosome. 
Basic transcription machinery is conserved from yeast to humans. Previous data 
from our lab identified genes in S. pombe encoding proteins similar to ELL and EAF, which 
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are not present in S. cerevisiae (Banks et al., 2007). Like their mammalian counterpart, 
SpELL-SpEAF interact with each other and stimulates RNA Polymerase II transcription 
elongation and pyrophosphorolysis in vitro. Hence fission yeast serves as a simpler 
system to genetically, biochemically and genomically study molecular mechanism 
elongation complexes. 
 
1.6 Scope of this thesis 
1.6.A Using fission yeast to explore the role of mediator and ELL complex in 
cells 
The Mediator complex isolated from the fission yeast Schizosaccharomyces 
pombe contains orthologs of the Head and Middle subunits of S. cerevisiae. However, 
subunits corresponding to the Tail module (MED2, MED3, MED5, MED15 and MED 16) 
were not found to be associated with this complex in S. pombe (Beve et al., 2005a; Spahr 
et al., 2001). The Tail module is important for the interaction of S. cerevisiae and 
metazoan Mediator with the DNA binding transcriptional activators (Myers et al., 1999). 
Even though S. pombe Mediator appears to lack the Tail domain, the genome of S. pombe 
encodes a putative MED15 ortholog (Linder et al., 2008a). S. pombe MED15 is reported to 
exist in a protein complex along with Hrp1, a CHD1 family ATP dependent chromatin 
remodeling protein (Khorosjutina et al., 2010). In addition, cryo-EM studies of the 
purified S. pombe Mediator complex were consistent with the idea that it may include 
only the Head and Middle domains (Elmlund et al., 2006). 
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ELL and EAF orthologs were not identified in fungi until recently. Previous data 
from our lab identified genes in S. pombe similar to ELL and EAF (ell1+ and eaf1+), which 
are not present in S. cerevisiae. Ell1 and Eaf1 from S. pombe also interact with each other 
to form a heterodimer and can positively regulate transcription by Pol II (Banks et al., 
2007). The mechanism of their recruitment in fungi has not been studied, and whether 
Mediator plays a role in it remains to be determined. Like many other elongation factors 
in yeast, deletion of the ell1+ gene in cells makes them sensitive to the drug 6-azauracil 
(Banks et al., 2007).  
Fission yeast is a valuable model system, having the advantage that it is easy to 
manipulate genetically and hence provides an excellent model for studying the regulation 
by Ell1 and Eaf1 in vivo and for exploring the potential roles of Mediator in orchestrating 
their activity. It has homologues of P-TEFb, raising a possibility that it may have 
complexes similar to mammalian super elongation complex (SEC).  
 
1.6.B Questions to be addressed 
Motivated by evidence that Mediator helps to regulate ELL function in metazoa, I 
initiated my thesis research with the goal of exploring potential connections between the 
Mediator complex and the functioning of Ell1 and Eaf1 in S. pombe. An essential first step 
in addressing this question was to understand the composition of S. pombe Mediator, 
which had not yet been established. Accordingly, this thesis begins by defining the 
Mediator complex of fission yeast by MudPIT proteomic analysis, in Chapter 2. I find a 
previously uncharacterized Tail module subunit that associate with the S. pombe 
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Mediator.  Also, other subunits were identified that were not shown to be components 
of S. pombe Mediator. 
The second goal of my work was to determine whether S. pombe Ell1 and Eaf1 
function as components of larger complexes, possibly related to SEC or LEC. In Chapter 3, 
I demonstrate that S. pombe Ell1 and Eaf1 associate with a new protein that is a 
‘sequence orphan’, having no substantial similarity to any known protein. We refer to 
this protein as ‘ELL binding protein 1 or Ebp1’ as it interacts directly with Ell1. Although I 
was unable to detect Ebp1’s effect on transcription elongation in vitro, results of my 
ChIP-seq experiments show that Ell1, Eaf1 and Ebp1 colocalize along with Pol II 
genomewide. It is consistent with the idea that they function together.  
In Chapter 4, I use ell1Δ, eaf1Δ and ebp1Δ deletion mutant strains to study the 
consequences of loss of these proteins in cells, by studying their growth phenotypes in 
various conditions and by performing RNA-seq experiments and PRO-Seq experiments. I 
also performed a large scale genetic screen called ‘Synthetic Genetic Array’ (SGA) to 
identify genes that genetically interact with the genes encoding Ell1, Eaf1 and the Ebp1, 
as described in Chapter 5. Some preliminary data also suggests role of Ell1 in 
subtelomeric heterochromatin formation, which has been described in more detail in 
Chapters 4 and 5. 
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CHAPTER 2: Defining the S. pombe Mediator 
2.1 Introduction 
The S. pombe mediator has been shown to contain orthologs of all of the S. 
cerevisiae Head and Middle subunits except Med9; however, subunits corresponding to 
the Tail module (MED2, MED3, MED5, MED15 and MED 16) were not found to be 
associated with this complex in S. pombe (Beve et al., 2005b; Spahr et al., 2001). The Tail 
module is thought to be important for the interaction of mediator with DNA binding 
transcriptional activators (Myers et al., 1999). Even though S. pombe Mediator appears to 
lack the Tail domain, the genome of S. pombe encodes a putative MED15 ortholog 
(Linder et al., 2008b) that had not been shown to be associated with Mediator but was 
reported to exist in a protein complex along with Hrp1, a CHD1 family ATP dependent 
chromatin remodeling protein (Khorosjutina et al., 2010).  Accordingly, it had been 
suggested that Mediator may influence gene chromatin structure by directly influencing 
the activity of the Hrp1 protein. Until recently, structural analysis of the S. pombe 
Mediator also only revealed the presence of a Head and Middle domain (Elmlund et al., 
2006).  
We wanted to know whether we could use S. pombe to study the functional 
interplay between Mediator and super elongation complex, as Ell1 and Eaf1 are also 
present in S. pombe.  To address that question we first needed define the composition of 
S. pombe mediator.  We were particularly interested in determining whether S. pombe 
mediator might be associated with a subunit that is related to the metazoan SEC-binding 
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subunit MED26, but so divergent in sequence as to be difficult to detect 
bioinformatically.  I started by tagging few subunits (Med4 and Med 7) with endogenous 
Flag tag and performing Flag immunoprecipitations followed by MudPIT mass 
spectrometry. The Tail subunit Med15 was seen to be associated with the purified 
mediator complex. We also identified two ‘sequence orphan’ proteins that always 
copurified with the mediator complex. Analysis of their sequence showed a weak 
sequence similarity with Mediator subunits called Med 2 and Med 9. Notably Med 2 is a 
component of the Tail module. Though we identified neither a Med26-like subunit nor 
any SEC components in association with Mediator, we were able to provide the first 
comprehensive definition of the S. pombe Mediator. We collaborated with Francisco J. 
Asturias’ Lab, which obtained a 4.4 Å cryo-electron microscopy map of the S. pombe 
Mediator in which conserved Mediator subunits are individually resolved (Tsai et al., 
2017). The structural studies further helped to resolve the role of essential Med14 
subunit as a central backbone that connects the Mediator Head, Middle and Tail 
modules. 
 
2.2 Identification of Mediator subunits in S. pombe 
To characterize the composition of Mediator complex in S. pombe I first selected 
two of its known subunits, Med7 and Med4, and endogenously tagged them with a 3X 
Flag tag at their C termini. After growing cells in rich media, Med7-FLAG and Med4-FLAG 
associated proteins were purified from lysates using anti-FLAG agarose immunoaffinity 
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chromatography. Mass spectrometry using multi-dimensional protein identification 
technology (MudPIT) was used to identify the proteins copurifying with Med4 and Med7. 
Chromatography-based proteomic techniques like Multidimensional Protein 
Identification Technology (MudPIT) offer significant advantages over gel-based proteomic 
approaches for analysis of large, relatively fragile complexes such as the S. pombe 
Mediator. After digestion, protein samples are loaded directly onto a triphasic 
microcapillary column packed with reversed phase, strong cation exchange, and reversed 
phase HPLC grade materials. This column is then placed directly in-line with a tandem 
mass spectrometer that generates data to determine the total protein content of the 
original sample.  This approach often allows detection of lower abundance proteins 
and/or proteins that are not readily visualized in SDS gels among the background of 
contaminant proteins that are often found in immunopurified samples (Wolters et al., 
2001).  MudPIT mass spectrometry was instrumental for defining the full complement of 
mammalian Mediator subunits (Sato et al., 2004). 
Table 2.1 shows a list of all the Mediator subunits units identified from mass 
spectrometry. It is interesting to note that Med15 ortholog in S. pombe, that was earlier 
reported not to be associated with Mediator also copurifies in all the samples tested. 
Apart from the annotated subunits and Med15, there are two sequence orphans that 
also show up in all the samples in very high amounts. None of these subunits were 
present in the control samples that were FLAG-immunopurified proteins from the 
standard parental 972h- strain.  
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Also, various subunits of the RNA Polymerase II were pulled down along with the 
Mediator suggesting a portion of it was purified as a holoenzyme (data not shown). 
 
 
Table 2.1 Identification of S. pombe Mediator subunits in Med4-FLAG and Med7-FLAG SpMED 
preparations by MudPIT mass spectrometry. 
This table shows the distributed normalized spectral abundance factor (dNSAF) for each Mediator subunit 
copurifying with S. pombe FLAG- Med4, and Med7. Control samples are FLAG-immunopurified proteins 
from the standard parental 972h- strain. dNSAF values provide a measure of the relative amount of the 
same protein across several different samples, but only a rough estimate of the relative amounts of each 
protein detected in a MudPIT data set. 
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2.3 Association of Med15 with Mediator  
Med15 protein had been previously suggested not to be a component of the S. 
pombe Mediator; however, our Flag purifications using FLAG- Med4 and Med7 identified 
it as a likely Mediator-associated protein.   
To further confirm this interaction, I Flag tagged endogenous Med15 and 
performed Flag purification followed by MudPIT analysis. Table 2.2 (lanes 1-2) shows that 
most of the annotated subunits of Mediator along with the two sequence orphans 
corresponding to MED2 and MED9 copurified with Med15. The yield of Mediator 
subunits was relatively low (based on dNSAF) in MED15-purified fractions, an observation 
that could be explained if MED15 tends to dissociate from Mediator or if the C-terminal 
tag is relatively inaccessible when MED15 is assembled into Mediator.  This could provide 
an explanation why Mediator subunits were not detected in previous analyses of MED15-
associated proteins using methods less sensitive than MudPIT. 
It is interesting to note that the chromatin remodeling protein, Hrp1, which was 
previously reported to form a complex with Med15, was also identified in these samples 
(Table 2.2, last row). However, the protein has almost similar abundance in the control 
samples having no Flag tag (last row, lanes 4-6), raising the possibility that Hrp1 might 
bind non-specifically to FLAG-agarose rather than being a bona fide Med15- or Mediator-
binding protein.   
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Table 2.2 Identification of S. pombe Mediator subunits in Med15-FLAG and Med2-FLAG SpMED 
preparations by MudPIT mass spectrometry. 
Similar to Table 2.1, this table shows the dNSAF for each Mediator subunit copurifying with S. pombe FLAG- 
Med15, and putative Med2. Control samples are FLAG-immunopurified proteins from the standard 
parental 972h- strain.  
 
 
2.4 Characterization of ‘sequence orphan’ Mediator subunits  
Two sequence orphans copurify in all the Mediator preparations, that had never been 
shown experimentally to be Mediator subunits. To confirm the association of these 
Common Name NCBI Locus Tag
MED15-
FLAG_
1
dNSAF
MED15-
FLAG_
2
dNSAF
MED2-
FLAG_
1
dNSAF
FLAG-
cont_
1
dNSAF
FLAG-
cont_
2
dNSAF
FLAG-
cont_
3
dNSAF
MED1 SPAC2F7.04 0.0001 0.0000 0.0250 X X X
sequence orphan (MED2) SPCC4F11.03c 0.0007 0.0001 0.0303 X X X
MED4 SPBC1105.06 0.0003 0.0004 0.0614 X X X
MED6 SPAC1002.15c 0.0000 0.0002 0.0248 X X X
MED7 SPBC14F5.08 0.0001 0.0002 0.0279 X X X
MED8 SPBC21.04 0.0004 0.0004 0.0185 X X X
sequence orphan (MED9) SPAC24C9.04 0.0002 0.0006 0.0943 X X X
MED10  SPBC31F10.09c 0.0008 0.0002 0.0215 X X X
MED11 SPAC644.10 0.0005 0.0005 0.0602 X X X
MED14 SPBC1A4.10c 0.0002 0.0000 0.0323 X X X
MED15 SPBC146.01 0.0209 0.0072 0.0303 X X X
MED17 SPBC31F10.04c 0.0002 0.0001 0.0388 X X X
MED18 SPAC5D6.05 X 0.0001 0.0163 X X X
MED19 SPCC1450.05c 0.0003 0.0004 0.0202 X X X
MED20 SPAC17G8.05 0.0001 0.0002 0.0199 X X X
MED21 SPBC1604.10 0.0005 0.0002 0.0256 X X X
MED22 SPAC29A4.07 0.0003 0.0003 0.0410 X X X
MED27 SPAC17C9.05c 0.0007 0.0002 0.0277 X X X
MED31 SPCP31B10.03c 0.0001 0.0001 0.0188 X X X
MED12 SPAC688.08 0.0000 0.0000 0.0043 X X X
MED13 SPAC589.02c 0.0002 X 0.0087 X X X
CDK8 SPAC23H4.17c X X 0.0023 X X X
Cyclin C SPBC12D12.06 X X 0.0008 X X X
hrp1 SPAC1783.05 0.0261 0.0218 0.0128 0.0245 0.078 0.0525
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putative Mediator subunit, I flag-tagged one of them (endogenous SpSPCC4F11.03c) at C 
terminal and did Flag purification followed by MudPIT analysis. And it pulls out all known 
Mediator subunits with Med15 and the other sequence orphan (Table 2.2). Taken 
together, that suggests all are Mediator subunits. 
We could not use standard psi-blast to identify sequence orphans as orthologs of 
Mediator subunits in other species.  Using sophisticated multi-sequence alignment 
approaches, Bourbon had proposed that the two sequence orphans might be Med2 and 
Med9, but relationship was quite distant, and it wasn’t at all clear whether they really 
were (Bourbon, 2008).  Figure 2.1 and 2.2 show a simplified version of the alignment 
published by Bourbon of Med2 and Med9 across many species, also having putative 
Med2 and Med9 of S. pombe (encoded by SPCC4F11.03c and SPAC24C9.04 in S. pombe, 
respectively). 
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Figure 2.1 Structural conservation of predicted Mediator subunit Med2 among yeast. 
Figure derived from (Bourbon, 2008; Tsai et al., 2014).  Primary sequences of few fungal 
(Schizosaccharomyces pombe(SP), Saccharomyces cerevisiae(SC), Candida albicans(CA), Neurospora 
crassa(NC), Aspergillus nidulans(AN)) MED2 subunits identified through PSIBlast or TBlastN analyses were 
aligned using MAFFT and colored with JALVIEW based on conservation across these species. Bottom panel 
shows the consensus sequence predicted based on conservation 
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Figure 2.2 Structural conservation of predicted Mediator subunit Med9. 
Figure derived from (Bourbon, 2008; Tsai et al., 2014).  Primary sequences of few fungal 
(Schizosaccharomyces pombe(SP), Saccharomyces cerevisiae(SC), Candida albicans(CA), Neurospora 
crassa(NC), Aspergillus nidulans(AN)) MED2 subunits identified through PSIBlast or TBlastN analyses were 
aligned using MAFFT and colored with JALVIEW based on conservation across these species. Bottom panel 
shows the consensus sequence predicted based on conservation 
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2.5 Structural studies on S. pombe Mediator 
By defining for the first time the complete repertoire of S. pombe Mediator 
subunits, our proteomic analysis of S. pombe Mediator provided information essential for 
interpretation of cryo-electron microscopy-based structural studies S. pombe Mediator 
performed in the laboratory of Francisco Asturias. Cryo-EM experiments performed by 
Kuang-Lei Tsai in Asturias Lab (Department of Integrative Structural and Computational 
Biology, The Scripps Research Institute). These cryo-EM studies localized specific 
Mediator subunits and defined in unprecedented detail the molecular architecture of the 
Mediator complex. As discussed above, my work led to identification of the ORFs 
corresponding to Med2, Med 9 and Med 15 as S. pombe Mediator subunits. The high-
resolution structure of Middle module showed that Med9-like molecule was present, 
supporting the ID of one the sequence orphan discussed above as Med9In addition, a 
possible ortholog of human Mediator MED27 was also identified. It is generally 
acknowledged that SpMED does not include Tail module subunits corresponding to Med5 
and Med16.  To determine whether the S. pombe putative Med2 subunit was, as 
predicted by sequence homology, a component of a previously unrecognized S. pombe 
Tail module, I generated a generated a med2Δ strain in a Med7-TAP, med13Δ genetic 
background that allowed purification of S. pombe Mediator suitable for EM.  Mediator 
purified from this strain was used in difference mapping experiments, in which one 
compares the structures of the complete Mediator complex to Mediator lacking specific 
subunit (in this case Med2).    EM analysis of med2Δ SpMED revealed a loss of partially 
ordered Tail density in a position corresponding to the Med2 position in S. cerevisiae 
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(Figure 2.3A), arguing that the location of this subunit is conserved across species. We 
were unable to obtain a med15Δ strain; however, Med15 in S. cerevisiae interacts 
directly with Med2 (Beve et al., 2005), and diffuse density in 2D and 3D SpMED maps is 
consistent with the existence of a poorly ordered Med2/Med15 Tail.  
Med27 is found in metazoan Mediator and, as I have shown, in S. pombe 
Mediator.  Because there are no known Med27 homologs in S. cerevisiae, its location had 
not been defined in previous structural studies of budding yeast Mediator.  Accordingly, 
it was of particular interest to exploit S. pombe to define the location of Med27.  I 
therefore generated a med27Δ strain that could be suitable for purification of Mediator 
lacking Med27.   Difference mapping experiments performed with med27Δ SpMED 
particles localized Med27 density to the distal end of Med20, connecting the Med18-
Med20 Head jaw to Med17 (Figure 2.3B). These results are consistent with biochemical 
studies showing that human Med27 can interact with several Head module subunits, 
including Med17, Med18, Med20 (Tsai et al., 2014). An extension of Med27 to the Tail 
was also apparent in the SpMED class averages (Figure 2.3C), suggesting it could from a 
weak connection between purported Med27 density in the Head and Tail modules, but 
further experiments will be needed to confirm this model.
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Figure 2.3 Subunit localization of S. pombe Mediator. 
(A, B), 2D class averages for wild-type, med2Δ (A) and med27Δ (B) SpMED, and color-coded (by standard 
deviation values from the average) difference maps indicating the position of Med2 and Med27 
(highlighted by yellow arrowheads). (C), Wild-type SpMED 2D class averages and a close-up showing a 
Med27–Tail connection (bottom-right arrowhead) comparable to the connection between the Med4–
Med9 four-helix bundle and the rest of the Middle module (top-left arrowhead).  (reprinted with 
permission from Francisco Asturias) 
 
 
2.6 Discussion  
Studies done to investigate the mechanism of action of Mediator from yeast to 
higher organisms revealed that Mediator can directly interact with both the Pol II 
initiation machinery and the DNA binding transcription factors. Mediator also helps in 
transcription elongation by (1) controlling phosphorylation of the heptad repeats of the 
64 
 
Pol II CTD, (2) by recruiting Pol II elongation factors and other pre-mRNA processing 
factors and (3) by overcoming the activities of the negatively regulating factors.  
Some Mediator subunits can be deleted without loss of viability.  Although not all 
subunits are essential for growth in rich media, many show phenotypes under specific 
growth conditions.  For example, the Med15 gene was identified as GAL11, which is 
required for optimal growth when galactose is carbon source and for induction of 
galactose-inducible genes (Nogi and Fukasawa, 1980). In S. cerevisiae, the Mediator Tail 
module interacts with many gene-specific transcription factors (e.g. Gal4 and Gcn4). 
Except for Med15, the S. pombe genome was not known to encode any obvious 
homologs to budding yeast Tail subunits. Notably, the S. pombe homolog of Med15 had 
been reported to be associated with the chromodomain-containing chromatin 
remodeling enzyme Hrp1 complex and was not known to associate with the SpMED.  
Our Mediator purifications and MudPIT mass spectrometry analyses, along with 
the EM structures from Asturias and colleagues, show that the fission yeast Mediator 
does indeed have an attenuated Tail module. Homologs of the Tail subunits Med2 and 
Med15 were identified in MudPIT analyses of the purified SpMediator.  EM analyses 
reveal densities in SpMediator structure corresponding to a Med2/Med15 Tail. Of note, 
initial analysis also suggests that Med27, which has been assigned to the Head module in 
metazoan Mediator (Tsai et al., 2014) appears to connect the jaw region (Med18/Med20) 
to Tail. 
Subunits of the S. cerevisiae Tail module have been shown to be 
substoichiometric relative to other core Mediator components in purified Mediator 
preparations (Myers et al., 1998), and it is therefore possible that the Tail module is 
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found in only a subset of budding yeast Mediator complexes. Others have also 
demonstrated that the Tail module of budding yeast Mediator can function as a separate 
entity in certain mutant backgrounds (Zhang et al., 2004). It is hence possible that S. 
pombe Tail module also flexibly associates with other Mediator subunits. It is worth 
noting that although S. pombe Med15 clearly binds Mediator, other Mediator subunits 
are present at rather low levels in FLAG-immunopurified fractions from Med15-FLAG-
expressing S. pombe.  This observation raises the possibilities that a substantial fraction 
of Med15 is present in free form, unbound to the Mediator, or is associated with some 
other protein(s) / complex(es). It is possible that the Tail module associates with the 
Mediator complex only in the presence of Activator proteins. Also, components of the 
Kinase module seem not to be associated with the Mediator pulled down by Med15 
immunoprecipitation, suggesting that association of the Tail module and the Kinase 
module with Mediator could be mutually exclusive in S. pombe. We did not check the 
Mediator composition under different growth conditions or cell cycle stages, but there is 
a possibility that the subunits’ association change under different conditions. We did not 
find associated proteins that could function as a putative Med26 in S. pombe, nor did we 
detect any association between the Mediator complex and elongation factors like Ell1, 
Eaf1 or Cdk9. Thus, other experimental strategies will be required to address the 
question whether and how Mediator plays a role in regulation of Ell1, Eaf1, and Cdk9 
function in S. pombe.  
Cryo-EM studies by Francisco Asturias’ group on Mediator and holoenzyme reveal 
crucial details, at a near-atomic resolution. The 4.3 Å cryo-EM structure of S. pombe 
Mediator provides first near-atomic view of Mediator in its native conformation. Well-
ordered Head and Middle modules, and a disordered Tail are organized around an 
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extended, central Med14 that facilitates all inter-module contacts. Changes in Med14 
structure facilitates large-scale changes in Mediator conformation and makes possible 
polymerase contacts and enhanced CTD interaction. Matching of the polymerase portion 
of the holoenzyme and preinitiation complex cryo-EM structures indicates that Mediator 
rearrangements would be essential to stabilize the preinitiation complex and facilitate 
targeting of the CTD for phosphorylation by TFIIK. It is speculated that factors involved in 
regulation of activated transcription might act by exploiting the Mediator conformational 
changes, for example, through internal flexibility of the Head or through Tail 
rearrangements facilitated by the Med14 C-terminal domain. 
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CHAPTER 3: Identification of a new ELL-EAF interacting partner 
3.1 Introduction 
The ELL gene was first identified as an MLL translocation partner in acute myeloid 
leukemia (Thirman et al., 1994). Subsequently, the Ell protein was purified from rat liver 
extract as an activity that can stimulate the rate of RNA Polymerase II transcription 
elongation in vitro (Shilatifard et al., 1996). ELL can bind directly to elongating Pol II and 
hence can help to promote productive elongation (Shilatifard et al., 1997c). Mammalian 
ELL binds directly to EAF1 and EAF2 (ELL associated factor), which act as positive 
regulators of ELL transcription in vitro (Kong et al., 2005). 
ELL and EAF in higher eukaryotes can also be present as part of larger complexes 
like the Super elongation complex (SEC). The SEC consists of the Pol II elongation factors 
ELL and P-TEFb and several frequent MLL translocation partners including the AF4 family 
members AF4 and AFF4, and the AF9 family members AF9 and ENL.  
Most of the components of the Pol II transcription machinery are conserved from 
yeast to humans, but early attempts to find orthologs of ELL and EAF in yeast were 
unsuccessful, suggesting that ELL-EAF function might have evolved only in higher 
eukaryotes having larger genes and genomes. More recent studies from our laboratory 
identified a Schizosaccharomyces pombe RNA polymerase II elongation factor with 
similarity to the metazoan transcription factor ELL (Banks et al., 2007). Using 
bioinformatic tools, genes encoding proteins with weak similarity to ELL and EAF were 
identified in the S. pombe genome. Recombinant proteins encoded by these predicted 
ORFs, SPBP23A10.14c and SPCC1223.10c, were shown to be capable of stimulating 
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elongation by S. pombe Pol II and accordingly were annotated ell1 and eaf1, respectively. 
No similar proteins could be identified in S. cerevisiae and related fungi. Notably, S. 
cerevisiae is different from other fungi and from higher eukaryotes as it lacks several 
enzyme systems, including those needed for regulating many splicing processes and for 
RNAi.  
Since S. pombe has ELL, EAF and P-TEFb orthologs, we considered the possibility 
that it might form larger elongation complexes such as the SEC. We searched the S. 
pombe genome and couldn’t find anything that looks obviously like an AF4 or AF9 family 
member but the Ell1/Eaf1-associated proteins maybe distantly related to AF4 or AF9 
proteins and hence biochemically we may have a better chance of finding them. I tagged 
Ell1 and Eaf1 with Flag tags and did Immunoprecipitation followed by MudPIT. We 
identified a previously uncharacterized protein encoded by the gene SPAC6G9.15c to be 
associated with the both Ell1 and Eaf1. Biochemical experiments with recombinant 
proteins showed that the protein encoded by SPAC6G9.15c (Ebp1) can bind directly to 
Ell1 and form a stable complex with Ell1 and Eaf1. Chip seq experiments showed that Ell1, 
Eaf1 and Ebp1 are co-recruited in vivo to genes having high Pol II occupancy. Ell1, Eaf1 
and Ebp1 occupancy also correlate with P-TEFb (Cdk9) occupancy. Ell1 and Eaf1 together 
can stimulate elongation in vitro but the presence of Ebp1 had no noticeable effect on 
transcription under the conditions tested. 
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3.2 Ell1 and Eaf1 copurify with an uncharacterized gene product  
  To determine the proteins that can interact with Ell1 and Eaf1, I 
individually tagged the endogenous protein with a C-terminal 3X FLAG tag. The cells were 
grown in rich media and Ell1-FLAG and Eaf1-FLAG associated proteins were purified using 
anti-FLAG agarose immunoaffinity chromatography. Mass spectrometry using multi-
dimensional protein identification technology (MudPIT) was used to identify the proteins 
copurifying with Ell1 and Eaf1 . As shown in Table 3.1 and 3.2, both Ell1 and Eaf1 
copurifies with a previously uncharacterized protein encoded by the gene SPAC6G9.15c. 
Gene product of SPAC6G9.15c was annotated as a sequence orphan as it had no 
sequence homology to any other protein in another species. Because it interacts directly 
with Ell1, we annotated this protein as “ELL binding protein 1” or “Ebp1”. 
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Table 3.1 Ell1 copurifies with Eaf1 and SPAC6G9.15c gene product. 
Cell lysates from S. pombe expressing Ell1-FLAG or untagged strain were purified by anti-FLAG 
immunochromatography and subjected to MudPIT mass spectrometry.  The table shows the number of 
peptides (P) and spectra (S) for Ell1, Eaf1 and SPAC6G9.15c gene product detected in samples purified from 
cells expressing either Ell1-FLAG or untagged strain. NSAF, normalized spectral abundance factor.  The 
number of spectra for a given protein detected in a MudPIT run has been shown to be a function of the 
protein’s size and abundance (122); hence, comparison of the spectral counts provides a rough estimation 
of the relative abundance of different proteins across samples.  NSAF is the spectral count for a given 
protein, normalized to the protein’s length and the total number of spectra detected in the MudPIT run.  
NSAF is calculated using the equation 
   
 where SpC is the number of spectra detected, k denotes a specific protein, and N is all proteins detected. 
Table 3.2 Eaf1 copurifies with Ell1 and SPAC6G9.15c gene product. 
Similar to Table 3.1, Eaf1-FLAG or untagged strain were used to detect proteins associated with Eaf1 using 
anti-FLAG IP and MudPIT. 
∑
=
= N
i
i
k
k
LengthSpC
LengthSpCNSAF
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 Ell1-FLAG No Tag control 
 1 2 3 1 2 3 
 P S dNSAF P S dNSAF P S dNSAF P S dNSAF P S dNSAF P S dNSAF 
Ell1 42 294 0.0066 38 344 0.0060 54 445 0.0429 0 0 X 0 0 X 0 0 X 
Eaf1 13 44 0.0022 21 240 0.0090 19 857 0.0472 2 3 0.0001 0  0 X 0  0 X 
SPAC6G9.15c 24 101 0.0024 31 145 0.0027 30 336 0.0180 0 0 X 0 0 X 0 0 X 
 Eaf1-FLAG No Tag control 
 1 2 3 1 2 3 
 P S dNSAF P S dNSAF P S dNSAF P S dNSAF P S dNSAF P S dNSAF 
Ell1 16 307 0.0131 32 392 0.0064 35 620 0.0395 0 0 X 0 0 X 0 0 X 
Eaf1 20 319 0.0290 21 421 0.0147 24 507 0.0686 2 3 0.0001 0  0 X 0  0 X 
SPAC6G9.15c 1 3 0.0001  20 68 0.0012 14 125 0.0085 0 0 X 0 0 X 0 0 X 
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3.3 Ebp1 binds directly to Ell1 and forms a stable “ELL complex” 
with Ell1/Eaf1 
To determine whether the interaction between Ell1, Eaf1, and Ebp1 is direct or 
not, I subcloned the Ell1, Eaf1 and SPAC6G9.15c ORFs into baculovirus vectors and 
expressed them in SF9 cells in several epitopes tagged forms. I expressed FLAG-Ell1, Myc-
Eaf1 and HA-Ebp1 in various combinations as indicated in the figures, and performed anti 
anti-FLAG, anti-Myc, or anti-HA agarose chromatography. As shown in the anti-FLAG-Ell1 
pull-downs in Fig. 3.1, FLAG-Ell1 could pull down both Eaf1 and Ebp1 when all three 
proteins were expressed together and when it was expressed with either Eaf1 or Ebp1 
independently.  
 
Figure 3.1 Ell1 interacts with both Eaf1 and Ebp1. 
Sf9 cells coinfected with baculoviruses encoding FLAG -Ell1, Myc-Eaf1 and HA-Ebp1 in the combinations 
indicated in the figure were prepared and immunoprecipitations were carried out with the anti-FLAG 
agarose beads. Bound proteins were eluted with 250ng/μl FLAG peptide, analyzed by SDS-PAGE, and 
detected by either Western blotting using the specified antibody. 
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On the other hand, the interaction between Eaf1 and Ebp1 seems to be 
dependent on the presence of Ell1. Using the same lysates as were used in Figure 3.2, 
Myc or HA IPs were performed.  As shown in Fig. 3.2, an interaction between Myc-Eaf1 
and HA-Ebp1 was detected only in cells that also expressed Ell1.  
 
Figure 3.2 Ell1 is required for Eaf1 and Ebp1 to interact. 
Similar to Figure 3.1, cells coinfected with baculoviruses encoding FLAG -Ell1, Myc-Eaf1 and HA-Ebp1 in the 
combinations indicated in the figure were prepared and immunoprecipitations were carried out with the 
indicated antibody. Bound proteins were eluted with HA or Myc peptide, analyzed by Western blotting 
using the specified antibody. 
 
 
3.4 Ell1, Eaf1 and Ebp1 are co-recruited to genes in vivo  
I hypothesized that since these proteins can bind to form a complex in vitro, they 
might also colocalize in the genome. We purified FLAG-Ell1, FLAG-Eaf1 and FLAG-Ebp1 
from SF9 insect cells and used the recombinant proteins to prepare polyclonal antibodies 
in rabbits (Bio-Synthesis®). The specificity and appropriate antibody dilutions were 
confirmed using western blots (data not shown). 
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These polyclonal antibodies were then used to perform chromatin immunoprecipitations 
(ChIPs) using a wild type strain (Pem2) of S. pombe. Immunoprecipitated DNA was then 
analyzed by Next-Gen sequencing.  To control for the specificity of ChIP signals, we 
performed parallel experiments in strains lacking genes encoding either Ell1, Eaf1 or 
Ebp1. 
 Figure 3.3A shows an IGV screenshot of 180kb region in S. pombe showing the 
peaks obtained from ChIP seq using α-Ell1, α-Eaf1 or α-Ebp1 antibodies in wildtype and 
corresponding deletion strains. We can see that there are various loci where Ell1, Eaf1 
and Ebp1 give strong enrichment in the wildtype strain. These loci seem to overlap across 
for all three proteins, suggesting that Ell1, Eaf1 and Ebp1 co-localize in the genome. We 
see the enrichment of the peaks is drastically decreased in the deletion strains lacking 
the protein against which the antibody was raised. The majority of peaks overlapped 
annotated transcripts. 
 Data from replicates were highly correlated and were merged using samtools 
merge.  Peaks were called using MACS2, using as background (input) the datasets 
generated by anti-Ell1, Eaf1, or Ebp1 ChIP of chromatin from ell1Δ, eaf1Δ, or ebp1Δ 
strains, respectively.  Peak lists were filtered as follows. We removed the annotated 
antisense gene of the protein coding genes from the gene list. Genes that were 
mitochondrial in nature were also filtered out.  
Figure 3.3B is a Venn diagram showing overlap between Ell1-, Eaf1-, and Ebp1 -occupied 
genes in wild type S. pombe (764 genes). Also, there is a subset of 670 genes that have 
colocalization of only Ell1 and Eaf1. 
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Figure 3.3 Ell1, Eaf1 and Ebp1 are co-recruited to genes in vivo. 
A) IGV screenshot of 180kb region in S. pombe. ChIP-seq tracks corresponding to Ell1 (purple), Eaf1 
(orange) and Ebp1 (brown) in Wildtype(WT) and corresponding deletion mutants are shown. Zooming into 
a peak of prl53 gene shows that the enrichment of Ell1, Eaf1 and Ebp1 proteins on the gene. The arrows at 
the bottom represent gene directions and the input track is shown in blue. (B) Venn diagram showing 
overlap between Ell1-, Eaf1-, and Ebp1-occupied genes in wild type S. pombe. ChIP peaks corresponding to 
anti-Ell1, Eaf1 and Ebp1 were assigned to the closest gene and the three colors represent the number of 
genes with significant enrichment (50>FC>5, q-value<0.01) 
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3.5 Genes enriched by Ell1, Eaf1 and Ebp1 also have high Pol II 
Ell1-EAF1 binds to Pol II in vitro and stimulates elongation. Accordingly, we 
expected that the ELL complex might co-localize with actively transcribing Pol II, so we 
asked whether Ell1, Eaf1, and Ebp1 occupancy is correlated with that of Pol II. To do so, I 
performed ChIP seq experiments using two Pol II CTD specific antibodies: 8WG16, which 
binds preferentially to unphosphorylated heptapeptides of the Rpb1 CTD, and 4H8, which 
preferentially binds to the phospho-Ser 5 (YSPTSpPS) form of the CTD.  The ChIP profiles 
obtained with both anti-Pol II antibodies were very similar; >95% peaks overlapped. 
Notably, most genes occupied by Ell1, Eaf1 and Ebp1 were also occupied by Pol II as 
shown in both 4H8 (Figure 3.4) and 8WG16 ChIP-seq datasets (data not shown). 
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Figure 3.4 Genes enriched by Ell1, Eaf1 and Ebp1 also have high Pol II 
A) IGV screenshot of 180kb region in S. pombe. ChIP-seq tracks corresponding to Pol II (4H8, shown in 
green), Ell1 (purple), Eaf1 (orange) and Ebp1 (brown) in Wildtype(WT) strain are shown. The arrows at the 
bottom represent gene directions. (B) Venn diagram showing overlap between Pol II-, Ell1-, Eaf1-, and 
Ebp1-occupied genes in wild type S. pombe. ChIP peaks corresponding to anti-4H8, Ell1, Eaf1 and Ebp1 
were assigned to the closest gene and the four colors represent the number of genes with significant 
enrichment (50>FC>5, q-value<0.01) 
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We also checked whether the genes highly enriched in Pol II also have higher levels 
of “ELL complex”. As shown in Figure 3.5, we observed a high correlation between the 
amount of Pol II and the amount of Ell1, Eaf1 and Ebp1 present on a gene. There were also 
a collection of genes that had more ELL complex associated with them than expected based 
on the Pol II levels. We analyzed these genes and found that Ace2-regulated genes were 
among the outliers and GO / pathway analysis indicates they are enriched among the 
outliers. Ace2 and a collection of genes regulated by Ace2, including Adg1, Eng1, and Agn1, 
show higher ratio of ell1, eaf1, and ebp1 to pol II than was found at many other genes in 
ChIP-seq. As will be discussed in the next chapter (Chapter 4), we also see that expression 
of the genes encoding Ace2, Agn1, Eng1 is consistently down-regulated in ell1 and eaf1 
mutants, and trend down-ward in ebp1 mutant. Ace2 is a transcription factor that is 
important for the activation of a cell separation program that results in the dissolution of 
the septum assembled during cytokinesis between the 2 daughter cells, allowing them to 
become independent entities. It is involved in the activation of a number of genes like eng1 
and atgn1 that encode the hydrolytic enzymes responsible for septum degradation. These 
observations might suggest that Ell1 and its associated factors Eaf1 and Ebp1 may have a 
role to play in Ace2-dependent regulatory processes. 
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Figure 3.5 Ell1, Eaf1 and Ebp1 occupancy correlate with pol II occupancy 
The graph is a plot of read counts per million reads (cpm) obtained in Ell1, Eaf1 or Ebp1 ChIP seq on the Y 
axis vs the cpm from Pol II ChIP (4H8). r2 denotes the correlation factor for each graph.  
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3.6 Ell1, Eaf1 and Ebp1 occupancy correlate with Cdk9 
occupancy 
In higher eukaryotes, ELL and EAF proteins can be recruited to genes as a part of a 
larger ELL-containing super elongation complex that also contains AF9 and AF4 family 
members and P-TEFb. P-TEFb is a highly conserved kinase-cyclin pair composed of CycT 
and Cdk9, encoded by the pch1+ and cdk9+ genes in S. pombe. Having observed that Ell1, 
Eaf1, and Ebp1 are co-recruited to genes in S. pombe, we wished to determine whether 
these Ell complex components are co-recruited with P-TEFb.  To do so, we  compared our 
ChIP-seq datasets to a published Cdk9 ChIP-chip dataset (Coudreuse et al., 2010a). As 
shown in Figure 3.6, we find that Ell1, Eaf1 and Ebp1 occupancy correlate remarkably 
well with P-TEFb (Cdk9) occupancy. Majority of the genes have the presence of both 
Cdk9 and Ell1 proteins, as can be seen in the Venn diagram (Figure 3.6B). 
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Figure 3.6 Ell1, Eaf1 and Ebp1 occupancy correlate with Cdk9 occupancy  
A) IGV screenshot of 180kb region in S. pombe. ChIP-seq tracks corresponding to Pol II (4H8, shown in green), 
Ell1 (purple), Eaf1 (orange), Ebp1 (brown) and Cdk9 (blue) in Wildtype(WT) strain are shown. The arrows at 
the bottom represent gene directions. (B) Venn diagram showing overlap between Cdk9-, Ell1-, Eaf1-, and 
Ebp1-occupied genes in wild type S. pombe. ChIP peaks corresponding to anti-Cdk9, Ell1, Eaf1 and Ebp1 were 
assigned to the closest gene and the four colors represent the number of genes with significant enrichment 
(50>FC>5, q-value<0.01). Cdk9 ChI-microarray data published by (Coudreuse et al., 2010b) was used for 
analysis. 
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3.7 Ebp1 does not stimulate elongation by Ell1/Eaf1 in vitro 
The Ell1/Eaf1 complex has been shown previously to stimulate pol II elongation in 
vitro (Banks et al., 2007). Since the Ebp1 protein forms a complex with Ell1/Eaf1 and is 
co-recruited to genes with Ell1/Eaf1, we wished to determine whether it could modulate 
Ell1/Eaf1 elongation activity.  To do so, we tested the effect of Ebp1 protein on the rate 
of transcription elongation by ternary Pol II elongation complexes assembled on a DNA-
RNA scaffold (Kellinger et al., 2012; Walmacq et al., 2009). For these experiments, Flag-
Ell1 and Flag-Eaf1 were co-expressed in insect cells and immunopurified on Flag agarose; 
Flag-tagged Ell1 and Eaf1 were present in the purified fraction in a near equimolar ratio.  
Flag-Ebp1 was expressed and immunpurified separately (Figure 3.7). 
 
 
Figure 3.7 Purification of recombinant Flag-tagged Ell1/Eaf1 and Flag-tagged Ebp1  
Coomassie blue-stained SDS–PAGE analysis (4–20% gradient gel) of purified recombinant Flag-tagged 
Ell1/Eaf1 and Flag-tagged Ebp1 from insect cells. Flag-tagged Ell1 and Eaf1 were present in the purified 
fraction in a near equimolar ratio. The asterisks show nonspecific bands. 
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As outlined in Figure 3.8, panel A and B, I first assembled an RNA: template strand hybrid 
and then incubated it with purified S. pombe pol II. Biotinylated non-template DNA 
strand was then added to form the ternary complex, and the mixture was incubated with 
streptavidin beads. Unbound template strand and Polymerase were then washed off. 
Transcription was initiated by the addition of ATP and [α-32P] UTP to the reaction 
mixture and incubated to allow accumulation of pol II ternary elongation complexes 
containing radioactively labelled, 23 nucleotide long transcripts (Figure 3.8C, lane1). I 
then chased nascent transcripts into longer products by the addition of ATP, GTP, CTP 
and UTP, in the presence or absence of Ell1/Eaf1 and Ebp1. In the absence of Ell1/Eaf1, 
labeled 23-mers were rapidly elongated to 24 nucleotide transcripts, but further 
elongation proceeded very slowly (Fig. 3.8C, lanes 2-4). As expected, the Ell1/Eaf1 
complex stimulated the rate of transcription elongation by its S. pombe pol II, as detected 
by an increase in the rate at which radioactively labelled 24 nucleotide transcripts were 
chased into longer products when reactions included the Ell1/Eaf1 complex (Figure 3.8C, 
compare lanes 2-4 to lanes 5-7).  We observed little effect on rates of transcript 
elongation after adding Ebp1 protein to reactions with (lanes 8-16) or without (lanes 17-
19) Ell1/Eaf1, suggesting that Ebp1 does not detectably alter Ell1/Eaf1s’ ability to 
stimulate Pol II elongation in vitro. The quantification of the assay is shown in the graph 
in Figure 3.8D. 
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Figure 3.8 Ell1/Eaf1 complex stimulates elongation by S. pombe Pol II, but Ebp1 does not 
A) Experimental design for ternary complex assembly and transcription. Ternary complexes were formed. 
Transcripts were labeled by transcription in the presence of  0.6μM ATP and 0.13μM [α-32P]UTP (400 
mCi/mmol). After a 10-min incubation, 5μM unlabeled ATP and 5μM UTP were added to ensure transcripts 
were extended to 23 nt. This 23mer was washed and then incubated in the presence of Ell1/Eaf1 or buffer 
with/without Ebp1 for 2, 5 or 10 mins of elongation in the presence of 7 μM ATP, CTP, UTP, and GTP. (B) A 
diagramatic representation of the ternary complex with sequence of the  template, RNA and nontemplate 
strands of the scaffold is shown. Addition of only UTP and ATP would form 23nt RNAs (C) Assays contained  
either only buffer (lanes 2-4), or 5 pmoles of Ell1/Eaf1 with varying amounts of Ebp1 as shown (lanes 5-16). 
Reactions shown in lanes 17-19 contained 5 pmoles of Ebp1 without Ell1/Eaf1. Triangles in the figure 
indicate increasing reaction times of 2, 5 or 10 minutes. (D) The graph shows the quantification of assays.  
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3.8 Discussion 
Ell1 and Eaf1 in S. pombe act as elongation factors that share functional 
similarities with the ELL-EAF complex found in higher eukaryotes.  In contrast, S. 
cerevisiae lacks the ELL/EAF homologs.  S. cerevisiae also lacks the apparatus needed for 
a number of transcription-linked events, including many splicing processes and RNAi 
(Kaufer and Potashkin, 2000). That these processes appear to have co-evolved raises the 
possibility that Ell1 and Eaf1 may have functions in vivo related to RNA processing or 
gene silencing.  
We performed MudPIT mass spectrometry analyses and found that both Ell1 and 
Eaf1 interact not only with each other but also copurify with a previously uncharacterized 
protein designated as a sequence orphan in Pombase and encoded by the gene 
SPAC6G9.15c (Table 3.1 and 3.2). Analyzing the sequence of this uncharacterized protein 
by Psi-blast gives regions of possible faint homology to the AF4 family of protein (data 
not shown), suggesting a possibility that the protein encoded by SPAC6G9.15c gene may 
function as an AF4-Like protein in S. pombe. Since this protein binds to S. pombe Ell1 we 
annotated it as an ELL binding protein 1 “Ebp1”. 
By coexpression of recombinant proteins in insect cells, I have shown that Elll1 
can interact directly with both Eaf1 and the gene product of SPAC6G9.15c (Ebp1), and 
most likely forms a bridge between Eaf1 and Ebp1 (Figure 3.1 and 3.2). ChIP-seq 
experiments using antibodies raised again Ell1, Eaf1 and Ebp1 indicate that these three 
proteins are colocalized on the S. pombe genome, and the pattern of their binding is very 
similar (Figure 3.3). Since Ell1 binds to Pol II in vitro (Banks et al, 2008), we compared Ell1, 
Eaf1, and Ebp1 occupancy with that of Pol II and observed a high correlation between the 
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two (Figure 3.4). Gene having the highest Pol II occupancy also had very high ‘ELL 
complex’ occupancy (Figure 3.5).  Nevertheless, there were many regions with detectable 
Pol II occupancy where ELL complex components were not enriched.  Whether there are 
many Pol II-occupied genes that lack the ELL complex or whether the apparent difference 
in the number of genes occupied by Pol II compared to ELL complex is due to differences 
in antibody affinity remains to be determined. 
Since in higher eukaryotes, ELL, EAF and AF4 are part of a larger SEC complex that 
also contains P-TEFb, we compared our data to a published Cdk9 ChIP-chip dataset and 
found that Cdk9 occupancy correlates remarkably well with that of the ELL complex and 
Pol II (Figure 3.6), raising the intriguing possibility that there might be a rudimentary 
super elongation complex in S. pombe. 
Finally, I asked whether this new Ell1/Eaf1 interacting protein would have any 
effect on Ell1/Eaf1s’ ability to stimulate Pol II elongation. Under the conditions used in 
our assays, we detected no Ebp1 stimulation of Pol II elongation rate, either in the 
presence or absence of Ell1/Eaf1.  In fact, if Ebp1 had any effect on Pol II elongation, it 
was slightly inhibitory.  At this point we cannot distinguish between the possibilities that 
Ebp1 has a weak inhibitory activity or that the purified Ebp1 fraction contained an 
inhibitory contaminant.  Finally, I note that Ebp1 protein’s inability to stimulate Pol II 
elongation may not come as a surprise, since in "bigger eukaryotes," members of the AF4 
family of proteins are predicted to act as a scaffolds that link ELL/EAF to P-TEFb (which 
does not alter elongation in the absence of additional negatively acting transcription 
factors) (Chou et al., 2013; Lu et al., 2016), and purified ELL-containing complexes with or 
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without AF4 family proteins stimulate Pol II transcription to similar extents (Biswas et al., 
2011). 
In the next chapter, I will focus on the effect of mutation or deletion in these 
genes and how they affect gene regulation. 
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CHAPTER 4: Consequences of mutation in ‘ELL complex’ 
4.1 Introduction 
In the previous chapter, I demonstrated that by mass spectrometry we identified 
a previously uncharacterized protein, encoded by the SPAC6G9.15c gene, as an Ell1/Eaf1 
interacting protein, Ebp1.  By ChIP-seq, I showed that this Ebp1 protein colocalizes with 
Ell1, Eaf1, and Cdk9 at genes with high pol II occupancy. Although I observed in 
biochemical experiments using purified recombinant proteins that the Ebp1 protein does 
not detectably alter Ell1/Eaf1s’ ability to stimulate Pol II elongation in vitro, we 
hypothesize that it contributes to Ell1/Eaf1 function in cells.   
In an effort to define in vivo functions of Ell1, Eaf1, and Ebp1, I generated S. 
pombe strains deleted for the genes encoding each protein and performed various 
phenotypic analyses using the resulting ell1Δ, eaf1Δ, and ebp1Δ strains.  Consistent with 
the possibility that Ell1 and/or the Ell1 complex functions in elongation control, I found 
that deletion of ell1+, but not eaf1+ or ebp1+, caused sensitivity to mycophenolic acid 
(MPA), a phenotype shared with a number of other transcription elongation factors 
(Reines, 2003).  In further experiments, I found that lack of Ell1 complex components had 
minimal consequences for transcript accumulation or Pol II distribution genome-wide 
under the growth conditions used.  I did, however, obtain evidence that some transcripts 
in subtelomeric regions may be de-repressed upon loss of ell1+, raising the possibility 
that Ell1 might contribute to heterochromatin formation or maintenance. Consistent 
with this possibility, I observed a significant decrease in H3K9 methylation marks in 
subtelomeric regions of ell1Δ cells. 
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4.2 Sensitivity of ell1Δ strain to Mycophenolic acid (MPA) 
Yeast strains carrying mutations in genes encoding several proteins implicated in 
regulation of transcription elongation grow slowly in the presence of the nucleotide-
depleting drug 6-azauracil and mycophenolic acid. Previous data from our lab shows that 
ell1+ deletion in S. pombe causes a 6-azauracil sensitivity (Banks et al., 2007). To 
determine whether ell1, eaf1 or ebp1 mutants are sensitive to Mycophenolic acid, I grew 
strains lacking Ell1, Eaf1 and Ebp1 proteins on plates containing the drug.  Although the 
eaf1Δ and ebp1Δ strains appeared to grow as well as the wild type S. pombe (data not 
shown), the ell1Δ strain exhibited a mild sensitivity to 30 µg/ml mycophenolic acid 
(Figure 4.1). 
 
Figure 4.1 Mycophenolic acid sensitivity of ell1Δ strain.    
The parental Pem2 and ell1Δ strains were grown to mid log phase in rich media, washed in 1X PBS, and 
resuspended in H2O at a density of 1 x 108 cells/ml.  5 μl of 3-fold serial dilutions of cells were spotted onto 
EMM plates supplemented with adenine, histidine and leucine (225 μg/ml) with or without the indicated 
concentrations of mycophenolic acid.   
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4.3 Effect of ell1+, eaf1+ or ebp1+ deletion on DNA damage. 
Transcription-coupled DNA repair pathways enable lesions that block transcription to be 
repaired more quickly than similar lesions in other parts of the genome. In mammalian 
cells, ELL has been implicated in restart of transcription after transcription-coupled repair 
(Mourgues et al., 2013b), and cells depleted of ELL were seen to be hyper-sensitive to UV-
irradiation.  We therefore wished to determine whether deletion of ell1+, eaf1+ and ebp1+ 
would render S. pombe hyper-sensitive to DNA damaging agents.  To do so, I performed 
spot assays to compare growth of wild type S. pombe to growth of ell1Δ, eaf1Δ and ebp1Δ 
strains in the presence of various DNA damaging agents, including UV irradiation, Methyl 
methanesulfonate (MMS) and Hydrogen peroxide(H2O2).  As shown in Figure 4.2, we 
observed no reproducible difference between growth of wild type and mutant strains over 
3 days of growth after spotting or plating. Recent studies (Dabas et al., 2018; Sweta et al., 
2017) have reported a role for Ell1 and Eaf1 under DNA damage stress, conferring upon 
the mutant cells a sensitivity when grown with MMS or hydroxyurea. We, however, see no 
significant changes in growth upon deletion of ell1+, eaf1+ and ebp1+ when grown under 
optimal conditions on plates containing DNA damage agents. 
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Figure 4.2 Effect of deletion of ell1+, eaf1+ or ebp1+ on sensitivity to DNA damaging agents.    
The parental strain Pem2 and the ell1Δ, eaf1Δ and ebp1Δ  strains, were grown to mid log phase in rich 
media, washed in 1X PBS, and resuspended in H2O at a density of 1 x 108 cells/ml.  5 μl of 3-fold serial 
dilutions of cells were spotted onto YES plates without or with varying concentration of (B) methyl 
methanesulfonate, and (C) hydrogen peroxide. (A) For UV damage, cells were first plated on YES plates and 
then exposed to the indicated dosage of UV. All plates were incubated at 32°C for 3 days and then imaged. 
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4.4 Effect of deletion of ell1+, eaf1+ or ebp1+ on stability of 
ELL complex 
We wished to determine whether recruitment of ELL complex components to 
genes is inter-dependent.  To do so, we performed ChIP using antibodies raised against 
Ell1, Eaf1 and Ebp1 in wild type and mutant strains lacking ell1+, eaf1+ and ebp1+ genes, 
and then quantified recruitment to the promoter region and 3’end of the tdh1 
(glyceraldehyde-3-phosphate dehydrogenase) gene and, as a control for the specificity of 
ChIPs, to a distant non-transcribed region (the K region). Based on results of the ChIP-seq 
experiments, we expect to see a high enrichment of Pol II and ELL complex at the tdh1+ 
gene body and promoter, but not at the transcriptionally silent K region.  We observed 
that deletion of ell1+ gene decreased the occupancy of not just the Ell1 protein at the 
tdh1+ gene, but also of the Eaf1 and Ebp1 proteins (Figure 4.3). Similarly, deletion of 
either eaf1+ or ebp1+ also reduced the occupancies of all three ELL complex proteins. 
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Figure 4.3 Deletion of either one of the proteins decreases Ell1, Eaf1 AND Ebp1 occupancies.    
Chromatin immunoprecipitation was performed using antibodies raised against Ell1 (α-Ell1), Eaf1 (α-Eaf1), 
Ebp1 (α-Ebp1) or Pol II (α-4H8) on wildtype strain and strains having ell1+, eaf1+ and ebp1+ deletion. 
Immunoprecipitated DNA was quantified by q-PCR using primers specific to the tdh1+ gene promoter 
region (blue), tdh1+ gene 3’ end (red) and adh1+ (green). Fold enrichment was calculated over the K region 
(control region) over the input DNA. The experiment was done in triplicates and the bars represent the 
standard errors. The “*” represents significant change from WT with p<0.05. 
 
 
These findings suggest either (i) that recruitment of Ell1, Eaf1, and Ebp1 is 
interdependent or (ii) that deletion of one or more protein(s) of the complex can 
modulate the expression of the others. To test the latter possibility, we asked whether 
expression of Ell1 and Eaf1 was reduced in eaf1Δ and ell1Δ strains respectively.  Because 
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our antibodies could not reliably detect Ell1 or Eaf1 in crude cell lysates against the 
background of total protein, we performed immunoprecipitation experiments with 
antibodies against Ell complex components and analysed the immunoprecipitated 
proteins by western blots. Figure 4.4 shows the results of immunoprecipitations 
performed using anti-Ell1 or anti-Eaf1 antibodies on equal amount of whole cell lysates 
from wildtype and ell1 Δ strains. In the wild type strains Eaf1 was readily detected in both 
anti-Ell1 (as it interacts with Ell1) and anti-Eaf1 immunoprecipitates. As expected neither 
Ell1 nor Eaf1 were detected in anti-Ell1 IPs performed using lysates from the ell1Δ strain.  
Surprisingly, however, much less Eaf1 protein was detected in anti-Eaf1 IPs performed 
with lysates from the ell1Δ strain than from wild type cells, suggesting that the stability 
or expression of the Eaf1 protein is dependent upon presence of Ell1. Similarly, 
immunoprecipitation experiments using anti-Ell1 or anti-Eaf1 antibodies were performed 
on equal whole cell lysates from wildtype and eaf1Δ strains.  While in the wildtype strain 
Ell1 can be pulled down through Eaf1, deletion of eaf1+ made Ell1 undetectable in both 
anti-Ell1 and anti-Eaf1 IPs, suggesting that expression of Ell1 also depends upon the 
presence of Eaf1 in the cell. 
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Figure 4.4 Expression of Ell1 and Eaf1 proteins seems to be interdependent. 
Immunoprecipitation using α-Ell1 and α-Eaf1 was performed on wildtype strain and strains having ell1+, or 
eaf1+ deletion. Immunoprecipitated proteins were analyzed by western blotting using anti-Eaf1 and anti-
Ell1 antibodies, respectively. The lanes marked ‘M’ are the molecular size marker lanes.  The strong red 
band in the anti-Eaf1 blot is the 37 kDa marker; the yellow band seen in anti-Ell1blot is 75 kDa. 
 
 
4.5 Effect of deletion of ell1+, eaf1+ or ebp1+ on Pol II 
occupancy 
Results from ChIP-seq experiments performed with wild type S. pombe suggest 
that ELL complex is recruited to genes with high Pol II. To determine whether deletion 
ell1+, eaf1+ and ebp1+ affects the amount or 5' to 3' distribution of Pol II genome-wide, 
we performed Pol II ChIP -seq experiments in the mutant strains using 4H8 and 8WG16 
antibodies.  As shown in the metagene plots in Figure 4.5, deletion of eaf1+ or ebp1+ 
does not detectably alter either the amount or 5'-3' distribution of Pol II ChIP signal, 
whether we included all genes in the analysis or focused specifically on the most highly 
expressed genes. On the other hand, the metagene analysis of Pol II distribution in the 
95 
 
ell1Δ strain hints at a possible shift in Pol II distribution towards the 5’ end of the gene. 
The possible 5' shift in Pol II localization is discernable in metagene plots including data 
from all expressed genes; however, it becomes more apparent in plots that include only 
the most highly expressed genes (top 5%, 351 genes). If these findings reflect a real shift, 
the data is consistent with the possibility that Ell1 is an elongation factor in vivo and that 
its deletion causes Pol II to move slower and hence accumulate toward the 5’ end of the 
gene. 
 
Figure 4.5 Effect of ell1+, eaf1+ or ebp1+ deletion on Pol II distribution 
Chromatin immunoprecipitation using 8WG16 and 4H8 antibodies was performed on wildtype strain and 
strains having ell1+, eaf1+ or ebp1+ deletion. Metagene plots of around all the genes having Pol II 
enrichment made. The blue lines show WT pol II enrichment whereas the red line shows the pol II 
enrichment in mutant strains as marked. The average normalized reads for “all” genes or the top 5% 
expressing “high” genes (351 genes) are plotted with the shaded region showing 95 percentile distribution 
of the average reads in replicates. 
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4.6 Nascent transcriptome analyses by PRO-seq 
Our ChIP-seq analyses provided information about the location of Pol II on genes 
and raised the possibility that there might be a modest shift in Pol II the 5' to 3' 
distribution of Pol II across genes.  ChIP-seq, however, is a relatively low-resolution 
method for mapping Pol II occupancy.  In addition, it provides no information about the 
directionality (sense vs antisense) of transcribing Pol II.  A recently developed method, 
Precision Run-On sequencing or PRO-seq (Kwak et al., 2013; Mahat et al., 2016), provides 
strand-specific information about the precise locations of the 3' end of nascent 
transcripts.  Notably, recent data obtained using PRO-seq identified a previously 
unrecognized pause in early elongation in S. pombe but not in S. cerevisiae (Booth et al., 
2016); this pause resembles the promoter-proximal pausing in metazoans. To explore the 
effect of ell1+ deletion on transcription and to get a base-pair resolution map of 
transcription elongation in S. pombe lacking ell1+, we investigated the effects of the 
mutation on the positions of RNA polymerase active sites genome-wide using Precision 
Run-On sequencing.  If loss of ell1+ leads to a major defect in release from promoter-
proximal pausing, we expect to observe a significant 5' shift in the distribution of reads 
within the first few hundred bases of the transcription start site. We performed PRO-seq 
experiments on wildtype and ell1Δ strains, in duplicate.  The resulting data, summarized 
in the metagene plots shown in Figure 4.6A, suggests that ell1+ deletion does not cause 
major changes in the distribution of polymerase within the first 500 bases of the 
transcription start site of genes that were separated from the boundaries of neighboring 
genes on the same strand by at least 1 kb.  In further analyses, we specifically selected 
for genes that may be paused, by calculating the pausing index (mappable reads within 
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the promoter-proximal region of the gene/mappable reads on gene body), and plotted 
the average PRO-seq signals around the TSS of these genes in the wildtype and ell1Δ 
strains (Figure 4.6B).  As expected, we detect a larger accumulation of polymerase at the 
5’ ends of these genes as compared to the complete gene set in Figure 4.6A, but again 
we observe no significant change in polymerase distribution in the wildtype and ell1Δ 
strains. 
 
Figure 4.6 5′ ends of genes exhibit no major change in Pol II density upon ell1+ deletion. 
 (A) Average PRO-seq signal in WT (blue) and ell1 Δ (red) strains, around the transcriptional start site (TSS) 
of active, filtered to include only genes that are longer than 1 kb and separated from the boundaries of 
neighboring genes on the same strand by at least 1 kb. (B) Average PRO-seq signal around the TSS of 
paused genes (having pausing index >1, total 960 genes) in WT (blue) and ell1Δ (red) strains. 
 
 
We and others (Chen et al., 2012; Ni et al., 2010) have observed prevalent anti-
sense transcription at many genes in S. pombe.  Because Pro-Seq provides information 
about the strand specificity of nascent transcripts, we interrogated our dataset to 
determine whether deletion of ell1+ would have any effect on the ratio of sense vs 
antisense transcription. To do so, we calculated the Log2 values of the ratios of the 
normalized (RPKM) reads on the sense strand to the normalized reads on the antisense 
98 
 
strand and plotted the values for all genes in ell1Δ and wildtype strains (Figure 4.7). We 
find that points corresponding to most of the genes fall on the ‘X=Y’ line with a slope of 1, 
suggesting that ratio of sense to antisense transcription of most annotated genes does 
not change upon ell1+ deletion. 
 
Figure 4.7 Antisense transcription on genes is not affected by ell1+ deletion. 
Log2 value of the RPKM ratios on the sense to the antisense strand of individual genes were calculated and 
plotted for wildtype and ell1+ deletion strains. (1 was added to both the numerator and denominator to 
account for strands with reads). The red dotted line denotes the ‘X=Y’ line with a slope of 1. 
 
 
4.7 Effect of deleting ell1+, eaf1+ or ebp1+ on mRNA 
abundance 
To explore the consequences of deleting components of the ELL complex for 
global gene expression in S. pombe, we investigated the effects of deleting ell1+, eaf1+ or 
ebp1+ on the abundance of poly-adenylated transcripts. To assay the relative abundance 
of all expressed transcripts, we prepared strand-specific, poly-A selected RNA-seq 
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libraries from the wild-type and ell1Δ, eaf1Δ, and ebp1Δ strains of fission yeast. The 
deletions of each gene in the mutant strains were confirmed by the absence of any reads 
from the deleted locus.  Transcript levels were found to be highly reproducible between 
biological replicates. 
We identified genes that were differentially expressed in the mutant strain 
compared to wild type using EdgeR.  As summarized in Fig. 4.8, we observed that in all 
three deletion strains tested, only a fairly small number of genes were up or down 
regulated upon ell1+, eaf1+ or ebp1+ deletion (data for poly-A selected RNA seq libraries 
shown in Figure 4.8A). A significant number of these genes overlap in both the 
upregulated (Figure 4.8B) and the downregulated categories (Figure 4.8C).  
 
Figure 4.8 Differentially expressed genes in poly A selected RNA seq libraries upon ell1+, eaf1+ or ebp1+ 
deletion. 
(A) Differentially expressed (DE) genes in the polyA selected RNA-seq analysis of ebp1Δ, eaf1Δ or ell1Δ with 
respect to the wildtype strain (with 1.5-fold difference or more, P<0.05). The overlap between the genes 
that were (B) upregulated or (C) downregulated in the three strains tested is shown. 
 
 
We find that many genes that were up or down regulated upon deletion of one 
gene do not show up in other mutant strains as differentially expressed. This is probably 
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because we are using stringent cutoffs to call a gene differentially expressed. Although 
they do not pass our cutoffs for significant differential expression, most of these genes 
do exhibit a similar trend in expression change over the wild type strain, with the 
foldchange and/or the adjusted p-value barely making the cutoffs. Of note, Ace2 and 
Ace2-regulated genes were also seen to be downregulated upon Ell1 deletion. The eaf1+ 
and ebp1+ deletion also decreased the stable transcripts of these genes modestly. 
We also generated ‘ribo-depleted RNA’ libraries to allow comparison of the 
expression of non-coding RNAs that may lack poly-A signal and find that the overall 
trends are similar to what was found in polyA+ group. We again found a very modest 
effect of depletion of Ell1, Eaf1 or Ebp1 on steady state RNA levels; however, on closer 
examination, we noticed that some of the genes upregulated upon ell1+ deletion were 
located next to one another, and quite close to the right end of chromosome 1, 
suggesting that their increased expression could be a consequence of their similar 
chromosomal locations rather than any functional relationship. It should be noted that 
the total reads of many of the genes in the telomeric and subtelomeric regions are quite 
low as these genes, located in the heterochromatin region, are expressed at extremely 
low levels. A group of genes that seems to be upregulated in the subtelomeric region in 
the ell1Δ strain are shown in Figure 4.9. This observation raised the possibility that Ell1 
might play a role in the telomeric/subtelomeric region of 
chromosomes. 
 
Figure 4.9 Subtelomeric genes upregulated in ell1Δ 
Genes with at least a 1.4-fold (log2 > 0.48) increase in transcript abundance 
in the ell1Δ strain relative to wildtype. 
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4.7 Altered subtelomeric H3K9 methylation in ell1Δ strain 
The regulation of heterochromatin is essential for proper chromosome 
segregation, genomic stability, and cell fate determination. In S. pombe, heterochromatin 
is found at the telomeric, subtelomeric, and peri-centromeric regions and at the mating 
type loci and is characterized by high levels of H3K9 methylation. To examine the 
heterochromatin state at the centromeric and the telomeric regions, we performed ChIP-
seq experiments in the wild type and ell1+ deletion strains using an antibody that 
recognizes the H3K9 dimethylation mark.  We also performed ChIP seq with an antibody 
that recognizes histone H3 to determine whether any observed changes could be due to 
changes in total H3 occupancy.  We detected no effect of ell1+ deletion on the 
methylation pattern at the centromeric regions of the three S. pombe chromosomes 
(Figure 4.10). 
 
Figure 4.10 Heterochromatin distribution around the centromere is similar in wild type and ell1Δ strains. 
IGV tracks showing outer centromeric repeat (OTR) and the central core domain of centromeric regions in 
S. pombe. The tracks show H3K9(me2) ChIP and H3 ChIP in the wildtype (red) and ell1Δ (green) strains on 
the three chromosomes of S. pombe.  An example of an input DNA track is shown in blue. 
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To examine the effect of ell1+ deletion on H3K9 methylation in subtelomeric 
regions, we focused on chromosomes I and II, since interpretation of ChIP-seq data at the 
ends of chromosome III is complicated by the presence of rDNA repeats.  As shown in 
Figure 4.11, we see altered subtelomeric H3K9 methylation patterns in the ell1+ deletion 
strain at the left and right ends of chromosome I and II (Figure 4.11). We calculated 
H3K9methlyation enrichment over the input DNA and see no change in H3K9 methylation 
levels immediately proximal to the telomeres (shown in green boxes). In contrast, when 
we look at the subtelomeric region shown in red boxes, we see a significant decrease in 
the methylation marks in the ell1Δ cells, suggesting that Ell1 may play a role in 
maintaining the heterochromatin at the subtelomeric regions.  
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Figure 4.11 Altered subtelomeric H3K9 methylation in ell1Δ strain. 
IGV browser shots of telomeric regions at the left and right ends of Chromosome I and II in S. pombe. The 
tracks show normalized H3K9(me2) enrichment (ChIP/input DNA) in wildtype and ell1Δ strains. The green 
boxes show region proximal to the telomere. The red boxes show the subtelomeric region with decreased 
H3K9 methylation in the ell1+ deletion strain. The genes in the region are shown below the tracks as 
arrows denoting the directionality of the genes. The green and red bars at each chromosome end show the 
position of primers used for q-PCR in Section 4.8 and Figure 4.12. 
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4.8  eaf1+ or ebp1+ deletion does not alter subtelomeric H3K9 
methylation  
To confirm the changes in H3K9 dimethylation mark in the ell1Δ strain detected 
by ChIP-seq and to determine whether deletion of eaf1+ or ebp1+ would give rise to the 
same phenotype, we performed ChIP-qPCR experiments using primers specific for the 
ends of chromosome I and II for all the mutant strains. The red and green bars denoting 
the primer positions are shown in Figure 4.11. The ‘red’ primers are in the subtelomeric 
region where H3K9 methylation is altered in the ell1Δ strain, whereas the ‘green’ primers 
are in the regions closer to telomere where the heterochromatin is unaltered upon ell1+ 
deletion.  We observe that deletion of ell1+ causes the enrichment of DNA amplified by 
‘red’ primers to go down while the region recognized by ‘green’ primers remains 
unaltered. This result is consistent with the ChIP-seq data from section 4.7, as in the ell1Δ 
strain the subtelomeric H3K9 methylation mark goes down, but there is little or no 
change in the region closer to telomeres. In contrast, deletion of eaf1+ or ebp1+ does not 
decrease the enrichment of H3K9 dimethylation in the subtelomeric region or the region 
closer to the telomere, suggesting that Ell1 may have roles independent of Eaf1 and 
Ebp1. We do see an increase in one replicate of eaf1Δ strain, but the control values were 
also higher, hence we are not focusing on it. 
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Figure 4.12 Unlike ell1+ deletion, deletion of eaf1+ or ebp1+ does not alter subtelomeric H3K9 methylation. 
ChIP qPCR experiments were performed on Wildtype (WT), ell1Δ, eaf1Δ and ebp1Δ strains using antibodies 
recognizing the H3K9(me2) mark. The enrichment is calculated as % input DNA. The ‘red’ and ‘green’ 
primers from the left and right ends on Chromosome I and II are used (position as indicated in Figure 4.11) 
and the control set of primers are in regions in each Chromosome having no H3K9 methylation (from ChIP 
seq data).  
 
4.9 Discussion 
6-Azauracil (6AU) is an inhibitor of IMP dehydrogenase (IMPDH), the rate-limiting 
enzyme in de novo GTP synthesis and therefore treatment of cells with 6AU results in 
depletion of intracellular nucleotide pools. Mycophenolic acid is also a specific inhibitor 
of IMPDH. Mutations in a number of genes encoding proteins implicated in elongation 
control give rise to 6AU and mycophenolic acid sensitivity.  Loss of Ell1 also gives rise to 
decreased growth rate in the presence of drugs that inhibit nucleotide synthesis, 
including 6AU (Banks et al., 2007) and MPA, and therefore is consistent with the idea it 
has a role in transcription elongation. 
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We also checked the deletion mutants for growth defects when grown with 
various DNA damage causing agents and found that the mutants grow very similarly to 
the wildtype strain.  Thus, at least under the growth conditions used, the ELL complex 
does not appear to play a major role in the response to DNA damage.  As noted earlier, 
work from another lab (Dabas et al., 2018; Sweta et al., 2017) reported increased 
sensitivity to DNA damaging agents in ell1 and eaf1 deletion mutants, including some of 
the same strains I have used.  At present, we do not understand the reason for this 
discrepancy.   
Deletion of ell1+ did lead to a subtle shift in pol II distribution toward the 5' end of 
genes, suggesting that polymerase could lag behind upon loss of ell1+. This again points 
towards role of Ell1 in transcription elongation in vivo.  However, deletion of eaf1+ or 
ebp1+ did not lead to a discernable change in pol II distribution across genes.  
Steady state levels of RNA transcripts did not seem to be not greatly affected by 
deletion of ELL complex components. However, we noted a cluster of genes in the region 
close to the right arm of Chromosome 1 that seemed to be modestly upregulated upon 
ell1+ deletion. Chromosomal location of these genes rather than the functions may be 
key regulation.  
Fission yeast subtelomeric regions can be divided into 2 regions having high H3K9 
methylation in the telomere-proximal region and lower H3K9 methylation in the region 
more distal from the telomeres. It is possible that H3K9methylated subtelomeric 
heterochromatin protects S. pombe subtelomeres from recombination between nearly 
identical paralogs, while the lower level of H3K9methylation in the more distal region still 
permits transcription of genes in this region as needed.  
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It is interesting to note that phosphorylation-site mutations in the CTD of the 
largest Pol II subunit have also been reported to alter subtelomeric gene expression in 
pombe (Inada et al., 2016). In addition, these authors observed that manipulation of the 
Y1S2P3T4S5P6S7 heptapeptide repeat of the CTD by substituting non-phosphorylatable 
alanines for Ser2 and/or Ser7 led to the alteration of the repressive histone H3 lysine 9 
methylation (H3K9me) landscape. Similar phenotypes were observed when cohesin 
loader mutants were studied in S. pombe, suggesting a role for cohesin in formation of 
heterochromatin domains at the the subtelomeres (Dheur et al., 2011).  CTD 
phosphorylation is mediated by the protein kinase and transcription elongation factor P-
TEFb, which is known to interact with ELL as a part of SEC in higher organisms. Studies 
also report that mutations in cohesin impairs both Pol II transcription initiation at 
promoters and elongation through the gene body (Mannini et al., 2015). It is interesting 
to note that the changes in subtelomeric H3 K9 methylation patterns in CTD and cohesin 
loader mutants were very similar to those we observed in our ell1Δ strain. The precise 
mechanisms by which these mutations affect chromatin structure and gene expression 
remain to be elucidated.  It could be interesting in the future to determine whether 
mutations in ell1 or cdk9 lead to increased recombination between subtelomeric regions 
These 20- to 40-kb regions between the chromosome arm euchromatin and the 
telomere define a functionally distinct so-called subtelomeric region of their respective 
chromosomes. Chromosome 3 in S. pombe has a different structure than the other two 
chromosomes in that ribosomal RNA gene repeats exist near the ends of chromosome 3, 
perhaps explaining the distinct change in H3K9me2 patterns seen in ell1Δ strain for 
chromosomes 1 and 2, but not chromosome 3. It is possible that the relatively low level 
of H3K9methylated subtelomeric heterochromatin protects S. pombe subtelomeres from 
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recombination between nearly identical paralogs of subtelomeric regions, while still 
permitting the expression of the corresponding genes when needed. 
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CHAPTER 5: Synthetic Genetic Array (SGA) 
5.1 Introduction 
In the previous chapters, I demonstrated that we identified a novel Ell1 and Eaf1 
interaction partner, which we have named ELL binding protein 1 or Ebp1.  I found that 
Ebp1 colocalizes with Ell1 and Eaf1 at many genomic loci but does not detectably 
stimulate the rate of transcription elongation by Ell1/Eaf1 in our in vitro assays.  
Together, we refer to Ell1, Eaf1 and Ebp1 as the ELL complex. 
We made gene deletions of each of these genes individually to study the role 
these genes may be playing in the cell.  Despite a reported role for mammalian ELL and 
EAF in the response to UV irradiation (Mourgues et al., 2013a), S. pombe strains lacking 
ELL complex components showed no hyper-sensitivity to DNA damaging agents under 
the conditions tested.  On the other hand, deletion of the ell1+  gene gave rise to 
sensitivity to 6-azauracil and mycophenolic acid, a characteristic of many genes involved 
in transcription elongation (Riles et al., 2004). The deletion of ell1+, eaf1+ or ebp1+ did 
not affect the Pol II occupancy genome-wide and affected expression of a relatively small 
fraction of genes.  Results of RNA seq experiments indicated, however, that among those 
affected by ell1+ deletion was a group of up-regulated genes near telomeric regions.  We 
performed ChIP seq experiments using antibody that recognizes H3K9 methylation mark, 
a characteristic mark for heterochromatin in eukaryotes, and found that upon deletion of 
ell1+ the heterochromatin pattern at the sub telomeric region was altered. eaf1+ or 
ebp1+ deletions, on the other hand, did not seem to alter the subtelomeric H3K9 
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methylation mark, suggesting Ell1 may have an independent role in regulating 
heterochromatin at the subtelomeric regions in fission yeast. 
In this section, we exploit yeast genetics in an effort to gain additional insight into 
the roles of Ell1, Eaf1 and Ebp1 in cells. Our aim is to find genetic interactions of these 
three genes in S. pombe using a high throughput approach. Large-scale genetic 
interaction mapping can be performed using synthetic genetic array (SGA) analysis, a 
method that offers an efficient approach for the systematic construction of double 
mutants and enables a global analysis of synthetic genetic interactions (Roguev et al., 
2007a). In a typical SGA screen in S. pombe, a query mutation is crossed to an ordered 
array of ~5000 viable gene deletion mutants such that meiotic progeny harboring both 
mutations can be scored for fitness defects. Estimating the fitness of the two single 
mutants and their corresponding double mutant gives a quantitative measurement of 
genetic interactions, distinguishing negative (synthetic lethal) and positive interactions. 
Proteins that act separately but have overlapping important functions show negative 
genetic interaction such that loss of both genes results in severe growth defect. Positive 
genetic interactions refer to double mutants with a less severe fitness defect than 
expected and include interactions such as epistasis and suppression 
We performed the screen in triplicate for all three of our genes, ell1, eaf1 and 
ebp1. We focused our analysis on the identification of synthetic lethal or sick 
interactions, in which a combination of mutations in two genes results in cell death or 
reduced fitness. We found multiple genes that interact with genetically with ell1, eaf1 
and ebp1.  A second group of genes showed significant interactions with only ell1. We 
focused on the most interesting interactions from each group of these genes. 
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Brl1, an E3 ubiquitin ligase enzyme catalyzes the mono-ubiquitylation of histone 
H2B at a conserved site in the carboxyl-terminus (H2Bub1) throughout coding regions of 
genes. brl1Δ was found to have a strong genetic interaction with ell1Δ, eaf1Δ and ebp1Δ. 
H2Bub1 plays a central role in the interplay between chromatin and the RNAPII 
elongation complex. Formation of H2Bub1 on transcribed chromatin also requires PAF 
and H2Bub1 promotes co-transcriptional generation of H3K4me by methyltransferase 
Set1. Reports suggest interdependence of Cdk9-mediated Spt5 phosphorylation and 
H2Bub1, a co-regulation governed by positive feedback. We explore the interaction 
between ELL complex and Brl1 further in this section. 
It was also interesting to note that we got many genes that are involved in 
maintaining the heterochromatin at centromeres and telomeres in our ell1Δ SGA screen. 
Our previous data from RNA seq and H3K9me2 ChIP-seq already suggest that Ell1 may 
have a role formation or maintenance of H3K9 methylation at subtelomeric regions in 
pombe. Genetic interaction of ell1Δ with genes involved in heterochromatin formation 
further supports this idea.  
This section first explains the strategy of performing SGA and then discusses some 
of the interesting negative genetic interaction we found in our screens. 
 
5.2 Strain construction and synthetic genetic array 
SGA analysis requires a relatively simple set up that involves generating the query 
strain of interest and crossing it to an array of all the viable deletion mutant strains.  
Through a series of several replica-plating steps, the double mutants are selected and 
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scored for growth. Each step of the procedure is described in detail below (also shown in 
Figure 5.1A). 
Query strain construction:  
The genes of interest were individually deleted using PCR based techniques to 
generate ell1Δ, eaf1Δ or ebp1Δ, containing a gene deletion marker natMX4. natMX4 
provides the cells resistance against the drug nourseothricin, commonly referred to as 
clonNAT. The strain background used for generation of query strain was Pem2 and 
followed the protocol as described in (Roguev et al., 2007a). The h– Pem2 cell contains 
cyhS in the h– locus and a cycloheximide-resistance (cyhR) allele at the endogenous rpl42 
locus.  This configuration mimics a cyhS- cyhR diploid and hence is sensitive to 
cycloheximide. After mating and sporulation, growth in the presence of cycloheximide 
serves as both anti-diploid and mating-type selection as it allows selection for only the 
meiotic h+ haploid and eliminating any remaining diploids or unmated parent cells 
(shown in Figure 5.1B). The S. pombe deletion array was obtained from Bioneer Inc. 
having all viable gene deletions in h+ ade6-M210 ura4-D18 leu1-32 genotype with 
KanMX6 marker providing resistance to G418. 
SGA procedure:  
The array of G418 resistant mutants were pinned onto an agar plate such that 
each plate has 384 clones. Position of each deletion was noted. Similarly, the query strain 
was spotted onto an agar plate (384 spots/ plate). The plates were incubated at 32°C for 
2 days for the cells to grow. After 2 days, 384 clones were robotically pinned onto SPAS 
plate (minimal media that causes sporulation), followed by the pinning of query strain on 
top of it and finally 384 spots of water were put on the plate to facilitate sporulation. The 
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plates were kept at room temperature for ~5 days or until tetrads can be seen under 
microscope. The spores were printed onto YES plates containing G418 and cycloheximide 
(100µg/ml) as quadruplicate spots (1530 spots/plate). Cells were grown for 2 days to 
select for h- mutants. For further selection, the colonies were replica printed onto YES 
plates containing G418 and cycloheximide again and grown for 2 days. Finally, the 
colonies were replica printed onto ‘Control’ plates (YES+G418+cycloheximide) and ‘Test’ 
plates (YES+G418+clonNAT+cycloheximide). Only the double mutants would grow on the 
Test plates as it contains both G418 and clonNAT, whereas, on the control plates 
containing only G418 both the single and double mutants survive. 
Figure 5.1 SGA methodology using Pem2 strategy.  
(A) Two haploid strain carrying differently marked mutation (X and Y) are mated and following meiosis and 
sporulation, haploid progenies are produced. Anti-diploid selection, mating-type selection and double-
mutant selection are then applied. (B) PEM-2 strategy: a cyhS allele is expressed from within the mating 
type locus of h– cells while a cyhR allele is expressed from the endogenous locus, creating a genotype that 
mimics a heterozygous diploid. After meiosis, the only cells able to survive on medium containing 
cycloheximide are haploids from the opposite mating type (h+). 
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Image processing and quantitative scoring using colony size-based fitness 
measurements: 
Double mutant array plates are photographed in a light-controlled chamber using 
a high-resolution digital imaging system. Richard Alexander, from Stowers microscopy 
center helped quantitate the colony sizes by measuring the area of each colony (in pixels 
squared) using an Axiovision script. A computational pipeline for processing SGA raw data 
was then created to identify quantitative genetic interactions by applying a series a 
normalization to correct for numerous systematic experimental effects like Plate-specific 
effect, Row/column effect, Spatial effect, competition effect etc. At least 2 of the four 
quadruplicate spots should have grown in the control plate for that gene to be 
considered. For each spot, a Z score was calculated using the equation (x- mean of all 
samples)/ (standard deviation of all samples), where x is the intensity of a given spot. For 
a spot to be considered significantly down, z score should be less than 2*(- standard 
deviation) with a median change of <0.5 for atleast 2 of the spots. A list of significantly 
sick genes or the negative genetic interactions for each experiment was created. 
 
 
5.3 Interpretation and analysis of negative genetic interactions 
We performed the screen in triplicate for all three deletion mutants.  From these 
screens, we found two classes of genes; (1) show negative genetic interactions with all 
three genes ell1, eaf1 and ebp1, and (2) show strong genetic interaction with ell1, and 
very little with the eaf1 or ebp1, again raising the possibility that Ell1 may exert some 
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functions independent of the other factors. The latter observation is perhaps not 
surprising since, since Ell1 binds directly to Pol II and at least in vitro can weakly enhance 
elongation on its own. Some of the interesting hits from both the classes are listed 
below. Proteins that act separately but have overlapping important functions show 
negative genetic interaction or synthetic lethality, such that loss of both genes results in 
severe growth defect. The components do not act in the same pathway. 
 
1) Genes interacting genetically with all three strains; ell1Δ, eaf1Δ and ebp1Δ: 
A group of genes show negative genetic interactions in many of our screens with 
the three genes tested. Table 5.1 shows some of these genes. The list is extensive.  We 
found one of the most interesting hits to be brl1. brl1 I encodes a ubiquitin protein ligase 
was found in 6 of the 9 screens, genetically interacting with ell1, eaf1 and ebp1. We 
chose to pursue it because of its obvious connection to transcription and chromatin 
structure. Brl1 is essential for histone H2B ubiquitylation and is known to be important 
for recruitment of P-TEFb kinase (Sanso et al., 2012a). I will discuss the interaction 
between brl1Δ and ell1Δ, eaf1Δ, and ebp1Δ in the next section (Section 5.4). 
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Table 5.1 Negative genetic interaction  
SGA screens for ell1Δ, eaf1Δ and ebp1Δ were performed in triplicate. Some of the hits for each screen are 
shown here. ‘0’ represents no detectable genetic interaction whereas a positive hit or a ‘negative genetic 
interaction’ for a given screen is represented by ‘1’ (red box).  
 
 
2) Genes that genetically interact with only ell1Δ: 
The screens identified a large number of genes that interact genetically with ell1Δ but not 
with eaf1Δ or ebp1Δ, raising the possibility that Ell1 has functions that are partially or 
wholly independent of its binding partners Eaf1 and/or Ebp1. This observation is 
somewhat surprising in light of the finding that deletion of eaf1 decreases ell1 expression 
levels; however, it suggests that enough residual ell1 protein remains in the eaf1 deletion 
strain to support key ell1 functions. As noted above, we know Ell1 is the only one of the 
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three that can directly bind Pol II, and in vitro experiments show that Ell1 can stimulate 
rate of elongation by itself. Hence, a larger list of genetic interaction may be an indication 
that the Ell1 protein is more important for cellular functions than Eaf1 or Ebp1. One 
interesting group of genes that fell into this category were multiple genes involved in 
heterochromatin formation and maintenance. These interactions are explored further 
later in the chapter. 
 
5.4 Genetic Interaction between brl1Δ and ell1Δ, eaf1Δ, and 
ebp1Δ 
The brl1 gene was among the genes found to have negative genetic interaction 
with ell1, eaf1 and ebp1 in the SGA screens.  Brl1 was of particular interest as an SGA hit 
as it has genetic interactions with genes encoding all three of the ELL complex 
components, and because Brl1 has role in maintaining the chromatin state and in 
transcription in cells. Brl1 is a ubiquitin protein ligase E3 that puts a mono-ubiquitin mark 
at the K119 position of histone H2B. Mono-ubiquitylation of histone H2B (H2Bub1) is 
required for co-transcriptional generation of H3K4 marks by the methyltransferase Set1 
in yeast, and it contributes to global H3K4me levels in metazoans. H2Bub1 also regulates 
gene expression through an unidentified, methylation-independent mechanism. Notably, 
H2B ubiquitylation has been linked to Pol II elongation.  For example, in metazoa, 
cotranscriptional monoubiquitylation of H2B and the Pol II elongation rate are tightly 
coupled (Fuchs et al., 2014). In S. pombe, H2Bub1 and Cdk9 (P-TEFb) are regulated by a 
positive feedback loop, where Cdk9 activity is needed for co-transcriptional H2B 
ubiquitylation, and H2Bub1 in turn stimulates Cdk9 activity toward Spt5 (Sanso et al., 
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2012b). H2Bub1 is also needed for centromeric chromatin maintenance, promoting 
noncoding transcription, centromere integrity, and accurate chromosomal segregation 
(Sadeghi et al., 2014a).   It is also interesting to note that multiple proteins involved in 
centromeric integrity during chromosome segregation also showed up in the SGA screens 
(Table 5.2). This further suggested that Ell complex and Brl1 functions might be linked. 
 
 
Table 5.2 ell1, eaf1 and ebp1 interact genetically with multiple genes implicated in centromeric integrity 
SGA screen for the ell1Δ, eaf1Δ and ebp1Δ was performed in triplicates and these proteins were seen to 
interact with multiple genes important for the centromeric architecture 
 
To further confirm the synthetic sickness of the Ell complex-brl1 double mutants, 
we made the following strains independently; ell1Δ brl1Δ, eaf1Δ brl1Δ and ebp1Δ brl1Δ. 
We checked the growth of these strains in liquid medium using TECAN microplate reader, 
which allows measurement of the absorbance of the culture with time. Single deletions 
of ell1+, eaf1+ and ebp1+ had no effect on cell growth in rich medium, while cells carrying 
the brl1+ deletion grew more slowly than wild type. As shown in Figure 5.2, the double 
deletion strains grew much more slowly than wildtype or the single brl1Δ strains, again 
suggesting that the ELL complex has strong genetic interaction with brl1. 
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Figure 5.2 ell1+, eaf1+ and ebp1+ deletion when combined with brl1+ deletion makes the cells sick. 
Graphs showing change in absorbance with time for various strains tested. The slope of the graph denotes 
the growth rate. 
 
5.5 Effect of ell1+, eaf1+ and ebp1+ deletions on Brl1 function 
Brl1 plays a key role in H2B ubiquitylation and, because it helps to recruit Set1, 
the subsequent Set1-dependent H3K4 methylation. For these reasons, we wanted to 
determine whether deletion of ell1+, eaf1+ and ebp1+ would have any effect on overall 
H2B mono-ubiquitylation or H3K4 methylation in cells.  For this, we made whole cell 
extracts from all strains and performed western analysis using antibodies specific for 
H2Bub1 and H3K4me1.  As shown in Figure 5.3, I found that deletion of ell1+, eaf1+ or 
ebp1+ had no effect on the overall levels of H2Bub1 and H3K4me1. A strain in which H2B 
cannot be ubiquitylated by Brl1 was used as a control to ensure that we observe the 
expected loss of H3K4me1 and H2Bub1 in these assays. 
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Figure 5.3 ell1+, eaf1+ or ebp1+ deletion does not affect the overall levels of H3K4me1 or H2Bub1 
Western analysis using specific antibodies against H3 (used as loading control), H3K4me1 and H2Bub1. 
Different amounts of whole cell extracts for each strain were loaded and the blots were probed with 
indicated antibody. 
 
 
Because H2B is the major target for Brl1 ubiquitin ligase, we anticipated that double 
mutant strains carrying the htb1-K119R mutation along with the ell1+, eaf1+ or ebp1+ 
deletions would behave similarly the Brl1-ELL complex double mutant strains. To our 
surprise, however, we found that deletion of the ELL complex in the htb1-K119R mutant 
strain had no effect on the growth of cells (Figure 5.4), as the double mutants grow 
similarly to the htb1-K119R single mutant. This observation suggests that the genetic 
interaction we observe between the ELL complex and Brl1 could be due to ubiquitylation-
independent mechanisms. 
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Figure 5.4 ell1+, eaf1+ and ebp1+ deletion combined with htb1-K119R mutation does not mimic the growth 
defects seen with brl1 deletion 
Graphs showing change in absorbance with time for various strains tested. The slope of the graph denotes 
the growth rate. 
 
Previous experiments have suggested a role of H2Bub1 in mitotic progression by 
using htb1 mutants with affected ubiquitylation status. We therefore wished to 
determine whether mutants in ELL complex components exhibit mitotic phenotypes. 
First, we tested whether deletion of ell1+ affects centromere function by growing mutant 
strains in the presence of the microtubule-destabilizing drug thiabendazole (TBZ). Figure 
5.5 shows that as previously reported (Sadeghi et al., 2014b) H2Bub1-deficient cells 
(htb1-K119R) were sensitive to TBZ, thus confirming that H2B monoubiquitylation acts 
synergistically with TBZ during chromosome segregation. Of note, deletion of ell1+ also 
rendered cells sensitive to TBZ.  
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Mutations causing loss of H2Bub1 are also known to increase chromosomal mis-
segregation.  For a direct measurement of genome stability, we sought to analyze the 
chromosome segregation in M phase cytologically. We DAPI stained the cells to look for 
aberrant chromosomal segregation.  As expected, the brl1Δ and htb1-K119R exhibited 
increased (OR severe) chromosomal lagging and stretching leading to mis-segregation; 
however, the ell1Δ, eaf1Δ and the ebp1Δ strains behaved similar to the wildtype strain 
(data not shown).   
 
Figure 5.5 TBZ sensitivity of ell1Δ strain.    
The Wildtype, ell1Δ and htb1-K119R strains, were grown to mid log phase in rich media, washed in 1X PBS, 
and resuspended in H2O at a density of 1 x 108 cells/ml.  5 μl of 3-fold serial dilutions of cells were spotted 
onto YES plates with or without thiabendazole.   
 
 
Deletion of brl1+ affects recruitment of Cdk9 kinase (Sansó et al., 2012).  As I have 
shown, Cdk9 and the ELL complex co-occupy many genomic loci, prompting us to 
determine whether Brl1 or H2B ubiquitylation are needed for optimal ELL complex 
recruitment in S. pombe.  We performed ChIP-qPCR analysis to test whether recruitment 
of ELL complex is affected in brl1Δ and htb1-K119R strains, and found that absence of 
H2Bub1 had no effect on the recruitment of Ell1, Eaf1 or EBP1 (data not shown).  
123 
 
5.6 ell1Δ shows negative interaction with genes involved in 
heterochromatin formation 
As discussed in Chapter 5, I found that deletion of ell1+ led to a significant 
decrease in H3K9me2 at subtelomeric regions of chromosomes 1 and 2.  In addition, I 
detected an increase in expression of a number of genes within the affected loci in the 
ell1Δ strain, suggesting that Ell1 could play a role in heterochromatin formation or 
maintenance.  Heterochromatin formation is mediated by distinct histone-modifying 
enzymes (H3K9me), RNAi proteins, components of the Pol II machinery and homologs of 
heterochromatin protein 1 (HP1) (Allshire and Ekwall, 2015). These mechanisms are 
conserved in higher eukaryotes.  
 A major hallmark of heterochromatin in most eukaryotes is the methylation of 
histone H3 at lysine 9 (H3K9) and histone hypocetylation. In fission yeast, H3K9 
methylation is carried out by a histone methyltransferase, Clr4, which is responsible for 
mono-, di- and tri-methylation of H3K9. H3K9me forms a binding site for chromodomain-
containing heterochromatin proteins, including the HP1 homologs Swi6 and Chp1, and 
importantly, for Clr4 itself, leading to models for perpetuation and spreading of 
heterochromatin (Ekwall et al., 1996; Ivanova et al., 1998; Zhang et al., 2008). Clr4 can be 
isolated as part of a complex containing a cullin 4 (Cul4)-based E3 ubiquitin ligase and 
Rik1 protein, termed the CLRC (CLr4-Rik1-Cul4) complex, that help in heterochromatin 
formation (Hong et al., 2005). Heterochromatic silencing also requires multiple conserved 
deacetylases (HDACs) like Clr3, Clr6 and Sir2, and the components of the RNAi machinery. 
Among these are the Argonaute-containing RNA-induced transcriptional silencing (RITS) 
RNAi effector complexes (Sadaie et al., 2004). RITS is required for H3K9 methylation by 
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Clr4 and conversely, H3K9 methylation can attract RITS to chromatin via binding of the 
Chp1 protein. RITS also interact with RNA-directed RNA polymerase (RDRC) whose 
activity is critical for siRNA generation and heterochromatin assembly (Motamedi et al., 
2004). 
Interestingly, when we performed SGA screen with ell1Δ strain, we found that a 
collection of genes encoding proteins involved in heterochromatin formation or 
maintenance were identified as negative interactors with ell1Δ. These interactions did 
not seem to occur with eaf1Δ or ebp1Δ.  This finding is particularly interesting in light of 
our observation that heterochromatin formation is altered specifically in ell1Δ cells and is 
consistent with the idea that Ell1 may have a role independent of Eaf1 and Ebp1 in 
maintaining heterochromatin in S. pombe. Table 5.3 show some of these interactions. 
 
 
Table 5.3 ell1Δ interacts genetically with genes implicated in heterochromatin formation and/or 
maintenance 
SGA screens with ell1Δ, eaf1Δ or ebp1Δ strains were performed in triplicates. Only ell1Δ interacted 
reproducibly with multiple genes involved in heterochromatin formation and/or maintenance. 
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5.7 ell1Δ interactions in presence of mycophenolic acid 
 From work presented in this thesis and elsewhere (Banks et al., 2007), we know 
that strains deleted for ell1 exhibit sensitivity to drugs such as mycophenolic acid and 6-
azauracil, phenotypes associated with a number of transcription elongation regulators. 
To determine whether ell1Δ would interact with additional genes when grown under 
conditions thought to compromise transcription elongation, we performed additional 
SGA screens on MPA-containing medium.   
We performed the SGA screen in triplicates as before with ell1Δ cells, but at the 
last plating used plates containing 15 µg/ml mycophenolic acid in addition to the 
selection markers. We identified a few genes that interacted with ell1Δ only in the 
presence of MPA and that could possible play a role in transcription (Table 5.4). Ssr4 is a 
part of Chromatin remodelers like SWI/SNF and RSC and can hence modulate 
transcription. Cdk11 phosphorylates the Med27 and Med4 Mediator subunits on 
conserved residues and is required for the assembly of Mediator complex in S. pombe 
(Drogat et al., 2012). Studies indicate that Rhp41, a fission yeast homolog of human XPC, 
is involved in transcription-coupled repair of MMS-induced DNA damage (Kanamitsu and 
Ikeda, 2011). Splicing associated factor, Saf4, is an interesting hit because it splicing can 
influence the rate of transcription elongation. We also got hits like the protein coded by 
SPAC18B11.11 that have no known transcription role, but showed up in all our screens in 
the presence of MPA. In the future, it would be worth analyzing these interactions 
further as they may shed light on elongation specific functions of Ell1.  
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Table 5.4 ell1Δ interacts genetically with some genes only in the presence of MPA 
SGA screen for the ell1Δ was performed in triplicates with or without MPA (15 ug/ml) and some 
interactions were seen only in the presence MPA. 
 
5.8 Discussion 
A genetic interaction occurs when the combination of two mutations leads to an 
unexpected phenotype. Screens for synthetic genetic interactions have been used 
extensively to identify genes whose products are functionally related (Baryshnikova et al., 
2013) Using a method termed synthetic genetic array, is a high-throughput technique for 
identifying genetic interactions (Baryshnikova et al., 2010), we performed three separate 
screens – each in triplicate – to identify genes that interact with the ell1, eaf1, and ebp1 
genes. SGA is a powerful technique for large-scale construction of mutants and 
assessment of phenotypic consequences associated with combinatorial genetic 
perturbations.  From our screens, we obtained a list of genes that show negative genetic 
interactions with ell1Δ, eaf1Δ or ebp1Δ strains. Many of the genes identified were 
identified in all three screens, and some were involved in related pathways We focused 
first on the Brl1 gene, which encodes an E3 ligase involved in H2B ubiquitination at K119 
position in S. pombe.  
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H2Bub1 levels in chromatin generally correlate with Pol II and transcription but 
H2Bub1 has also been implicated in diverse cellular functions, such as DNA replication, 
differentiation and DNA-damage responses. H2B monoubiquitylation, which appears to 
play a central role in the interplay between chromatin and the RNAPII elongation 
complex, is catalyzed in budding yeast by the ubiquitin-conjugating enzyme Rad6 and the 
E3 ubiquitin ligase Bre1 (Osley, 2004). Formation of H2Bub1 on transcribed chromatin 
also requires PAFc (Jaehning, 2010).  H2Bub1 is important for co-transcriptional 
generation of H3K4me by the methyltransferase Set1 in yeast (Racine et al., 2012; Sun et 
al., 2015; Sun and Allis, 2002), and contributes to global H3K4me levels in metazoans 
(Dover et al., 2002). A positive feedback loop, in which phosphorylation by Cdk9 
stimulates H2Bub1, and H2Bub1 stimulates chromatin association of Cdk9 and 
phosphorylation of Spt5 (DSIF subunit), is reported to regulate elongation in S. pombe 
(Sanso et al., 2012b). Noncoding centromeric transcription is dependent on H2Bub1, and 
in H2Bub1-deficient cells, centromere functionality is hampered resulting in unequal 
chromosome segregation (Sadeghi et al., 2014b). 
We generated independent double mutants having deletion of brl1+ with ell1Δ, 
eaf1Δ or ebp1Δ and confirmed that the double mutants indeed grow much slower than 
the wildtype or the single mutants. But surprisingly, lack of H2Bub1 in a mutant that 
cannot monoubiquitinate H2B did not incite the same growth phonotype when combined 
with ell1Δ, eaf1Δ or ebp1Δ. This suggests that the genetic interaction that ell1Δ, eaf1Δ or 
ebp1Δ show with brl1Δ could be due to functions independent of H2B ubiquitination. 
Furthermore, we found that the overall levels of H2b ubiquitination or H3K4 methylation 
were not detectably changed upon ell1+, eaf1+ or ebp1+ deletion; whether the ELL 
complex contributes to placement of these marks at specific locations within the genome 
128 
 
remains to be determined. Deletion of ell1+ did show a sensitivity when grown in 
presence of the microtubule-destabilizing drug thiabendazole, but what if any role ell1+ 
may play in chromosome segregation needs to be tested further. 
ell1Δ showed genetic interaction with many more genes than eaf1Δ or ebp1Δ, 
which may suggest that Ell1 has functions independent of Eaf1 and Ebp1 and/or plays a 
more central role in processes regulated by the ELL complex than Eaf1 and Ebp1. 
Consistent with this observation, only deletion of ell1+ causes a sensitivity to 6-azauracil 
and mycophenolic acid, and studies show that Ell1 by itself can stimulate in vitro 
elongation by Pol II, suggesting that it may have a bigger role than Eaf1 and Ebp1. Some 
of the genes/pathways that showed up as genetic interactors of ell1Δ were interesting 
and worth studying further in the future.  In further experiments, we performed the SGA 
screen for ell1Δ in the presence of MPA and found identified additional interactions 
detected only under these conditions. Some of the interactions that we found only in the 
presence of MPA are SWI/SNF and RSC subunit Ssr4, DNA repair protein Rhp41 and 
splicing associated factor Saf4. These genetic interactions can be studied more in the 
future as they may help to elucidate the role of Ell1 in transcription elongation.  
It was interesting to find that that multiple genes with roles in heterochromatin 
formation or maintenance were identified in our SGA screens. Argonaute or Ago1 in S. 
pombe showed up in all 3 ell1Δ SGA screen. Ago1, a component of RNA-induced 
transcriptional silencing complex (RITS), is needed for co-transcriptional gene silencing by 
RNA interference machinery. RITS is proposed to be the key initial trigger for 
heterochromatin assembly and regulation of histone H3K9 methylation. Clr4 (Cryptic loci 
regulator 4) is the only histone H3K9 methyltransferase in S. pombe and therefore is 
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absolutely required for heterochromatin regulation. Clr4 has been found to be part of a 
multiprotein complex termed “Clr4 methyltransferase complex” (CLRC). CLRC is 
composed of Clr4, Raf1, Raf2, Cul4, and Rik1. Rik1, Clr1, Clr2, Clr3, Clr4 and Swi6 were all 
identified in S. pombe screens for factors involved in heterochromatin silencing (Ekwall 
and Ruusala, 1994; Thon and Klar, 1992). Clr1, Clr2 and Clr3 are part of the Snf2/HDAC-
containing Repressor Complex (SHREC) that mediates heterochromatin transcriptional 
gene silencing in fission yeast (Sugiyama et al., 2007). Clr3 is a an H3-K14-specific histone 
deacetylase II.  SHREC is recruited to the telomeres by multiple independent mechanisms 
and acts to restrict Pol II occupancy at heterochromatin repeats. SHREC interacts with 
Ccq1, a telomere binding protein that along with Taz1 acts in a parallel mechanism to 
RNAi pathway to facilitate recruitment of SHREC to the telomeric ends (Moser et al., 
2015). Clr4, Rik1, Clr1 and Clr3 were all found to be strong negative genetic interaction in 
the ell1Δ screens, again consistent with the possibility that Ell1 plays a role in 
heterochromatin maintenance.  In the future, it will be of considerable interest to 
explore the connections between Ell1 and the genes and proteins regulating 
heterochromatin formation and maintenance.
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CHAPTER 6: Conclusion 
This thesis elucidates the role of Ell1 and Eaf1 in S. pombe that act as elongation factors 
and share functional similarities with the ELL-EAF complex found in higher eukaryotes.   
Since S. pombe has genes encoding P-TEFb, Ell1 and Eaf1 we hypothesized that a larger 
elongation complex like the Super elongation complex in mammals might be present. 
Proteomic experiments found that both Ell1 and Eaf1 interact with a previously 
uncharacterized protein encoded by the gene SPAC6G9.15c. Upon performing Psi-blast 
with relaxed stringency we find that that this new protein, that we refer to as Ell1 binding 
protein (Ebp1) might have sequences of faint homology to the AF4 family of proteins 
from higher eukaryotes. We showed that Ell1, Eaf1 and Ebp1 can stably interact and are 
recruited together to places having high Pol II and P-TEFb (cdk9), suggesting that fission 
yeast may have an SEC-like complex. In-vitro transcription assays performed using 
recombinant proteins showed that while Ell1/Eaf1 can stimulate the rate of elongation as 
previously reported, the addition of Ebp1 had no detectable effect on the elongation by 
Pol II under the conditions tested, indicating that Ebp1 plays a role undetectable in our 
assays. Ebp1 might play a potential role as a scaffold on which other proteins can 
assemble, or by helping to recognize chromatin marks, or by linking Ell1/Eaf1 to other 
regulatory proteins. Deletion of Ell1 causes a 5’ shift in the pattern of Pol II occupancy 
across genes, which is consistent with the idea that it acts as an elongation factor such 
that the deletion of Ell1 causes Pol II to lag behind. In the future, it would be interesting 
to check whether the loss of Ell complex might lead to changes in CTD S2 
phosphorylation, a mark that is placed by the P-TEFb kinase Cdk9 and is diminished in 
higher eukaryotes upon ELL depletion. The deletion of these genes had minimal effect on 
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steady state levels of messenger and other RNAs in cells grown in rich media under 
optimal conditions, though it is worth noting that a group of genes regulated by the 
transcription factor Ace2, including the Ace2 transcript itself were downregulated. These 
Ace2 and Ace2 regulated genes also exhibit disproportionally high Ell complex binding 
relative to Pol II compared to the genome-wide average, suggesting that Ell complex 
could play a direct role in the regulation of expression of Ace2 and Ace2 regulated genes. 
It would be interesting to check whether the absence of Ell1, Eaf1 or Ebp1 influences the 
cell cycle stages or causes septation defects as in ace2Δ cells. 
Genetic screens performed to identify the proteins that may work in similar 
pathways (negative genetic interactions) gave us multiple targets that interacted 
genetically with either all three of the proteins or Ell1 alone. It is perhaps not surprising 
that deletion of Ell1 has a more prominent phenotype, as Ell1 is the subunit that can 
directly bind to Pol II and stimulate the rate of transcription elongation by itself. 
It was interesting to find that that multiple genes with roles in heterochromatin 
formation or maintenance were identified in our SGA screens, suggesting that Ell1 may 
play a role in heterochromatin maintenance. Heterochromatin distribution was checked 
by H3k9me2 ChIP, and it was found that deletion of Ell1 gene changes the pattern of 
heterochromatin at the sub -telomeric regions of the chromosomes 1 and 2. 
Interestingly, a few CTD mutants have also been reported to give rise to similar 
H3K9methylation phenotypes as ell1 deletion (Inada et al., 2016). It is interesting to note 
that in RNA seq a cluster of genes in the region close to the right arm of Chromosome 1 
(where the H3K9 methylation mark is reduced) seemed to be modestly upregulated upon 
ell1+ deletion, again reinforcing the possibility that Ell1 may play a role in 
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heterochromatin regulation/maintenance at the sub-telomeric regions. Reintroducing 
ell1+ into the mutant strains to see whether the phenotype can be rescued might 
validate the role of Ell1 in heterochromatin formation and maintenance.
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CHAPTER 7: Materials and Methods 
7.1 S. pombe strain construction 
The gene manipulations necessary to generate fission yeast strains required for 
mass spectrometry and EM analyses were carried out using standard protocols. The 
strains used in this study are listed in Appendix A. A PCR-based genomic epitope-tagging 
method was used to construct subunit deletion strains, where coding region of the gene 
of interest was replaced by a selection marker (NatMX6 or KanMX6). 
 
Figure 7.1 Construction of gene deletion strains. 
PCR primers (indicated by arrows) were used with the pFA6a plasmid as template to generate a PCR 
product with 90bp of homology to regions flanking  the sequence to be deleted as indicated. 
Transformation of the PCR product into S.pombe cells resulted in replacement of the target sequence with 
a Nourseothricin or kanamycin resistance cassette under the control of promoter sequences from Ashbya 
gossypii (black box represents the STOP codon). Transformed cells were plated and isolated on YES 
containing 200 mg/l  clonNAT/ G418. Deletion of the target sequence and insertion of the resistance 
cassete at the correct locus were both confirmed by PCR. 
 
Strains used for MudPIT analysis were C-terminally Flag-tagged on by replacing 
the stop codons of each gene with sequences encoding 3× Flag followed by a stop codon 
and the NatMX6 marker (Bahler et al., 1998).  
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Figure 7.2 Construction of epitope tagged strains.   
The target gene is indicated as the blue box with the stop codon (black). PCR primers were designed with 
90 bases of homology to the region immediately upstream of the stop codon (5’) and a region downstream 
of the stop codon (3’). These were used to generate a PCR product using the pFA6a 3X FLAG natMX6 
plasmid as a template. This includes 3 tandem repeats coding for the flag epitope with a transcription 
termination sequence followed by a nourseothricin antibiotic cassette. The PCR product was used to 
generate recombinant strains as described in Figure 7. . 
 
7.2 Immunopurification for Mass spectrometry 
S. pombe Mediator and Ell1/Eaf1 preparations used for MudPIT mass 
spectrometry were purified by anti-Flag immunopurification from 972 h- derivatives 
expressing Flag-tagged Mediator subunits. Flag-immunopurified proteins were treated 
with benzonase, TCA precipitated, denatured, reduced and alkylated, digested with 
endoproteinase Lys-C and trypsin, and analyzed by MudPIT mass spectrometry.  
972 h- cells or 972 h- derivatives expressing Flag-tagged proteins were grown at 
32 °C in rich medium (YES) supplemented with adenine, histidine, leucine and uracil (225 
μg/ml). Cells were harvested at mid-log phase, washed in cold H2O, and washed in buffer 
containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP40, and 10% glycerol with 
protease inhibitor cocktail (Sigma P8849). Cells were pulverized in liquid nitrogen using a 
mortar and pestle and then re-suspended in the same buffer. Whole-cell lysates were 
centrifuged at 40,000 rpm to remove cell debris. Supernatants were incubated overnight 
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at 4°C with anti-Flag agarose beads (Sigma, 500μl beads per 108 starting cells) that had 
been pre-equilibrated in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% NP40, and 10% 
glycerol with protease inhibitor cocktail. Beads were washed four times with 
approximately 10 bead volumes of buffer containing 50 mM Tris-HCl (pH 7.5), 300 mM 
NaCl, 10% glycerol and 0.1% NP40, and bound proteins were eluted using 0.2 mg/ml 3× 
Flag peptide (Sigma) in 50 mM Tris-HCl, 300 mM NaCl, 10% glycerol and 0.1% NP40. Flag-
immunopurified proteins were treated with benzonase and TCA precipitated before 
analysis by multidimensional protein identification technology (MudPIT). 
  TCA-precipitated proteins were urea-denatured, reduced, alkylated and digested 
with endoproteinase Lys-C (Roche) followed by modified trypsin (Roche) (Washburn et 
al., 2001). Peptide mixtures were loaded onto 100-μ m fused silica microcapillary 
columns packed with 5-μm C18 reverse phase (Aqua, Phenomenex), strong cation 
exchange particles (Partisphere SCX, Whatman), and reverse phase (Florens and 
Washburn, 2006). Loaded microcapillary columns were placed in-line with an LCQ or LTQ 
ion trap mass spectrometer equipped with a nano-LC electrospray ionization source 
(ThermoFinnigan). Fully automated MudPIT runs were carried out on the electrosprayed 
peptides. Tandem mass (MS/MS) spectra were interpreted using SEQUEST against a 
database of a database of S. pombe proteins (downloaded from NCBI on 23 January 
2012), and complemented with 177 sequences from usual contaminants (human 
keratins, IgGs, proteolytic enzymes). To estimate false positive discovery rates, each 
sequence was randomized keeping amino acid composition and length the same, and the 
resulting ‘shuffled’ sequences were added to the ‘normal’ database (doubling its size) 
and searched at the same time. Peptide/spectrum matches were sorted and selected 
using DTASelect with the following criteria set: spectra/peptide matches were only 
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retained if they had a DeltaCn of at least 0.08, and minimum XCorr of 1.8 for singly, 2.0 
for doubly, and 3.0 for triply charged spectra. In addition, peptides had to be fully tryptic 
and at least 7 amino acids long. Combining all runs, proteins had to be detected by at 
least 2 such peptides or by 1 peptide with 2 independent spectra. Under these criteria, 
the overall false discovery rate was less than 0.2%. Peptide hits from multiple runs were 
compared using CONTRAST (Tabb et al., 2002). To estimate relative protein levels, 
distributed normalized spectral abundance factors (dNSAFs) were calculated for each 
detected protein (Florens et al., 2006). 
 
7.3 Expression and purification of Recombinant Proteins in Insect 
Cells 
cDNAs encoding wild-type ell1+, eaf1+ and ebp1+ containing N-terminal FLAG or 
c-Myc epitope tags were subcloned into pBacPAK8. Recombinant baculoviruses were 
generated with the BacPAK expression system (Clontech) using pBacPAK6 viral DNA 
prepared as described (Kitts and Possee, 1993), and stored in 50ml centrifuge tubes 
spray-painted black to prevent exposure to light during storage. Sf21 insect cells were 
cultured at 27 °C in Sf-900 II SFM (Invitrogen). Flasks containing 1 x 108 Sf9 cells were 
infected with the recombinant baculoviruses. Forty-eight hours after infection, cells were 
collected and lysed in 15 ml of ice-cold buffer containing 50 mM Hepes-NaOH (pH7.9), 
300mM NaCl, 5 mM MgCl2, 0.2% Triton-X-100 and 20% (v/v) glycerol with protease 
inhibitor cocktail. Lysates were centrifuged 40,000 rpm for 30 min at 4°C. 
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FLAG-tagged proteins were purified from Sf9 cell lysates by anti-FLAG agarose 
immunoaffinity chromatography. Lysates from 1 x 108 cells were incubated with 0.5 ml 
anti-FLAG (M2) agarose beads overnight at 4°C. The beads were washed three times with 
Tris-buffered saline (TBS, 25 mM Tris-HCl (pH 7.4), 137 mM NaCl, 2.7 mM KCl), and bound 
proteins were eluted from the beads with TBS containing 10% (v/v) glycerol and 0.3 
mg/ml 3X FLAG peptide.  
 
7.4 in-vitro transcription using scaffold assembly 
For the assembly of scaffolds for transcription first a hybrid between the template 
strand and RNA was made by incubating 1 µM template DNA with 2 µM RNA in a buffer 
containing 25 mM Tris (pH 7.5), 5 mM MgCl2 and 50 mM KCl at 45°C for 5 mins and then 
dropping the temperature by 2°C every 2 minutes until it reaches 21°C.  This hybrid was 
used for the formation of ternary complex by incubating it at 30°C for 10 mins with S. 
pombe RNA polymerase II with 25 mM tris (pH 7.5), 50 mM KCl, 5 mM MgCl2, 3% glycerol, 
2% PVA, 0.5 mM DTT and 0.5 mg/ml BSA. 5 µM non-template strand bound to biotin was 
then added and incubated for 10mins at 37°C maintaining the same buffer as before. 
Biotin beads were then washed with 20 mM tris (pH 7.9), 3 mM HEPES (pH 7.9), 0.2% 
PVA, 3% glycerol, 60mM KCl, 0.5 mM DTT and 0.5 mg/ml BSA to remove the unbound 
DNA /RNA or polymerase. 
Radioactive labelled 23ntd long transcript was synthesized off this scaffold by 
doing in-vitro transcription in the presence of 0.6 µM ATP and 0.13 µ for M 10 μCi [α-32P] 
UTP at 30°C for first 10 mins and then incubating for 5 minutes further after adding 5 µM 
ATP and UTP. Transcription were carried out in a buffer containing 20 mM tris (pH 7.9), 3 
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mM HEPES (pH 7.9), 8 mM MgCl2, 3% Glycerol, 2% PVA, 60mM KCl, 0.5mM DTT and 0.5 
mg/ml BSA. This 23-nucleotide long, elongating transcript was then chased to get longer 
transcripts by carrying out in-vitro transcription in the presence of all 4 nucleotides at a 7 
µM concentration. Effect of addition of elongation factors like Ell1 was studies by adding 
it the assay. Reactions were stopped after incubation at 30 °C for the times indicated in 
the figures, and transcription products were purified and resolved on 15% 
polyacrylamide gels containing 7 M urea, 45 mM Tris-borate, and 1 mM EDTA (pH 8.3) 
and detected with a Molecular Dynamics Typhoon PhosphoImager. 
DNA sequences (ordered from IDT): 
Template strand:   CTACGGTTAAGCTCACGGTACATTTCTGAATTAAGCATCATGG 
RNA:    ACUCUCAUGUCUGAUGCUUA 
Non-template strand:  ATCAGAAATGTACCGTGAGCTTAACCGTAG (With 3' Biotin 
tag) 
 
7.5 Chromatin immunoprecipitation (ChIP) 
S. pombe strains were grown in 200 ml YES to an OD600 between 0.8 and 1.0. Cells 
were crosslinked by adding formaldehyde to a final concentration of 1% for 15 minutes at 
room temperature. The crosslinking reaction was quenched with the addition of 10 ml of 
2.5 M glycine for 15 minutes. Cells were harvested by centrifugation and the cell pellets 
were washed twice with ice-cold Phosphate-buffered saline (PBS).  Cells were 
resuspended in 2 ml FA lysis SDS buffer (40 mM HEPES/KOH (pH 7.5), 150 mM NaCl, 1 
mM EDTA, 1 % Triton X-100, 0.1% sodium deoxycholate, 0.2% SDS and protease 
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inhibitor). Equal volume of acid washed glass beads (Sigma G8772) were added and cells 
were disrupted by vortexing using a Vortex-Genie with a Turbomix attachment for 60 
minutes at 4°C. Lysates were recovered from the beads and combined in a 15-ml 
centrifuge tube and the total volume increased to approximately 2 ml with FA-lysis SDS 
buffer. Lysates were sonicated at 4°C using a probe sonicator (11 cycles 10 seconds on, 
30 seconds off) to generate chromatin fragments in the range 200-800 bp. Cellular debris 
was removed by centrifuging the sonicated extracts in 1.5 ml microfuge tubes at 4°C for 
20 min at 14000 rpm.  
Input DNA: 
An aliquot of chromatin extract was used to prepare DNA to check the degree of 
chromatin shearing.  60 μl of chromatin extract was combined with 140 μl TE, pH 8.0 (10 
mM Tris-HCl, 1 mM EDTA), 200 μl proteinase K buffer (50 mM Tris-HCl, 12.5 mM EDTA, 
300 mM NaCl, 1% SDS) and 2 μl proteinase K (20 mg/ml New England Biolabs), and 
incubated at 55°C for 1 hour and then at 65°C overnight to reverse the crosslinks. 
Contaminating RNA was removed by treatment with 2 μl RNaseA (5 mg/ml), followed by 
DNA purification by phenol/chloroform extraction and ethanol precipitation using 2 μl 
GlycoBlue (Ambion) as a carrier. DNA was resuspended in TE to a final volume of 30 μl, 10 
μl of which was run out on a 1% agarose gel. Majority of the DNA fragments were 
between 200 bp and 800 bp. 
Chromatin Immunoprecipitations: 
Usually 10 µg of antibody to be used was incubated with appropriate dynabeads 
(50 µl) for 2 hours at 4°C and then washed with FA-lysis buffer (40 mM HEPES/KOH (pH 
7.5), 150 mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate). 400 μl 
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chromatin solution was mixed with 400 μl FA-lysis buffer containing AeBSF and 80 μl 10% 
sarkosyl. Extracts were incubated with Dynabeads (prebound with the antibodies) 
overnight at 4°C. Beads were concentrated with a magnetic particle concentrator, the 
supernatant removed and the beads washed with: 
• FA lysis buffer (150 mM NaCl) for 10 minutes 
• FA lysis buffer (500 mM NaCl) for 10 minutes (twice) 
• TEL buffer (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA, 10 mM 
Tris-HCl pH 8.0) for 10 minutes 
• TE pH 8.0 for 5 minutes twice 
Bound complexes were eluted from the beads by incubating with 400 μl of elution 
buffer (10 mM TRIS-HCl pH 8.0, 1 mM EDTA, 250 mM NaCl, 1% SDS) at 65°C for 30 
minutes. 2 μl Proteinase K (10 mg/ml) was added for digesting the protein and left 
overnight for reverse crosslinking at 65°C. After reversing the crosslinks, DNA was 
purified by phenol/chloroform extraction followed by ethanol precipitation with 2 μl 
GlycoBlue (Ambion) as a carrier. DNA pellets were resuspended in 60 μl TE and analyzed 
by either sequencing or real time PCR. 
 
7.5.A ChIP seq 
The libraries for the input and the immunoprecipitated DNA were synthesized in 
the Molecular Biology Core of Stowers Institute and size selected using Pippin Prep®. The 
libraries were then pooled and run on HiSeq machine with single read lengths of 50bp. 
The reads were aligned to the reference genome 
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“Schizosaccharomyces_pombe.ASM294v2.27. gff3” using bowtie2. Samtools was used to 
sort and index the Bam files. Low quality and true multi-mapped reads were filtered out 
with a MAPQ > 10 using samtools view. Mac2 was used to call peaks using default 
parameters (50>FC>5; q value<0.01), and bedtools intersect was used to assign peaks to 
the nearest gene. 
 
7.5.B Real time PCR 
Quantitative real time polymerase chain reactions (qPCR) were done using iQ 
SYBR Green Supermix (Bio-Rad) in 96 wells plates sealed with Microseal “B” sealing film 
(Bio-Rad). 5µl of diluted template (input or CHIP sample) was used in each 25µl reaction, 
and reactions were done in duplicate. Reactions were cycled on MyiQ thermocyclers 
(Bio-Rad), and results were analyzed by either using the percent input method or as fold 
enrichment over nonspecific region (ΔΔCt method).  
7.6 Gene expression analysis 
7.6.A RNA isolation 
RNA was prepared by hot phenol extraction method. 200 ml cultures were grown 
to mid log phase (OD600 = 0.8-1.0), harvested on ice and were washed in DEPC water. 
Cells were then pulverized in liquid nitrogen using a mortar and pestle and re-suspended 
in 10 ml 50mM sodium Acetate (NaOAc (pH5.2)) with 1% SDS. After addition of 10 ml 
phenol: chloroform 5:1 (equilibrated with NaOAc (pH 5.2)), samples were vortexed for 
approximately 5 seconds in a fume hood and incubated at 65°C in a water bath for 2 
144 
 
minutes. Samples were incubated on ice for 1 minutes, vortexed for 20 seconds and 
centrifuged at 7500g for 5 minutes. The aqueous phase was transferred to a new tube 
containing 10 ml phenol: chloroform. The phenol extraction step was repeated 4 more 
time and then the aqueous phase (now ~4-6 ml) was mixed with 2.5 volumes 100 % 
ethanol and 1/10th volume 3M NaOAc and RNA precipitated using standard procedures. 
100 µg of the RNA was purified further using an RNeasy mini spin column (Qiagen) per 
the manufacturer’s instructions. The quality of the RNA was then checked on bioanalyzer. 
 
7.6.B Library preparation 
The Molecular Biology Core of the Stowers Institute for Medical Research 
prepared the mRNA libraries following the Illumina TruSeq Stranded mRNA sample 
preparation protocol using the TruSeq Standard mRNA LT Sample Prep Kit. The polyA+ 
RNA was purified using oligo dT magnetic beads, while the Ribo-depleted RNA was 
purified using Epicentre Ribo-Zero Magnetic Gold Kit (for Yeast). The purified mRNAs 
were fragmented, randomly primed and reverse transcribed to generate first and second 
strand cDNAs. The 3’-ends of the cDNAs were adenylated, adaptors ligated to the ends 
and the final cDNA enriched through PCR. The library was then sized selected using the 
Pippen Prep and validated using Agilent 2100 Bioanalyzer. The barcoded libraries were 
pooled together and loaded onto a flow-cell for sequencing to generate 50 bp single 
reads. 
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7.6.C RNA seq 
The reads obtained were aligned to the reference genome using tophat. Samtools 
was used to sort and index bam files. The raw counts were obtained and then analyzed 
using edgeR to obtain differentially expressed genes. 
 
7.7 Precision Run-On sequencing  
PRO-seq was performed as described in (Kwak et al., 2013)and (Booth et al., 2016).  
7.7.A Nuclear Run-on and RNA extraction 
Strains were grown to mid-log phase in rich media (YES). 10 ml cultures of equal 
cell concentration were spun down and 10% equivalent of S. cerevisiae cells were added 
as spike-in. Cells were then washed in cold H20 and then resuspended in 10 mL 0.5% 
sarkosyl at 4°C, and incubated on ice for 20 min. Cells were then spun at a reduced RCF 
(400g) for 5 min at 4°C. Yeast pellets were resuspended in 120 µL of 2.5× transcription 
buffer (50 mM Tris –HCl, pH 7.7, 500 mM KCL, 12.5 mM MgCl2) with 6 µL 0.1 M DTT and 
3.75 µL of each 1 mM biotin-NTP and the volume was brought to 285 µL with DEPC-
treated H20. Finally, 15 µL 10% sarkosyl was added, and the reaction was placed at 30°C 
and allowed to run on for 5 min. RNA was extracted using a hot phenol approach after 
the run-on reaction, cells were pelleted at 400g for 5 min at 4°C and quickly resuspended 
in 500 µL acid phenol. An equal volume of AES buffer (50 mM NaAc pH 5.3, 10 mM EDTA, 
1% SDS) was added and placed for 5 min at 65°C with periodic vortexing, followed by 5 
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min on ice. Two hundred microliters chloroform was added and mixed followed by 
centrifugation at 14,000g for 5 min (4°C). To the aqueous layer, 3 M NaOAc was added 
followed by ethanol precipitation with a 3× volume of 100% ethanol. The RNA pellet was 
air dried before being resuspended in 20 µL DEPC-treated water. 
 
7.7.B Library preparation 
The RNA was heat denatured at 65°C for 40 secs. Denatured RNA samples were 
then fragmented by addition of 5 µl of 1N NaOH and incubated on ice for 10 min, and 
neutralized by adding an equal volume of 1 M Tris-HCl pH 6.8.  Buffer exchange was 
performed using P-30 columns following manufacturer’s protocol to remove excess salt 
and residual NTPs. The sample was collected in 50 µL, 10mM Tris buffer and 1 µL of 
RNase inhibitor is added.  
Prior to enriching for biotinylated RNAs, 90 µl of streptavidin-coated magnetic 
beads per library were washed once in buffer containing 0.1 N NaOH and 50 mM NaCl, 
and twice in 100 mM NaCl. Beads were then resuspended in 150 µl binding buffer (10mM 
Tris-HCl pH7.4, 300mM NaCl, 0.1% Triton X-100) and divided into 3 aliquots. Biotinylated 
RNA transcripts were then enriched by binding 50 µL of fragmented RNAs to 50 µL of pre-
washed streptavidin M280 beads. Sample was incubated for 20 min at room temperature 
on a rotator. Bead-bound RNA samples were then washed twice in ice-cold high salt wash 
buffer (50 mM Tris-HCl pH 7.4, 2M NaCl, 0.5% Triton X-100), twice in binding buffer, and 
once in low salt buffer (5 mM Tris-HCl pH 7.4, 0.1% Triton X-100). Finally, RNAs were 
extracted from the beads using Trizol and ethanol precipitation.  
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The 3’ RNA adaptor 
(5Phos/rGrArUrCrGrUrCrGrGrArCrUrGrUrArGrArArCrUrCrUrGrArArC/3’Inverted dT) was 
ligated to the fragmented RNAs by resuspending RNA in 4 µl 3’ RNA adaptor dilution (0.5 
µl of 100 µM 3’ RNA adaptor in 3.5 µl of DEPC water) and heat denaturing at 65 °C for 20 
s. Denatured RNA samples were mixed with 6 µl RNA ligation mix (1 X T4 RNA ligase 
buffer, 1 mM ATP, 10 % PEG, 4 u/µl RNase inhibitor and 1 u/µl T4 RNA ligase I) and 
incubated at 20 °C for 4 h. To remove excess adaptors and salts from the ligated RNA, 
second biotin enrichment and purification were performed using streptavidin beads as 
described previously.  
RNA pellets were resuspended in 5 µl DEPC water, heat denatured briefly at 65 °C 
for 20 s. 5’ end of RNA was then modified by mixing RNA with 5 µl 5’cap repair enzyme 
mix (1X ThermoPol Reaction Buffer, 2 u/µl RNase inhibitor, 0.5 u/µl RNA 5’ 
pyrophosphohydrolase, RppH) and incubating at 37°C for 1 h. Decapped RNAs were then 
mixed with 90 µl PNK mix (1 X PNK buffer, 1 mM ATP, 1 u/µl RNase inhibitor and 0.25 
u/µl T4 Polynucleotide Kinase) and incubated at 37°C for 1h. The 5’end modified RNAs 
were then purified using Trizol LS followed by ethanol precipitation. To ligate the 5’ 
adaptor (rCrCrUrUrGrGrCrArCrCrCrGrArGrArArUrUrCrCrA), RNAs were dissolved in 4 µl of 
5’ RNA adaptor dilution (0.5 µl of 100 µM 3’ RNA adaptor in 3.5 µl of DEPC water) and 
heat-denatured at 65°C. RNAs were then mixed with 6 µl RNA ligation mix (1 X T4 RNA 
ligase buffer, 1 mM ATP, 10 % PEG, 4 u/µl RNase inhibitor and 1 u/µl T4 RNA ligase I) and 
incubated at 20°C for 4 h. The cloned RNA products were then subjected to another 
round of biotin enrichment and purification as before and resuspended in 10 µl of DEPC 
water. To reverse transcribe the cloned products, RNAs were mixed with 2.5 µl RT primer 
mix (2.5 µM RP1 primer (AAT GAT ACG GCG ACC ACC GAG ATC TAC ACG TTC AGA GTT 
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CTA CAG TCC GA), 625 µM dNTP mix) and incubated at 70°C for 2 min and chilled on ice 
for 2 min.  6 µl of RT buffer mix (1 X First strand buffer, 5 mM DTT, 2 u/µl RNase inhibitor) 
was added to each RNA-primer mix and incubated at 37°C for 5 min. 1.5 µl Superscript III 
reverse transcriptase was mixed with the RNAs and incubated for 15 min at 45 °C, 40 min 
at 50 °C, 10 min at 55 °C and finally 15 min at 70 °C. 6 µl of DEPC water was then added 
to the RT reaction. 
An aliquot of the 26 µl cDNA from each replicate was used to carry out trial 
amplifications to determine the optimal number of cycles to avoid over amplification of 
the library. Primers RPI4 (RNA PCR Primer Index 4, CAA GCA GAA GAC GGC ATA CGA GAT 
TGG TCA GTG ACT GGA GTT CCT TGG CAC CCG AGA ATT CCA), RPI5 (RNA PCR Primer 
Index 5, CAA GCA GAA GAC GGC ATA CGA GAT CAC TGT GTG ACT GGA GTT CCT TGG CAC 
CCG AGA ATT CCA), RPI6 (RNA PCR Primer Index 6 CAA GCA GAA GAC GGC ATA CGA GAT 
ATT GGC GTG ACT GGA GTT CCT TGG CAC CCG AGA ATT CCA) and RPI7 (RNA PCR Primer 
Index 7, CAA GCA GAA GAC GGC ATA CGA GAT GAT CTG GTG ACT GGA GTT CCT TGG CAC 
CCG AGA ATT CCA) were used to barcode the cDNA samples. Final full-scale PCR 
amplifications were carried out by mixing the remaining 24 µl cDNA samples with 0.5 µl 
RPI-n (25 µM) pimer, 25.5 µl full scale primer mix (1 X HF buffer, 1 M Betaine, 250 µM 
each dNTP mix, 250 nM RP1 primer, 0.04 u/µl Phusion DNA polymerase), and running 
samples using the following thermal conditions: 95 °C for 2 min, 5 cycles of 95 °C, 56°C, 
72 °C each for 30 s, 13 cycles of 95 °C, 65 °C, 72 °C each for 30 s, followed by 72°C for 10 
min. PCR products were purified using ethanol precipitation and resuspended in 32 µl of 
water. PCR amplicons running from 140 bp to 350 bp were selected using the 2% Agarose 
Gel Cassette (Cassette type: 2% DF Marker L) on the Pippen Prep™ (Sage Science, 
Software: v.5.8) instrument. Samples were then quantified using the bioanalyser. 
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Equimolar concentrations of library fractions were pooled together and sequenced using 
a mid-output flow cell on the Illlumina NextSeq platform. 
 
7.7.C PRO-Seq analysis 
The raw sequences obtained were first processed to remove the adaptor 
sequences and then trimmed further to a maximum length of 36 nucleotides (minimum: 
15 nt). The reads then aligned to the pombe rRNA and cerevisiae rRNA were removed 
and rest of the reads were aligned using Bowtie to a combined genome consisting of all 
chromosomes from both S. pombe and S. cerevisiae facilitating the removal of reads with 
an ambiguous origin. Samtools was used to sort and index joint bam files and the joint 
reads were split by species.  Bedgraph files were created by recording only the most 3′ 
base of each read, which represents the position of the Pol II active site. The counts at 
each position in the bedgraph file were normalized based on the relative amount of 
reads aligning to the spike-in genome. 
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Appendix A: S. pombe Strains used in this study 
972 h- 
Med7-Flag (972) med7+::3Xflag natMX6 h- 
Med4- Flag (972) med4+::3Xflag natMX6 h- 
Med15- Flag (972) med15+::3Xflag natMX6 h- 
Med2- Flag (972) med2+::3Xflag natMX6 h- 
Med7 TAP med13ΔMed27Δ med7+::TAP-kanMX6 Δmed13::kanMX4 Δmed27::natMX6 
Med7 TAP med13ΔMed2Δ med7+::TAP-kanMX6 Δmed13::kanMX4 Δmed2::natMX6 
Ell1-FLAG (972) ell1+::3Xflag natMX6 h- 
Eaf1-FLAG (972) eaf1+:: 3Xflag natMX6 h- 
ED666 From Bioneer Inc. h+ 
Pem2 From (Roguev et al., 2007b) h- 
ell1∆ (Pem2) Δell1::natMX6 h- 
eaf1∆ (Pem2) Δeaf1::natMX6 h- 
ebp1∆ (Pem2) ΔSPAC6G9.15c::natMX6 h- 
brl1∆ (Pem2) Δbrl1::kanMX4 h- 
brl1Δ ell1Δ (Pem2) Δbrl1::kanMX4 Δell1::natMX6 h- 
brl1Δ eaf1Δ (Pem2) Δbrl1::kanMX4 Δeaf1::natMX6 h- 
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brl1Δ ebp1Δ (Pem2) Δbrl1::kanMX4 ΔSPAC6G9.15c::natMX6 h- 
Htb1-K119R (Ub mutant) otr1R(Sph1)::ura+ htb1::htb1-K119R kanMX6 (from Shiv 
Grewal) 
 
 
  
153 
 
Appendix B: Primers used in this study 
For strain construction: 
 
 
Med4_Forward ATAAAGAAGTAGAATCGCCAGCTAATAAGGATGTCTTTGCAGGATTTGATCTTTTTGATCCAGAAATGGAAGAAGATTTTCGGATCCCCGGGT
TAATTAA 
Med4_Reverse GGTATTTGGTCAAAGCAAAAAACTCTATAATTAGAAAAGTAAAATACCAGATATCACTTGACAAATAACACAATTTAGAAGAATTCGAGCTCGT
TTAAAC 
MED15_Forwar
 
TAAAGCAGCTTCAAGTGGGTAACGAAGATGAAGACAACATCGCATTTCCAACATCTACAAACATATGGCAAGTTGTGATTCGGATCCCCGGGT
TAATTAA 
MED15_Revers
 
CAAATATGTCCAATTTGCTTTTTGAGACGACGTGCAATAAATAAATAAAAAACAATTGCGAACCATCGTATCACAAAATTGAATTCGAGCTCGT
 
MED2_Forward TAAATCTTCCTACAGACATTCCAACCACTGAAAGCATAAATGACTTGTTTGGTGAGAACTTTGACTTCACCATGACAAAACGGATCCCCGGGTT
 
Med2_del_F CATCCTATTTAACTAAAAGGTTGTTCAGATCTATTCAGCTTTGTGATTGCATAGAACTCCCATTGTTTGTTATTCCTTCC 
 
Med2_Reverse TAATACATGAAAAAAACATTGACAAATTGAAACAACCACGTTAAACCGATCATACATAGCTGAACTGAAGTCAACTCAACGAATTCGAGCTCGT
 
Med27_del_F CCATCAATATTTATTTAATATACGCATTGTTAATTTTTTTTTCATAATTATTTTAAGTTTGTTAAGGCTACCAGAAATGCGGATCCCCGGGTTAAT
 
Med27_Revers
 
AATTGTAACTCAAGCTCAAAACGAAGCAAAAATGGCAATTATGAACGTCTTATTTCATTTGAATATCAAAATTAGTGTTGAATTCGAGCTCGTTT
 
Ell1_Forward AAGATGAACTTATATCTCTACATTCTCAGCTCAAAAGCTGGAAAAATACACTTTACGATGCTTCCTCGGAGCTAGCCCTCCGGATCCCCGGGTTA
 
Ell1_Del_F 
 
CTTAAACAAGCTTCTCCGTTGTGCCATCTAGCTAATATAATCATTTTGAGAGGCTTTTACTATCGATCTATTTGGGTTGACGGATCCCCGGGTTA
 
Ell1_Reverse AAGCTGAGATAACCGTCACCTTTATAAAACATTGGAAATAAAACTGAGTGTTAAGAAAACCGGAAATTTATTGAGAAAAGGAATTCGAGCTCG
 
Eaf1_Forward GGGGTCTATCTTCGCAAGAGAGGGATTATGCTTCTTCTGCTCAGGCAGAGGGTATCAGCAGCGCTTCCGAGGATGAGGATCGGATCCCCGGG
 
Eaf1_Del_F 
 
TCTTACCTTACGTTATTTATTTGATTTATATCGAAATTTCCAATTTCGTACAGGCCTGACTTTTACCATTATAAACAATCCGGATCCCCGGGTTAAT
 
Eaf1_Reverse TTTCGTTGCAAGTCGTTCATTAACAGATTTTCTCATTATCGTGTTTGGAAAGTGTATACGAAACACAGCATAAAGCATACGAATTCGAGCTCGTT
 
Ebp1_Del_F CGAAATCTTTTAATTCCATAGCATATCTCTTTTTTAAGTAAATACTTTTATTTGAATAGTTTATACAGCGCATGCGATGACGGATCCCCGGGTTAA
 
Ebp1_reverse AACTTTATTAGTGAAAGAATGACATTCTGTTATTGAAGACCGACTCAAATCTTTCAAGTTATGGGAGTTAATACAATTATGAATTCGAGCTCGTT
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For qPCR: 
 
 
Tdh promoter_F GTCGGTGTCAACGAGGAGAA 
Tdh promoter_R AGTGGTCATGAGACCCTCCT 
Tdh 3’_F TCGTCAAGCTCGTCTCTTGG 
Tdh 3’_R GCAGTGTAGGCAACCAAGTC 
Chr1_left_F    CCTGCTTACCCTTGGACTTT 
 Chr1_left_R   CTTCACCACCATTTCGCTTTAC 
 Chr1_left _F    CTCCCAAACTCCACACCATATC 
 Chr1_left _R CAGTTGCGAGTCCTGACAATAG 
 Chr1_right_F AGCCTGAAACCAGCAATCA 
 Chr1_right_R   TTAGGTCCGGCCAACAATAC 
 Chr1_right _F    TGGCCGATTGGCTTAAAGTAG 
 Chr1_right _R  GTAGGCGAAGAACCACCTAATG 
Chr2_left_F    GTCCTGGGATTAGTGGTTTGAT 
 Chr2_left_R   CTTCACCACCATTTCGCTTTAC 
 Chr2_left _F    ACTGAGTTTGGGTAGACTTGTATT 
  Chr2_left _R CAACCCTTCTGACATTCGTTTATT 
 Chr2_right_F   GTCCTGGGATTAGTGGTTTGAT 
 Chr2_right_R CTTCACCACCATTTCGCTTTAC 
 Chr2_right_F   CCTAGAGCAGGGACTTGATTTG 
 Chr2_right_R TGGTGTTGGTAAAGAGGGATTG 
Chr1_control_F GCTCCTTATCCCAATCCTTACC 
Chr1_control_R CCTATCCTCACCACCATCAAC 
Chr2_control_F GGTTCCTCCGTGTTCGATATT 
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Appendix C: SGA results 
id gene product ell1Δ  eaf1Δ ebp1Δ ell1Δ 
_mpa 
SPAC22A12.07c ogm1 protein O-mannosyltransferase Ogm1 1 1 0 1 1 1 1 1 1 1 1 0 
SPCC1919.15 brl1 ubiquitin-protein ligase E3 Brl1 1 1 1 0 1 1 0 1 0 1 1 1 
SPAC31G5.03 rps1101 40S ribosomal protein S11 (predicted) 1 1 1 0 0 0 1 0 1 1 1 1 
SPAC6F6.12 atg24 autophagy associated protein Atg24 
(predicted) 
1 1 0 1 1 0 0 1 1 1 1 0 
SPCC794.08 efr3 HEAT repeat protein involved in protein 
localization to plasma membrane 
1 1 1 0 1 1 0 1 1 0 1 0 
SPBC1105.10 rav1 RAVE complex subunit Rav1 1 1 0 1 1 1 0 1 0 1 1 0 
SPAC3H5.13 new4 conserved eukaryotic protein 1 1 1 0 0 1 0 1 0 1 1 1 
SPAC3G6.02 rpn15 proteasome regulatory particle, lid 
subcomplex subunit Rpn15/Dss1 
1 1 1 0 1 0 0 0 1 1 1 1 
SPAC1486.04c alm1 medial ring protein Alm1 1 0 0 0 0 1 1 1 1 1 1 0 
SPAC6G10.12c ace2 transcription factor Ace2 1 1 0 0 0 0 1 1 1 1 1 0 
SPBC4F6.06 kin1 microtubule affinity-regulating kinase 
Kin1 
1 1 1 0 1 1 0 1 1 0 0 0 
SPBC577.15c sim3 NASP family CENP-A chaperone 1 1 1 0 1 0 0 1 0 1 1 0 
SPCC306.09c cap1 adenylyl cyclase-associated protein Cap1 1 1 1 0 1 1 0 0 1 1 0 0 
SPBC3D6.08c lsm1 mRNA decapping complex subunit 
(predicted) 
1 1 1 0 1 0 0 0 1 1 1 0 
SPAC8C9.07 fyv7 rRNA processing protein Fyv7 (predicted) 1 1 1 0 0 0 0 0 1 1 1 1 
SPCC285.13c nup60 nucleoporin Nup60 1 1 0 1 1 1 0 0 0 1 1 0 
SPBC1A4.09 pus7 pseudouridine synthase Pus7 (predicted) 1 1 1 1 0 0 0 0 0 1 1 1 
SPBC215.08c arg4 arginine specific carbamoyl-phosphate 
synthase Arg4  
1 1 1 0 1 1 0 0 0 1 0 1 
SPCC830.06 cnb1 calcineurin regulatory subunit (calcineurin 
B) 
1 1 1 0 1 0 0 0 0 1 1 1 
SPBC21H7.04 dbp7 ATP-dependent RNA helicase Dbp7 
(predicted) 
1 1 1 0 0 1 0 0 0 1 1 1 
SPAPB1E7.11c 
 
Schizosaccharomyces specific protein 1 1 0 0 0 0 1 1 1 1 0 0 
SPAC3H5.10 rpl3202 60S ribosomal protein L32 (predicted) 1 1 0 0 0 0 1 1 0 1 1 0 
SPBC16C6.01c 
 
lysine methyltransferase (predicted) 0 0 1 0 0 0 1 0 1 1 1 1 
SPAC3G9.08 png1 ING family homolog Png1 1 1 0 0 0 0 0 1 1 1 1 0 
SPAC15E1.05c ect1 ethanolamine-phosphate 
cytidylyltransferase (predicted) 
1 1 0 0 0 0 0 1 1 1 1 0 
SPBC530.06c clu1 clustered mitochondria (cluA/CLU1) 
homolog Clu1 (predicted) 
1 1 1 0 1 1 0 1 0 0 0 0 
SPAC26A3.04 rpl2002 60S ribosomal protein L20 (predicted) 1 1 0 0 1 0 0 1 0 1 1 0 
SPAP7G5.03 prm1 conjugation protein Prm1 1 1 0 0 0 1 0 1 0 1 1 0 
SPAP7G5.05 rpl1002 60S ribosomal protein L10 1 1 0 0 0 1 0 1 0 1 1 0 
SPBC13G1.14c 
 
RNA-binding protein (predicted) 1 1 1 0 0 0 0 1 0 1 1 0 
SPBC577.05c rec27 meiotic recombination protein Rec27 1 1 1 1 0 0 0 0 1 1 0 0 
SPAC607.02c SPAC607.02c conserved fungal protein 1 0 0 0 1 1 0 0 1 1 1 0 
SPAC926.03 rlc1 myosin II regulatory light chain Rlc1 1 1 0 0 0 1 0 0 1 1 1 0 
SPBC21C3.12c 
 
DUF953 thioredoxin family protein 1 1 0 0 0 0 0 0 1 1 1 1 
SPCC1020.01c pma2 P-type proton ATPase, P3-type Pma2 0 1 1 1 1 0 0 0 0 0 1 1 
SPBC30D10.10c tor1 phosphatidylinositol kinase Tor1 1 0 1 1 0 0 0 0 0 1 1 1 
SPBC2G2.03c sbh1 translocon beta subunit Sbh1 (predicted) 1 1 0 0 1 1 0 0 0 1 1 0 
SPBC216.03 
 
conserved fungal protein 1 1 0 0 1 0 0 0 0 1 1 1 
SPBC1A4.03c top2 DNA topoisomerase II 0 1 1 0 1 0 0 0 0 1 1 1 
SPAC31F12.01 zds1 zds family protein phosphatase type A 
regulator Zds1 (predicted) 
1 1 1 0 0 1 0 0 0 1 1 0 
SPBC19G7.04 
 
HMG box protein 1 1 1 0 0 1 0 0 0 1 1 0 
SPCC1753.05 rsm1 RNA export factor Rsm1 1 1 1 0 0 1 0 0 0 1 1 0 
SPBC2F12.11c rep2 MBF transcription factor activator Rep2 1 1 0 0 0 1 0 0 0 1 1 1 
SPAC3H1.09c avt3 vacuolar amino acid transmembrane 
transporter Avt3 
0 1 1 0 0 1 0 0 0 1 1 1 
SPBC21C3.13 rps1901 40S ribosomal protein S19 (predicted) 1 1 1 0 0 0 0 0 0 1 1 1 
SPAC57A7.04c pabp mRNA export shuttling protein 1 1 1 0 0 0 0 0 0 1 1 1 
SPCC736.11 ago1 argonaute 1 1 1 0 0 0 0 0 0 1 1 1 
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SPCC1450.03 
 
ribonucleoprotein (RNP) complex 
(predicted) 
1 1 1 0 0 0 0 0 0 1 1 1 
SPBC16E9.18 psd1 phosphatidylserine decarboxylase Psd1 1 1 1 0 0 0 0 0 0 1 1 1 
SPCC1739.06c 
 
uroporphyrin methyltransferase 
(predicted) 
1 1 1 0 0 0 0 0 0 1 1 1 
SPAC22F3.12c rgs1 regulator of G-protein signaling Rgs1 1 1 1 0 0 0 0 0 0 1 1 1 
SPCC1682.13 laf2 Clr6 associated factor 2, Laf2 1 1 1 0 0 0 0 0 0 1 1 1 
SPBP23A10.14c ell1 RNA polymerase II transcription 
elongation factor SpELL 
1 1 1 0 0 0 0 0 0 1 1 1 
SPBC16E9.07 mug100 Schizosaccharomyces pombe specific 
protein Mug100 
1 1 1 0 0 0 0 0 0 1 1 1 
SPCC584.03c 
 
Ran GTP-binding protein (predicted) 1 1 1 0 0 0 0 0 0 1 1 1 
SPCC576.12c mhf2 CENP-X homolog, FANCM-MHF complex 
subunit Mhf2 
1 1 1 0 0 0 0 0 0 1 1 1 
SPCC962.01 
 
C2 domain endoplasmic reticulum 
membrane organization protein 
(predicted) 
1 1 1 0 0 0 0 0 0 1 1 1 
SPBC839.15c tef103 translation elongation factor EF-1 alpha 
Ef1a-c 
1 1 1 0 0 0 0 0 0 1 1 1 
SPBC713.08 mim1 mitochondrial TOM complex assembly 
protein Mim1 (predicted) 
1 1 1 0 0 0 0 0 0 1 1 1 
SPCC16C4.03 pin1 peptidyl-prolyl cis-trans isomerase Pin1 1 1 1 0 0 0 0 0 0 1 1 1 
SPBC11G11.05 rpa34 DNA-directed RNA polymerase I complex 
subunit Rpa34 (predicted) 
1 1 1 0 0 0 0 0 0 1 1 1 
SPAC6G9.14 
 
RNA-binding protein (predicted) 0 1 0 0 0 0 1 1 1 0 1 0 
SPAC6G9.15c Ebp1 Schizosaccharomyces specific protein 0 0 1 0 0 0 1 1 1 0 1 0 
SPCC1739.12 ppe1 serine/threonine protein phosphatase 
Ppe1 
0 0 1 0 1 0 1 1 0 0 0 1 
SPAC11E3.01c swr1 SNF2 family ATP-dependent DNA helicase 
Swr1 
1 1 0 0 0 0 1 1 0 1 0 0 
SPAC16E8.01 shd1 cytoskeletal protein binding protein Sla1 
family, Shd1 (predicted) 
1 1 0 0 0 0 1 0 0 1 1 0 
SPCC1739.01 
 
zf-CCCH type zinc finger protein 1 1 0 0 0 0 0 1 1 1 0 0 
SPBC1D7.04 mlo3 RNA binding protein Mlo3 1 1 1 0 0 1 0 1 0 0 0 0 
SPCC24B10.12 cgi121 EKC/KEOPS complex subunit Cgi121 
(predicted) 
1 1 0 0 0 0 0 1 0 1 1 0 
SPBC2D10.18 abc1 ABC1 kinase family ubiquinone 
biosynthesis protein Abc1/Coq8 
1 1 1 0 0 1 0 0 1 0 0 0 
SPAC227.07c pab1 protein phosphatase regulatory subunit 
Pab1 
1 1 0 0 0 1 0 0 1 0 1 0 
SPAC15A10.11 ubr11 UBR ubiquitin-protein ligase E3 Ubr11 1 0 1 0 0 1 0 0 1 1 0 0 
SPAC15A10.03c rad54 DNA-dependent ATPase Rad54/Rhp54 1 1 1 0 0 0 0 0 1 1 0 0 
SPAC15A10.16 bud6 actin interacting protein 3 homolog Bud6 1 1 0 0 0 0 0 0 1 1 1 0 
SPAC1071.02 mms19 Dos2 silencing complex subunit Mms19 1 1 0 0 0 0 0 0 1 1 1 0 
SPBC32F12.11 tdh1 glyceraldehyde-3-phosphate 
dehydrogenase Tdh1 
1 1 0 0 0 0 0 0 1 1 1 0 
SPBC660.09 mug168 Schizosaccharomyces specific protein 
Mug168 
1 1 0 0 0 0 0 0 1 1 1 0 
SPAC22F3.10c gcs1 glutamate-cysteine ligase Gcs1 1 1 0 0 0 0 0 0 1 1 1 0 
SPAC17G6.08 pep7 prevacuole/endosomal FYVE tethering 
component Pep7 (predicted) 
1 1 0 0 0 0 0 0 1 1 1 0 
SPCC285.14 trs130 TRAPP complex subunit Trs130 
(predicted) 
0 1 0 1 1 1 0 0 0 0 1 0 
SPCC1223.05c rpl3702 60S ribosomal protein L37 (predicted) 0 0 1 1 1 1 0 0 0 0 0 1 
SPCC1235.11 mpc1 mitochondrial pyruvate transmembrane 
transporter subunit Mpc1 (predicted) 
1 1 0 1 1 0 0 0 0 0 1 0 
SPBC1718.07c zfs1 CCCH tandem zinc finger protein, human 
Tristetraprolin homolog Zfs1, involved in 
mRNA catabolism 
1 1 0 1 0 0 0 0 0 1 1 0 
SPCC74.02c ppn1 mRNA cleavage and polyadenylation 
specificity factor complex associated 
protein 
1 1 0 1 0 0 0 0 0 1 1 0 
SPCC285.17 spp27 RNA polymerase I upstream activation 
factor complex subunit Spp27 
1 1 0 1 0 0 0 0 0 1 1 0 
SPBC8D2.03c hhf2 histone H4 h4.2 1 1 0 1 0 0 0 0 0 1 1 0 
SPCC364.03 rpl1702 60S ribosomal protein L17 (predicted) 1 1 0 1 0 0 0 0 0 0 1 1 
SPAC30C2.06c dml1 mitochondrial inheritance GTPase, 
tubulin-like (predicted) 
1 0 0 0 1 1 0 0 0 1 1 0 
SPCC5E4.07 rpl2802 60S ribosomal protein L27/L28 1 0 0 0 1 1 0 0 0 1 1 0 
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SPCC11E10.04 ppr6 mitochondrial PPR repreat protein Ppr6 0 1 0 0 1 1 0 0 0 0 1 1 
SPBC14C8.17c spt8 SAGA complex subunit Spt8 1 1 0 0 1 0 0 0 0 1 1 0 
SPCC1322.10 
 
cell wall protein Pwp1 1 1 0 0 1 0 0 0 0 1 1 0 
SPBC19C2.14 smd3 Sm snRNP core protein Smd3 1 1 0 0 1 0 0 0 0 1 1 0 
SPAC1556.01c rad50 DNA repair protein Rad50 1 1 0 0 1 0 0 0 0 1 1 0 
SPAC458.05 pik3 phosphatidylinositol 3-kinase Pik3 1 1 0 0 1 0 0 0 0 1 1 0 
SPBC365.16 
 
conserved protein 1 0 1 0 1 0 0 0 0 1 1 0 
SPCC1259.01c rps1802 40S ribosomal protein S18 (predicted) 1 0 1 0 1 0 0 0 0 0 1 1 
SPBC646.12c gap1 GTPase activating protein Gap1 0 1 1 0 1 0 0 0 0 0 1 1 
SPAC1F7.01c spt6 nucleosome remodeling protein Spt6 0 1 1 0 1 0 0 0 0 0 1 1 
SPAC1556.08c cbs2 AMP-activated protein kinase gamma 
subunit cbs2 
1 1 0 0 0 1 0 0 0 1 1 0 
SPAC6B12.15 cpc2 RACK1 ortholog Cpc2 1 1 0 0 0 1 0 0 0 1 1 0 
SPBC651.09c prf1 RNA polymerase II associated Paf1 
complex (predicted) 
1 1 0 0 0 1 0 0 0 1 1 0 
SPBC4B4.07c usp102 U1 snRNP-associated protein Usp102 1 1 0 0 0 1 0 0 0 1 1 0 
SPAC3A12.10 rpl2001 60S ribosomal protein L20a (predicted) 1 1 0 0 0 1 0 0 0 1 1 0 
SPAC57A7.13 
 
RNA-binding protein, involved in splicing 
(predicted) 
0 1 1 0 0 1 0 0 0 0 1 1 
SPBC32F12.05c cwf12 complexed with Cdc5 protein Cwf12 0 1 1 0 0 1 0 0 0 0 1 1 
SPBC56F2.01 pof12 F-box protein Pof12 1 1 1 0 0 0 0 0 0 1 1 0 
SPCC1795.02c vcx1 CaCA proton/calcium exchanger 
(predicted) 
1 1 1 0 0 0 0 0 0 1 1 0 
SPCC794.10 ugp1 UTP-glucose-1-phosphate 
uridylyltransferase-like Ugp1 
1 1 1 0 0 0 0 0 0 1 1 0 
SPBC83.03c tas3 RITS complex subunit 3 1 1 1 0 0 0 0 0 0 1 1 0 
SPAC13G7.12c eki1 choline/ethanolamine kinase Eki1 
(predicted) 
1 1 1 0 0 0 0 0 0 1 1 0 
SPCC11E10.08 rik1 silencing protein Rik1 1 1 1 0 0 0 0 0 0 1 1 0 
SPBC1A4.04 
 
Schizosaccharomyces specific protein 1 1 1 0 0 0 0 0 0 1 1 0 
SPAC15A10.10 mde6 Muskelin homolog (predicted) 1 1 1 0 0 0 0 0 0 1 1 0 
SPAC26H5.03 pcf2 CAF assembly factor (CAF-1) complex 
subunit B, Pcf2 
1 1 1 0 0 0 0 0 0 1 1 0 
SPAC2F7.02c psr1 NLI interacting factor family phosphatase 
Psr1 (predicted) 
1 1 1 0 0 0 0 0 0 1 1 0 
SPAC22H10.07 scd2 scaffold protein Scd2 1 1 1 0 0 0 0 0 0 1 1 0 
SPCC895.05 for3 formin For3 1 1 1 0 0 0 0 0 0 1 1 0 
SPAC30D11.13 hus5 SUMO conjugating enzyme E2 Hus5 1 1 1 0 0 0 0 0 0 1 1 0 
SPBC725.10 
 
mitochondrial transport protein, tspO 
homolog (predicted) 
1 1 1 0 0 0 0 0 0 1 0 1 
SPBC776.17 rrp7 rRNA processing protein Rrp7 (predicted) 1 1 0 0 0 0 0 0 0 1 1 1 
SPAC23C11.02c rps23 40S ribosomal protein S23 (predicted) 1 1 0 0 0 0 0 0 0 1 1 1 
SPBC16C6.06 vps10 sorting receptor for vacuolar proteins, 
Vps10 
1 1 0 0 0 0 0 0 0 1 1 1 
SPCC1259.05c cox9 cytochrome c oxidase subunit VIIa 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 1 
SPBP23A10.12 frg1 FRG1 family protein, involved in mRNA 
splicing (predicted) 
1 1 0 0 0 0 0 0 0 1 1 1 
SPBC16E9.09c erp5 COPII vesicle coat component Erp5/Erp6 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 1 
SPCC613.03 
 
conserved fungal protein 1 1 0 0 0 0 0 0 0 1 1 1 
SPAC17A5.14 exo2 exonuclease II Exo2 1 1 0 0 0 0 0 0 0 1 1 1 
SPBC16E9.20 
 
dubious 1 1 0 0 0 0 0 0 0 1 1 1 
SPBC16E9.16c lsd90 Lsd90 protein 1 1 0 0 0 0 0 0 0 1 1 1 
SPBC16E9.15 
 
heat shock factor binding protein 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 1 
SPBC29A3.14c trt1 telomerase reverse transcriptase 1 
protein Trt1 
1 1 0 0 0 0 0 0 0 1 1 1 
SPAC1783.04c hst4 Sirtuin family histone deacetylase Hst4 1 1 0 0 0 0 0 0 0 1 1 1 
SPAC2H10.04 
 
dubious 1 0 1 0 0 0 0 0 0 1 1 1 
SPAC26H5.11 mug56 spore wall assembly protein Mug56 
(predicted) 
1 0 1 0 0 0 0 0 0 1 1 1 
SPAPB2B4.02 grx5 monothiol glutaredoxin Grx5 1 0 1 0 0 0 0 0 0 1 1 1 
SPBC3H7.15 hhp1 serine/threonine protein kinase Hhp1 0 1 1 0 0 0 0 0 0 1 1 1 
SPBC902.03 
 
Nem1-Spo7 complex regulatory subunit 
(predicted) 
0 1 1 0 0 0 0 0 0 1 1 1 
SPAC821.05 tif38 translation initiation factor eIF3h (p40) 0 1 1 0 0 0 0 0 0 1 1 1 
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SPBC3B8.10c nem1 Nem1-Spo7 phosphatase complex 
catalytic subunit Nem1 (predicted) 
0 1 1 0 0 0 0 0 0 1 1 1 
SPBC3H7.05c 
 
mitochondrial Membrane Bound O-Acyl 
Transferase (MBOAT) family 
0 1 1 0 0 0 0 0 0 1 1 1 
SPCC16C4.12 naa20 NatB N-acetyltransferase complex 
catalytic subunit Naa20 (predicted) 
0 0 0 0 0 1 1 1 1 0 0 0 
SPAC1142.05 ctr5 copper transporter complex subunit Ctr5 1 0 0 0 0 0 1 1 0 1 0 0 
SPAC26A3.16 dph1 UBA domain protein Dph1 1 0 0 0 0 0 1 0 1 1 0 0 
SPAC6G9.04 spo7 sporulation protein Spo7 0 0 0 0 0 1 0 1 1 0 1 0 
SPAC6G9.05 pcd1 coenzyme A diphosphatase (predicted) 0 0 1 0 0 0 0 1 1 0 0 1 
SPBC1E8.05 
 
conserved fungal protein 0 1 0 0 1 1 0 1 0 0 0 0 
SPCP1E11.04c pal1 membrane associated protein Pal1 0 1 0 0 0 1 0 1 0 0 1 0 
SPBC18H10.11c ppr2 mitochondrial PPR repeat protein Ppr2 1 1 1 0 0 0 0 0 1 0 0 0 
SPBC18H10.14 rps1601 40S ribosomal protein S16 (predicted) 1 1 0 0 0 0 0 0 1 0 1 0 
SPAC23A1.07 
 
ubiquitin-protein ligase E3 (predicted) 1 0 0 0 0 0 0 0 1 1 1 0 
SPAC18G6.04c shm2 serine hydroxymethyltransferase Shm2 
(predicted) 
1 0 0 0 0 0 0 0 1 1 1 0 
SPAC3H5.12c rpl501 60S ribosomal protein L5 (predicted) 1 0 0 0 0 0 0 0 1 1 0 1 
SPAC5D6.05 med18 mediator complex subunit Med18 0 1 0 0 0 0 0 0 1 1 1 0 
SPCC594.05c spf1 Set1C PHD Finger protein Spf1 0 1 0 0 0 0 0 0 1 1 1 0 
SPBC409.19c 
 
metaxin (predicted) 0 1 0 0 0 0 0 0 1 1 1 0 
SPCC1223.13 cbf12 CBF1/Su(H)/LAG-1 family transcription 
factor Cbf12 
1 0 0 1 1 1 0 0 0 0 0 0 
SPCC297.06c 
 
conserved fungal protein 0 0 0 1 1 1 0 0 0 1 0 0 
SPCC737.09c hmt1 vacuolar transmembrane transporter 
Hmt1 
0 0 0 1 1 1 0 0 0 0 1 0 
SPCC297.04c set7 histone lysine methyltransferase Set7 
(predicted) 
0 0 0 1 1 1 0 0 0 0 0 1 
SPCC1223.15c spc19 DASH complex subunit Spc19 0 0 0 1 1 0 0 0 0 1 1 0 
SPCC14G10.04 
 
Schizosaccharomyces specific protein 1 0 0 1 0 0 0 0 0 1 0 1 
SPAC15E1.07c moa1 meiotic cohesin complex associated 
protein (Meikin) Moa1 
0 1 1 0 1 0 0 0 0 0 1 0 
SPBC4F6.10 vps901 guanyl-nucleotide exchange factor 
Vps901 (predicted) 
0 1 1 0 1 0 0 0 0 0 1 0 
SPBC725.11c php2 CCAAT-binding factor complex subunit 
Php2 
0 1 1 0 1 0 0 0 0 0 1 0 
SPCC24B10.11c tho7 THO complex subunit Tho7 (predicted) 1 1 1 0 0 1 0 0 0 0 0 0 
SPAC57A10.02 cdr2 serine/threonine protein kinase Cdr2 1 0 1 0 0 1 0 0 0 1 0 0 
SPCC736.07c uri1 unconventional prefoldin chaperone 
involved protein complex assembly Uri1 
(predicted) 
1 0 0 0 0 1 0 0 0 1 1 0 
SPBC428.08c clr4 histone H3 lysine methyltransferase Clr4 0 1 1 0 0 1 0 0 0 0 1 0 
SPAC521.03 
 
short chain dehydrogenase (predicted) 0 1 1 0 0 1 0 0 0 0 1 0 
SPBC776.02c dis2 serine/threonine protein phosphatase PP1 
subfamily, Dis2 :  
0 1 0 0 0 1 0 0 0 1 1 0 
SPCC162.12 tco89 TORC1 subunit Tco89 0 1 0 0 0 1 0 0 0 1 1 0 
SPCC285.11 dsc5 UBX domain containing protein required 
for Sre1 cleavage 
0 0 1 0 0 1 0 0 0 0 1 1 
SPAC22H10.11c 
 
TOR signaling pathway transcriptional 
corepressor Crf1 (predicted) 
1 1 1 0 0 0 0 0 0 1 0 0 
SPBC725.14 arg6 acetylglutamate synthase Arg6 
(predicted) 
1 1 1 0 0 0 0 0 0 1 0 0 
SPBC839.19 new20 conserved eukaryotic protein 1 1 1 0 0 0 0 0 0 1 0 0 
SPBC530.07c 
 
TENA/THI family protein 1 1 1 0 0 0 0 0 0 1 0 0 
SPBC609.05 pob3 FACT complex subunit Pob3 1 1 1 0 0 0 0 0 0 0 1 0 
SPAC2C4.05 cor1 cornichon family protein (predicted) 1 1 1 0 0 0 0 0 0 0 1 0 
SPAC17H9.13c 
 
glutamate 5-kinase (predicted) 1 1 1 0 0 0 0 0 0 0 1 0 
SPCC4B3.10c ipk1 inositol 1,3,4,5,6-pentakisphosphate (IP5) 
kinase 
1 1 1 0 0 0 0 0 0 0 1 0 
SPBC3H7.03c 
 
2-oxoglutarate dehydrogenase 
(lipoamide) (e1 component of 
oxoglutarate dehydrogenase complex) 
(predicted) 
1 1 1 0 0 0 0 0 0 0 1 0 
SPCC16C4.11 pef1 Pho85/PhoA-like cyclin-dependent kinase 
Pef1 
1 1 1 0 0 0 0 0 0 0 1 0 
SPCC613.06 rpl902 60S ribosomal protein L9 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC9B6.07 nop52 nucleolar protein Nop52 family Rrp1 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
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SPBC428.06c rxt2 histone deacetylase complex subunit Rxt2 1 1 0 0 0 0 0 0 0 1 1 0 
SPCC1322.03 trp1322 TRP-like ion channel (predicted) 1 1 0 0 0 0 0 0 0 1 1 0 
SPCC1840.08c pdi5 protein disulfide isomerase (predicted) 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC23E6.10c mri1 methylthioribose-1-phosphate isomerase 
Mri1 (predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPCC126.15c sec65 signal recognition particle subunit Sec65 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPAC23C11.13c hpt1 xanthine phosphoribosyltransferase 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPCC18B5.03 wee1 M phase inhibitor protein kinase Wee1 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC25D12.02c dnt1 nucleolar protein Dnt1 1 1 0 0 0 0 0 0 0 1 1 0 
SPCC1235.08c pdh1 Golgi to ER protein (predicted) 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC1093.01 ppr5 mitochondrial PPR repeat protein Ppr5 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC2F3.12c plp1 thioredoxin fold protein Plp1 (predicted) 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC16E9.02c 
 
CUE domain protein 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC17G8.13c mst2 histone acetyltransferase Mst2 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC22E12.04 ccs1 superoxide dismutase copper chaperone 
Ccs1 
1 1 0 0 0 0 0 0 0 1 1 0 
SPBC23E6.09 ssn6 transcriptional corepressor Ssn6 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC1071.07c rps1502 40S ribosomal protein S15 (predicted) 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC146.13c myo1 myosin type I 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC1F12.05 any2 arrestin-related endocytic adaptor Any2 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPBC19G7.10c pdc2 topoisomerase II-associated 
deadenylation-dependent mRNA-
decapping factor Pdc2 (predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPBC1E8.02 
 
ubiquitin family protein (predicted) 1 1 0 0 0 0 0 0 0 1 1 0 
SPCC794.04c 
 
amino acid transmembrane transporter 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPBP23A10.10 ppk32 serine/threonine protein kinase Ppk32 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPAC27E2.07 pvg2 galactose residue biosynthesis protein 
Pvg2 
1 1 0 0 0 0 0 0 0 1 1 0 
SPBC18H10.02 lcf1 long-chain-fatty-acid-CoA ligase Lcf1 1 1 0 0 0 0 0 0 0 1 1 0 
SPCC794.11c ent3 ENTH/VHS domain protein Ent3 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPAC29B12.04 snz1 pyridoxine biosynthesis protein 1 1 0 0 0 0 0 0 0 1 1 0 
SPCC1739.14 npp106 nucleoporin Npp106 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC22F3.13 tsc1 hamartin 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC16E9.17c rem1 meiosis-specific cyclin Rem1 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC23E6.08 sat1 Golgi membrane exchange factor subunit 
Sat1 (predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPCC613.11c meu23 mug2/mug135/meu2 family 1 1 0 0 0 0 0 0 0 1 1 0 
SPBP23A10.17 
 
conserved fungal protein 1 1 0 0 0 0 0 0 0 1 1 0 
SPCC553.04 cyp9 WD repeat containing cyclophilin family 
peptidyl-prolyl cis-trans isomerase Cyp9 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPCC1902.01 gaf1 transcription factor Gaf1 1 1 0 0 0 0 0 0 0 1 1 0 
SPBP16F5.04 ubc7 ubiquitin conjugating enzyme E2 
Ubc7/UbcP3 
1 1 0 0 0 0 0 0 0 1 1 0 
SPAC17H9.10c ddb1 damaged DNA binding protein Ddb1 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC1952.11c ure2 urease Ure2 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC8C9.14 prr1 transcription factor Prr1 1 1 0 0 0 0 0 0 0 1 1 0 
SPAC1952.02 tma23 ribosome biogenesis protein Tma23 
(predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPBC16H5.08c 
 
ribosome biogenesis ATPase, Arb family 
ABCF2-like (predicted) 
1 1 0 0 0 0 0 0 0 1 1 0 
SPBC776.05 
 
transmembrane transporter (predicted) 1 1 0 0 0 0 0 0 0 1 0 1 
SPBC800.03 clr3 histone deacetylase (class II) Clr3 1 0 1 0 0 0 0 0 0 1 1 0 
SPAC31G5.21 
 
human FAM32A homolog 1 0 1 0 0 0 0 0 0 1 1 0 
SPAC1399.03 fur4 uracil permease 1 0 1 0 0 0 0 0 0 1 1 0 
SPAC22G7.05 kri1 ribosome biogenesis protein Kri1 
(predicted) 
1 0 1 0 0 0 0 0 0 1 0 1 
SPAC1296.06 tah18 NADPH-dependent diflavin 
oxidoreductase, involved in iron-sulfur 
cluster assembly Tah18 (predicted) 
1 0 1 0 0 0 0 0 0 1 0 1 
SPBC16A3.18 cip1 RNA-binding protein Cip1 1 0 1 0 0 0 0 0 0 1 0 1 
SPBC725.15 ura5 orotate phosphoribosyltransferase Ura5 1 0 1 0 0 0 0 0 0 1 0 1 
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SPCC962.04 rps1201 40S ribosomal protein S12 (predicted) 1 0 1 0 0 0 0 0 0 1 0 1 
SPBC365.14c uge1 UDP-glucose 4-epimerase Uge1 1 0 1 0 0 0 0 0 0 0 1 1 
SPBC582.04c dsh1 RNAi protein, Dsh1 0 1 1 0 0 0 0 0 0 1 1 0 
SPCC1919.10c myo52 myosin type V 0 1 1 0 0 0 0 0 0 1 1 0 
SPBC11C11.07 rpl1801 60S ribosomal protein L18 0 1 1 0 0 0 0 0 0 0 1 1 
SPCC553.01c dbl2 meiotic chromosome segregation protein 
Dbl2 
0 1 1 0 0 0 0 0 0 0 1 1 
SPCC13B11.01 adh1 alcohol dehydrogenase Adh1 0 1 1 0 0 0 0 0 0 0 1 1 
SPBP22H7.08 rps1002 40S ribosomal protein S10 (predicted) 0 1 1 0 0 0 0 0 0 0 1 1 
SPCC126.09 zip2 vacuolar membrane zinc transmembrane 
transporter (predicted) 
0 1 1 0 0 0 0 0 0 0 1 1 
SPCC1494.07 
 
tRNA 2'-O-methylase subunit Trm72 
(predicted) 
0 1 1 0 0 0 0 0 0 0 1 1 
SPBC557.02c 
 
conserved fungal protein 0 1 1 0 0 0 0 0 0 0 1 1 
SPAC7D4.07c trx1 cytosolic thioredoxin Trx1 0 1 1 0 0 0 0 0 0 0 1 1 
SPCC1322.12c bub1 mitotic spindle checkpoint kinase Bub1 0 1 1 0 0 0 0 0 0 0 1 1 
SPBC3H7.09 erf2 palmitoyltransferase Erf2 0 1 0 0 0 0 0 0 0 1 1 1 
SPBP16F5.03c tra1 SAGA complex phosphatidylinositol 
pseudokinase Tra1 
0 1 0 0 0 0 0 0 0 1 1 1 
SPCC794.12c mae2 malic enzyme, malate dehydrogenase 
(oxaloacetate decarboxylating), Mae2 
0 1 0 0 0 0 0 0 0 1 1 1 
SPBPB2B2.01 
 
amino acid transmembrane transporter 
(predicted) 
0 1 0 0 0 0 0 0 0 1 1 1 
SPBP8B7.24c atg8 autophagy associated protein Atg8 0 0 1 0 0 0 0 0 0 1 1 1 
SPAC19G12.05 
 
mitochondrial citrate transmembrane 
transporter (predicted) 
0 0 1 0 0 0 0 0 0 1 1 1 
SPAC4H3.03c 
 
glucan 1,4-alpha-glucosidase (predicted) 0 0 1 0 0 0 0 0 0 1 1 1 
SPAC1071.04c spc2 signal peptidase subunit Spc2 (predicted) 0 0 1 0 0 0 0 0 0 1 1 1 
SPAPB1E7.04c 
 
chitinase (predicted) 0 0 0 0 0 0 1 1 1 0 0 0 
SPAC1782.11 met14 adenylyl-sulfate kinase (predicted) 0 0 0 1 1 0 1 0 0 0 0 0 
SPBC29A3.08 pof4 elongin-A, F-box protein Pof4 (predicted) 1 0 0 0 0 0 1 0 0 1 0 0 
SPAC6G9.12 cfr1 Chs five related protein Cfr1 0 0 1 0 0 0 0 1 1 0 0 0 
SPAC227.18 lys3 saccharopine dehydrogenase Lys3 0 0 0 0 0 0 0 1 1 0 1 0 
SPAC688.11 end4 Huntingtin-interacting protein homolog 0 0 0 0 0 0 0 1 1 0 1 0 
SPBC428.02c eca39 branched chain amino acid 
aminotransferase Eca39 
1 1 0 0 0 0 0 1 0 0 0 0 
SPBC16C6.04 dbl6 double strand break localizing protein 
Dbl6 
1 0 0 0 0 0 0 1 0 1 0 0 
SPBC56F2.02 rpl1901 60S ribosomal protein L19 1 0 0 0 0 0 0 1 0 1 0 0 
SPBC3B8.02 php5 CCAAT-binding factor complex subunit 
Php5 
0 1 1 0 0 0 0 1 0 0 0 0 
SPAPB1E7.14 iec5 Ino80 complex subunit Iec5 0 0 1 0 0 0 0 1 0 0 0 1 
SPCC1281.03c emc4 ER membrane protein complex subunit 4 
(predicted) 
0 0 0 0 0 0 0 1 0 0 1 1 
SPAC22F8.12c shf1 small histone ubiquitination factor Shf1 0 0 0 1 1 0 0 0 1 0 0 0 
SPAC1B3.21 coa3 cytochrome C oxidase assembly factor 3, 
Coa3 (predicted) 
0 1 0 0 1 0 0 0 1 0 0 0 
SPAC3G9.03 rpl2301 60S ribosomal protein L23 0 0 0 0 0 1 0 0 1 1 0 0 
SPBC1604.25 pet117 cytochrome c oxidase assembly protein 
Pet117 (predicted) 
1 1 0 0 0 0 0 0 1 0 0 0 
SPBC4C3.12 sep1 forkhead transcription factor Sep1 1 0 0 0 0 0 0 0 1 1 0 0 
SPAC1002.15c med6 mediator complex subunit Med6 1 0 0 0 0 0 0 0 1 1 0 0 
SPCC188.02 par1 protein phosphatase regulatory subunit 
Par1 
0 1 1 0 0 0 0 0 1 0 0 0 
SPAC15E1.02c 
 
DUF1761 family protein 0 1 0 0 0 0 0 0 1 0 1 0 
SPAC18G6.05c gcn1 translation elongation regulator Gcn1 
(predicted) 
0 0 0 0 0 0 0 0 1 1 1 0 
SPCC1223.10c eaf1 RNA polymerase II transcription 
elongation factor SpEAF 
0 0 0 1 1 1 0 0 0 0 0 0 
SPCC737.03c ima1 inner nuclear membrane protein Ima1 0 0 0 1 1 1 0 0 0 0 0 0 
SPCC1223.12c meu10 GPI anchored cell surface protein involved 
in ascospore wall assembly Meu10 
0 0 0 1 1 1 0 0 0 0 0 0 
SPCC1223.06 tea1 cell end marker Tea1 0 0 0 1 1 1 0 0 0 0 0 0 
SPCC1223.04c set11 ribosomal protein lysine 
methyltransferase Set11 
0 0 0 1 1 1 0 0 0 0 0 0 
SPCC737.06c gcs2 glutamate-cysteine ligase regulatory 
subunit Gcs2 (predicted) 
0 0 0 1 1 1 0 0 0 0 0 0 
SPAC9E9.09c atd1 aldehyde dehydrogenase (predicted) 0 0 0 1 1 1 0 0 0 0 0 0 
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SPCC297.05 
 
diacylglycerol binding protein (predicted) 0 0 0 1 1 0 0 0 0 0 1 0 
SPCC1223.11 ptc2 protein phosphatase 2C Ptc2 0 0 0 1 1 0 0 0 0 0 1 0 
SPBC1105.02c lys4 homocitrate synthase 1 0 1 1 0 0 0 0 0 0 0 0 
SPBC3B9.11c ctf1 mRNA cleavage and polyadenylation 
specificity factor complex subunit Ctf1 
1 0 0 1 0 0 0 0 0 1 0 0 
SPCC31H12.05c sds21 serine/threonine protein phosphatase PP1 
subfamily, Sds21 
1 0 0 1 0 0 0 0 0 1 0 0 
SPBC27B12.08 sip1 Pof6 interacting protein Sip1, predicted 
AP-1 accessory protein 
1 0 1 0 1 0 0 0 0 0 0 0 
SPCC777.13 vps35 retromer complex subunit Vps35 1 0 0 0 1 0 0 0 0 1 0 0 
SPBC713.11c pmp3 plasma membrane proteolipid Pmp3 1 0 0 0 1 0 0 0 0 1 0 0 
SPBC1734.08 hse1 STAM like protein Hse1 0 1 1 0 1 0 0 0 0 0 0 0 
SPBC4F6.08c mrpl39 mitochondrial ribosomal protein subunit 
L39 (predicted) 
0 1 0 0 1 0 0 0 0 0 1 0 
SPBC428.10 
 
Schizosaccharomyces pombe specific 
protein 
0 1 0 0 1 0 0 0 0 0 1 0 
SPAC1F12.04c 
 
conserved fungal protein 0 0 1 0 1 0 0 0 0 1 0 0 
SPAPB1A11.01 mfc1 copper transmembrane transporter, 
meiotic Mfc1 
0 0 1 0 1 0 0 0 0 0 1 0 
SPAC13G7.06 met16 phosphoadenosine phosphosulfate 
reductase 
0 0 0 0 1 0 0 0 0 1 1 0 
SPCC645.14c sti1 chaperone activator Sti1 (predicted) 0 0 0 0 1 0 0 0 0 1 1 0 
SPAC144.02 iec1 Ino80 complex subunit Iec1 0 0 0 0 1 0 0 0 0 1 1 0 
SPAC12G12.13c cid14 poly(A) polymerase Cid14 1 0 0 0 0 1 0 0 0 1 0 0 
SPBC3D6.04c mad1 mitotic spindle checkpoint protein Mad1 1 0 0 0 0 1 0 0 0 1 0 0 
SPAC19G12.12 dlp1 decaprenyl diphosphate synthase subunit 
2 Dlp1 
0 1 1 0 0 1 0 0 0 0 0 0 
SPAC110.02 pds5 mitotic cohesin-associated protein Pds5 0 1 0 0 0 1 0 0 0 0 1 0 
SPBC19F8.06c meu22 amino acid transmembrane transporter, 
predicted Meu22 
0 1 0 0 0 1 0 0 0 0 1 0 
SPCC61.02 spt3 SAGA complex subunit Spt3 0 1 0 0 0 1 0 0 0 0 0 1 
SPBC1861.01c cnp3 CENP-C ortholog Cnp3 0 0 1 0 0 1 0 0 0 0 1 0 
SPAC630.15 mug177 Schizosaccharomyces pombe specific 
protein 
0 0 1 0 0 1 0 0 0 0 1 0 
SPAC20H4.02 dsc3 Golgi Dsc E3 ligase complex subunit Dsc3 0 0 1 0 0 1 0 0 0 0 0 1 
SPCC18.09c hnt3 aprataxin Hnt3 0 0 1 0 0 1 0 0 0 0 0 1 
SPCC74.06 mak3 histidine kinase Mak3 0 0 1 0 0 1 0 0 0 0 0 1 
SPAC824.02 bst1 GPI inositol deacylase Bst1 (predicted) 0 0 0 0 0 1 0 0 0 1 1 0 
SPAC750.08c 
 
NAD-dependent malic enzyme 
(predicted), partial 
0 0 0 0 0 1 0 0 0 1 1 0 
SPBC405.07 rpl3602 60S ribosomal protein L36 0 0 0 0 0 1 0 0 0 1 1 0 
SPBC29A3.12 rps902 40S ribosomal protein S9 (predicted) 0 0 0 0 0 1 0 0 0 1 1 0 
SPAC8C9.04 
 
Schizosaccharomyces specific protein 0 0 0 0 0 1 0 0 0 1 1 0 
SPBC2F12.15c pfa3 palmitoyltransferase Pfa3 (predicted) 0 0 0 0 0 1 0 0 0 1 1 0 
SPBC106.19 
 
Schizosaccharomyces specific protein 0 0 0 0 0 1 0 0 0 0 1 1 
SPCC1450.16c ptl1 triacylglycerol lipase ptl1 0 0 0 0 0 1 0 0 0 0 1 1 
SPBC428.05c arg12 argininosuccinate synthase Arg12 1 1 1 0 0 0 0 0 0 0 0 0 
SPBP35G2.07 ilv1 acetolactate synthase catalytic subunit 1 1 1 0 0 0 0 0 0 0 0 0 
SPBC25H2.18 cox20 mitochondrial respiratory chain complex 
IV assembly protein Cox20 (predicted) 
1 1 1 0 0 0 0 0 0 0 0 0 
SPAC2F7.03c pom1 DYRK family protein kinase Pom1 1 1 0 0 0 0 0 0 0 1 0 0 
SPAC4C5.04 rad31 SUMO activating enzyme E1-type Rad31 1 1 0 0 0 0 0 0 0 1 0 0 
SPCC584.01c 
 
sulfite reductase NADPH flavoprotein 
subunit (predicted) 
1 1 0 0 0 0 0 0 0 1 0 0 
SPBC8D2.17 gmh4 alpha-1,2-galactosyltransferase 
(predicted) 
1 1 0 0 0 0 0 0 0 1 0 0 
SPBC1271.14 
 
glutamate N-acetyltransferase (predicted) 1 1 0 0 0 0 0 0 0 0 1 0 
SPBC2D10.17 clr1 SHREC complex subunit Clr1 1 1 0 0 0 0 0 0 0 0 1 0 
SPBC16E9.03c coa1 mitochondrial inner membrane protein 
involved in respiratory chain complex IV 
assembly Coa1 (predicted) 
1 1 0 0 0 0 0 0 0 0 1 0 
SPBC887.15c sur2 sphingosine hydroxylase Sur2 1 1 0 0 0 0 0 0 0 0 1 0 
SPAC4G8.11c atp10 mitochondrial F1-F0 ATPase assembly 
protein (predicted) 
1 1 0 0 0 0 0 0 0 0 1 0 
SPBC16E9.14c zrg17 cation diffusion family zinc 
transmembrane transporter Zrg17 
1 1 0 0 0 0 0 0 0 0 1 0 
SPCC1393.13 
 
protein carboxyl methyltransferase, 
implicated in DNA damage response 
1 0 1 0 0 0 0 0 0 1 0 0 
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SPBPB10D8.07c 
 
transmembrane transporter (predicted) 1 0 1 0 0 0 0 0 0 1 0 0 
SPAC11D3.18c 
 
plasma membrane nicotinic acid 
transmembrane transporter (predicted) 
1 0 1 0 0 0 0 0 0 1 0 0 
SPAC5H10.04 
 
NADPH dehydrogenase (predicted) 1 0 1 0 0 0 0 0 0 1 0 0 
SPAC637.09 
 
ribonuclease H70 (predicted) 1 0 1 0 0 0 0 0 0 1 0 0 
SPBC1271.12 kes1 oxysterol binding protein (predicted) 1 0 1 0 0 0 0 0 0 1 0 0 
SPBC83.13 
 
mitochondrial tricarboxylic acid 
transmembrane transporter (predicted) 
1 0 1 0 0 0 0 0 0 1 0 0 
SPAC8C9.19 
 
conserved fungal protein 1 0 1 0 0 0 0 0 0 1 0 0 
SPAC23A1.03 apt1 adenine phosphoribosyltransferase 
(APRT) (predicted) 
1 0 1 0 0 0 0 0 0 1 0 0 
SPBC14F5.09c ade8 adenylosuccinate lyase Ade8 1 0 1 0 0 0 0 0 0 1 0 0 
SPAC644.06c cdr1 NIM1 family serine/threonine protein 
kinase Cdr1/Nim1 
1 0 1 0 0 0 0 0 0 0 1 0 
SPAC25A8.01c fft3 SMARCAD1 family ATP-dependent DNA 
helicase Fft3 
1 0 1 0 0 0 0 0 0 0 1 0 
SPBC16D10.08c hsp104 heat shock protein Hsp104 (predicted) 1 0 1 0 0 0 0 0 0 0 1 0 
SPBP16F5.05c yar1 ribosome biogenesis protein Yar1 
(predicted) 
1 0 0 0 0 0 0 0 0 1 1 0 
SPCC1919.01 ckk2 calmodulin-dependent kinase kinase 2 1 0 0 0 0 0 0 0 0 1 1 0 
SPAC1F5.08c yam8 stretch-activated calcium ion channel 
Yam8 
1 0 0 0 0 0 0 0 0 1 1 0 
SPBC725.03 
 
pyridoxamine 5'-phosphate oxidase 
(predicted) 
1 0 0 0 0 0 0 0 0 1 1 0 
SPAC19G12.17 erh1 enhancer of rudimentary homolog Erh1 1 0 0 0 0 0 0 0 0 1 1 0 
SPAC56F8.02 
 
AMP binding enzyme (predicted) 1 0 0 0 0 0 0 0 0 1 1 0 
SPAC27D7.03c mei2 RNA-binding protein involved in meiosis 
Mei2 
1 0 0 0 0 0 0 0 0 1 1 0 
SPAC6F12.03c fsv1 SNARE Fsv1 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC725.01 
 
aspartate aminotransferase (predicted) 1 0 0 0 0 0 0 0 0 1 1 0 
SPCC24B10.06 
 
Schizosaccharomyces specific protein, 
predicted GPI anchor 
1 0 0 0 0 0 0 0 0 1 1 0 
SPAC1556.03 azr1 serine/threonine protein phosphatase 
Azr1 
1 0 0 0 0 0 0 0 0 1 1 0 
SPAC22F8.04 pet1 phosphoenolpyruvate transmembrane 
transporter Pet1 
1 0 0 0 0 0 0 0 0 1 1 0 
SPCC970.07c raf2 Rik1-associated factor Raf2 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC16A3.17c 
 
transmembrane transporter (predicted) 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC354.03 swd3 WD repeat protein Swd3 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC4.02c 
 
conserved fungal protein 1 0 0 0 0 0 0 0 0 1 1 0 
SPAC1527.02 sft2 Golgi transport protein Sft2 (predicted) 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC27.08c sua1 sulfate adenylyltransferase 1 0 0 0 0 0 0 0 0 1 1 0 
SPAC4G9.10 arg3 ornithine carbamoyltransferase Arg3 1 0 0 0 0 0 0 0 0 1 1 0 
SPCC24B10.22 pog1 mitochondrial DNA polymerase gamma 1 0 0 0 0 0 0 0 0 1 1 0 
SPAC17G6.13 slt1 Schizosaccharomyces specific protein Slt1 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC16E9.12c pab2 poly(A) binding protein Pab2 1 0 0 0 0 0 0 0 0 1 1 0 
SPCC11E10.07c 
 
translation initiation factor eIF2B alpha 
subunit (predicted) 
1 0 0 0 0 0 0 0 0 1 1 0 
SPAC11G7.02 pub1 HECT-type ubiquitin-protein ligase E3 
Pub1 
1 0 0 0 0 0 0 0 0 1 1 0 
SPBC3H7.11 abp140 actin binding methyltransferase Abp140 
(predicted) 
1 0 0 0 0 0 0 0 0 1 1 0 
SPCC330.03c 
 
NADPH-hemoprotein reductase 
(predicted) 
1 0 0 0 0 0 0 0 0 1 1 0 
SPAC1556.04c cdd1 cytidine deaminase Ccd1 (predicted) 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC16E9.13 ksp1 serine/threonine protein kinase Ksp1 
(predicted) 
1 0 0 0 0 0 0 0 0 1 1 0 
SPBC16E9.19 
 
conserved fungal protein 1 0 0 0 0 0 0 0 0 1 1 0 
SPBC32F12.08c duo1 DASH complex subunit Duo1 1 1 0 0 0 0 0 0 0 1 1 0 
SPBC1734.11 mas5 DNAJ domain protein Mas5 (predicted) 1 0 0 0 0 0 0 0 0 1 0 1 
SPBC19G7.16 iws1 transcription elongation factor complex 
subunit Iws1 (predicted) 
0 1 1 0 0 0 0 0 0 1 0 0 
SPCC777.06c 
 
hydrolase (predicted) 0 1 1 0 0 0 0 0 0 0 1 0 
SPCC24B10.10c yta4 mitochondrial outer membrane ATPase 
Msp1/Yta4 (predicted) 
0 1 1 0 0 0 0 0 0 0 1 0 
SPCC24B10.04 
 
Schizosaccharomyces specific protein 0 1 1 0 0 0 0 0 0 0 1 0 
SPBC24C6.11 cwf14 G10 protein 0 1 1 0 0 0 0 0 0 0 1 0 
SPBC6B1.09c nbs1 Mre11 complex subunit Nbs1 0 1 1 0 0 0 0 0 0 0 1 0 
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SPAC30.01c sec72 Sec7 domain protein, ARF GEF Sec72 0 1 1 0 0 0 0 0 0 0 1 0 
SPAC1B1.04c pan3 protein kinase-like PAN complex subunit 
Pan3 (predicted) 
0 1 1 0 0 0 0 0 0 0 1 0 
SPAC31G5.19 abo1 ATPase with bromodomain protein 
(predicted) 
0 1 1 0 0 0 0 0 0 0 1 0 
SPBC1709.09 rrf1 mitochondrial translation termination 
factor Rrf1 
0 1 1 0 0 0 0 0 0 0 1 0 
SPCC594.02c 
 
conserved fungal protein 0 1 1 0 0 0 0 0 0 0 1 0 
SPCC126.04c sgf73 SAGA complex subunit Sgf73 0 1 1 0 0 0 0 0 0 0 1 0 
SPCC63.14 eis1 eisosome assembly protein eis1 0 1 1 0 0 0 0 0 0 0 1 0 
SPAC1F3.07c rsc58 RSC complex subunit Rsc58 0 1 1 0 0 0 0 0 0 0 1 0 
SPCC645.07 rgf1 RhoGEF for Rho1, Rgf1 0 1 1 0 0 0 0 0 0 0 1 0 
SPAC1F7.07c fip1 iron permease Fip1 0 1 1 0 0 0 0 0 0 0 1 0 
SPBC557.04 ppk29 Ark1/Prk1 family protein kinase Ppk29 0 1 1 0 0 0 0 0 0 0 0 1 
SPCP1E11.11 puf6 Puf family RNA-binding protein Puf6 
(predicted) 
0 1 1 0 0 0 0 0 0 0 0 1 
SPCC663.03 pmd1 leptomycin transmembrane transporter 
Pmd1 
0 1 1 0 0 0 0 0 0 0 0 1 
SPAC25B8.03 psd2 phosphatidylserine decarboxylase Psd2 0 1 1 0 0 0 0 0 0 0 0 1 
SPBC17A3.09c aim22 lipoate-protein ligase A (predicted) 0 1 1 0 0 0 0 0 0 0 0 1 
SPAC22E12.18 
 
conserved fungal protein 0 1 0 0 0 0 0 0 0 1 1 0 
SPAC24B11.09 mpc2 mitochondrial pyruvate transmembrane 
transporter Mpc2 (predicted) 
0 1 0 0 0 0 0 0 0 1 1 0 
SPCC1393.12 
 
Schizosaccharomyces specific protein 0 1 0 0 0 0 0 0 0 1 1 0 
SPBC3H7.18 tam8 Schizosaccharomyces specific protein 
Tam8 
0 1 0 0 0 0 0 0 0 1 1 0 
SPAC15A10.15 sgo2 inner centromere protein, shugoshin Sgo2 0 1 0 0 0 0 0 0 0 1 1 0 
SPAC17H9.04c nrp1 RNA-binding protein 0 1 0 0 0 0 0 0 0 1 1 0 
SPBC27B12.07 
 
conserved fungal protein 0 1 0 0 0 0 0 0 0 1 1 0 
SPBPB10D8.06c 
 
transmembrane transporter (predicted) 0 1 0 0 0 0 0 0 0 1 1 0 
SPBC776.06c 
 
Arf3/6 docking factor (predicted) 0 1 0 0 0 0 0 0 0 1 1 0 
SPCC31H12.08c ccr4 CCR4-Not complex subunit Ccr4 
(predicted) 
0 1 0 0 0 0 0 0 0 1 1 0 
SPBP16F5.08c 
 
flavin dependent monooxygenase 
(predicted) 
0 1 0 0 0 0 0 0 0 1 1 0 
SPBC9B6.03 
 
zf-FYVE type zinc finger protein 0 1 0 0 0 0 0 0 0 1 1 0 
SPBC3H7.10 elp6 elongator complex subunit Elp6 
(predicted) 
0 1 0 0 0 0 0 0 0 1 1 0 
SPBC2F12.12c cay1 cactin, spliceosome complex subunit 0 1 0 0 0 0 0 0 0 1 1 0 
SPAC10F6.08c nht1 Ino80 complex HMG box subunit Nht1 0 1 0 0 0 0 0 0 0 1 1 0 
SPBC83.10 
 
transthyretin superfamily member, 
human ER membrane protein complex 
subunit 7 ortholog 
0 1 0 0 0 0 0 0 0 1 1 0 
SPBC16H5.06 rip1 ubiquinol-cytochrome-c reductase 
complex subunit 5 
0 1 0 0 0 0 0 0 0 1 1 0 
SPAC17C9.08 pnu1 mitochondrial endodeoxyribonuclease 
Pnu1 
0 1 0 0 0 0 0 0 0 1 1 0 
SPAC13A11.05 ysp2 peptidase family M17 cytoplasmic leucyl 
aminopeptidase yspII (LAP yspII) 
0 1 0 0 0 0 0 0 0 1 1 0 
SPBC30D10.13c pdb1 pyruvate dehydrogenase e1 component 
beta subunit Pdb1 
0 1 0 0 0 0 0 0 0 1 1 0 
SPCC74.09 mug24 RNA-binding protein, rrm type 0 1 0 0 0 0 0 0 0 1 1 0 
SPBC17D1.02 dph2 diphthamide biosynthesis protein 
(predicted) 
0 1 0 0 0 0 0 0 0 1 1 0 
SPBC16E9.06c uvi31 BolA domain UV induced protein Uvi31 0 1 0 0 0 0 0 0 0 1 1 0 
SPCC306.04c set1 histone lysine methyltransferase Set1 0 1 0 0 0 0 0 0 0 1 1 0 
SPCC191.11 inv1 external invertase, beta-
fructofuranosidase 
0 1 0 0 0 0 0 0 0 0 1 1 
SPCC31H12.04c rpl1202 60S ribosomal protein L12.1/L12A 0 1 0 0 0 0 0 0 0 0 1 1 
SPBP35G2.08c air1 zinc knuckle TRAMP complex subunit Air1 0 1 0 0 0 0 0 0 0 0 1 1 
SPCC1902.02 mug72 oxidoreductase (predicted) 0 1 0 0 0 0 0 0 0 0 1 1 
SPCC663.06c osr1 short chain dehydrogenase (predicted) 0 1 0 0 0 0 0 0 0 0 1 1 
SPBC56F2.08c 
 
RNA-binding protein (predicted) 0 1 0 0 0 0 0 0 0 0 1 1 
SPBC9B6.11c 
 
CCR4/nocturin family endoribonuclease 
(predicted) 
0 0 1 0 0 0 0 0 0 1 1 0 
SPBC3H7.12 rav2 RAVE complex subunit Rav2 0 0 1 0 0 0 0 0 0 1 1 0 
SPAC664.02c arp8 actin-like protein, Ino80 complex subunit 
Arp8 
0 0 1 0 0 0 0 0 0 1 1 0 
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SPAC328.09 
 
mitochondrial 2-oxoadipate and 2-
oxoglutarate transmembrane transporter 
(predicted) 
0 0 1 0 0 0 0 0 0 1 1 0 
SPAC22E12.11c set3 histone lysine methyltransferase Set3 0 0 1 0 0 0 0 0 0 1 1 0 
SPAC1B3.16c vht1 vitamin H transmembrane transporter 
Vht1 
0 0 1 0 0 0 0 0 0 1 1 0 
SPBC1703.12 ubp9 ubiquitin C-terminal hydrolase Ubp9 0 0 1 0 0 0 0 0 0 1 1 0 
SPCC1672.11c 
 
P-type ATPase P5 type (predicted) 0 0 1 0 0 0 0 0 0 1 1 0 
SPBC1198.11c reb1 RNA polymerase I transcription 
termination factor/ RNA polymerase II 
transcription factor Reb1 
0 0 1 0 0 0 0 0 0 1 1 0 
SPBC1348.02 
 
S. pombe specific 5Tm protein family 0 0 1 0 0 0 0 0 0 1 1 0 
SPAC20G8.09c nat10 ribosome biogenesis ATPase 0 0 1 0 0 0 0 0 0 1 1 0 
SPCC613.12c raf1 CLRC ubiquitin E3 ligase complex 
specificiy factor Raf1/Dos1 
0 0 1 0 0 0 0 0 0 1 0 1 
SPBP8B7.13 vac7 Vac7 ortholog (predicted) 0 0 1 0 0 0 0 0 0 1 0 1 
SPCC285.04 
 
transthyretin/hydroxyisourate hydrolase 
(predicted) 
0 0 1 0 0 0 0 0 0 1 0 1 
SPCC622.18 rpl6 60S ribosomal protein L6 (predicted) 0 0 1 0 0 0 0 0 0 1 0 1 
SPAC26F1.01 sec74 guanyl-nucleotide exchange factor Sec74 
(predicted) 
0 0 1 0 0 0 0 0 0 1 0 1 
SPAC3C7.12 tip1 CLIP170 family protein Tip1 0 0 1 0 0 0 0 0 0 0 1 1 
SPBC21B10.02 
 
conserved fungal protein 0 0 1 0 0 0 0 0 0 0 1 1 
SPBC776.03 
 
homoserine dehydrogenase (predicted) 0 0 1 0 0 0 0 0 0 0 1 1 
SPAC23H4.17c srb10 cyclin-dependent protein Srb mediator 
subunit kinase Srb10 
0 0 1 0 0 0 0 0 0 0 1 1 
SPBC337.13c gtr1 Gtr1/RagA G protein Gtr1 (predicted) 0 0 1 0 0 0 0 0 0 0 1 1 
SPBC409.18 
 
phosphatidic acid phosphatase 
(predicted) 
0 0 1 0 0 0 0 0 0 0 1 1 
SPAC3A11.06 mvp1 sorting nexin Mvp1 (predicted) 0 0 1 0 0 0 0 0 0 0 1 1 
SPBC21C3.01c vps1301 chorein homolog Vps13a (predicted) 0 0 1 0 0 0 0 0 0 0 1 1 
SPBC29A3.21 
 
Schizosaccharomyces pombe specific 
protein 
0 0 1 0 0 0 0 0 0 0 1 1 
SPCC569.06 
 
S. pombe specific multicopy membrane 
protein family 1 
0 0 1 0 0 0 0 0 0 0 1 1 
SPCC1322.02 pxd1 structure-specific DNA nuclease regulator 
Pxd1 
0 0 1 0 0 0 0 0 0 0 1 1 
SPBC83.09c lin1 U5 snRNP subunit Snu40 (predicted) 0 0 1 0 0 0 0 0 0 0 1 1 
SPBPJ4664.05 
 
conserved fungal protein 0 0 1 0 0 0 0 0 0 0 1 1 
SPAC4F8.03 sdo1 SBDS family ribosome maturation protein 
Sdo1 (predicted) 
0 0 1 0 0 0 0 0 0 0 1 1 
SPCC962.05 ast1 asteroid homolog, XP-G family protein 0 0 1 0 0 0 0 0 0 0 1 1 
SPAC5D6.09c mug86 acetate transmembrane transporter 
(predicted) 
0 0 1 0 0 0 0 0 0 0 1 1 
SPCC1259.12c gid1 GID complex subunit, Ran GTPase binding 
protein Gid1 (predicted) 
0 0 1 0 0 0 0 0 0 0 1 1 
SPCC132.04c gdh2 NAD-dependent glutamate 
dehydrogenase Gdh2 (predicted) 
0 0 1 0 0 0 0 0 0 0 1 1 
SPCC306.11 
 
Schizosaccharomyces specific protein 0 0 1 0 0 0 0 0 0 0 1 1 
SPCC306.08c mdh1 malate dehydrogenase Mdh1 (predicted) 0 0 1 0 0 0 0 0 0 0 1 1 
SPCC1442.03 mme1 mitochondrial magnesium ion 
transmembrane transporter Mme1 
(predicted) 
0 0 1 0 0 0 0 0 0 0 1 1 
SPCC4B3.15 mid1 medial ring protein Mid1 0 0 1 0 0 0 0 0 0 0 1 1 
SPBP23A10.05 ssr4 SWI/SNF and RSC complex subunit Ssr4 0 0 0 0 0 0 0 0 0 1 1 1 
SPAC18B11.11 
 
GTPase activating protein (predicted) 0 0 0 0 0 0 0 0 0 1 1 1 
SPBC21C3.07c trm140 tRNA (cytosine) methyltransferase 
Trm140 (predicted) 
0 0 0 0 0 0 1 1 0 0 0 0 
SPAC1486.10 thi1 transcription factor Thi1 0 0 0 0 0 0 1 1 0 0 0 0 
SPAC1486.01 
 
manganese superoxide dismutase 0 0 0 0 0 0 1 0 1 0 0 0 
SPBC26H8.03 cho2 phosphatidylethanolamine N-
methyltransferase Cho2 
0 0 0 0 0 1 1 0 0 0 0 0 
SPAPB1E7.05 gde1 glycerophosphoryl diester 
phosphodiesterase Gde1 (predicted) 
0 0 0 0 0 0 0 1 1 0 0 0 
SPAC959.08 rpl2102 60S ribosomal protein L21 (predicted) 0 0 0 0 0 0 0 1 1 0 0 0 
SPAC6G9.16c xrc4 XRCC4 nonhomologous end joining factor 
Xrc4 
0 0 0 0 0 0 0 1 1 0 0 0 
SPAC6G9.09c rpl2401 60S ribosomal protein L24 (predicted) 0 0 0 0 0 1 0 1 0 0 0 0 
SPCC4B3.14 cwf20 complexed with Cdc5 protein Cwf20 1 0 0 0 0 0 0 1 0 0 0 0 
165 
 
SPAC26A3.01 sxa1 aspartic protease Sxa1 0 0 1 0 0 0 0 1 0 0 0 0 
SPAC3A11.10c 
 
dipeptidyl peptidase (predicted) 0 0 1 0 0 0 0 1 0 0 0 0 
SPBC56F2.12 ilv5 acetohydroxyacid reductoisomerase 
(predicted) 
0 1 0 0 0 0 0 0 1 0 0 0 
SPAC26A3.02 myh1 adenine DNA glycosylase Myh1 0 0 1 0 0 0 0 0 1 0 0 0 
SPAC6G10.08 idp1 isocitrate dehydrogenase Idp1 (predicted) 0 0 1 0 0 0 0 0 1 0 0 0 
SPAC26A3.09c rga2 Rho-type GTPase activating protein Rga2 0 0 1 0 0 0 0 0 1 0 0 0 
SPAC31G5.12c maf1 repressor of RNA polymerase III Maf1 0 0 1 0 0 0 0 0 1 0 0 0 
SPAC6G9.03c mug183 histone chaperone Rtt106-like (predicted) 0 0 0 0 0 0 0 0 1 0 1 0 
SPBC12C2.01c 
 
Schizosaccharomyces specific protein 0 0 0 0 0 0 0 0 1 0 1 0 
SPAC12G12.17 
 
non-classical export protein 1 (predicted) 0 0 0 0 0 0 0 0 1 0 1 0 
SPBC2D10.11c nap2 nucleosome assembly protein Nap2 0 0 0 0 0 0 0 0 1 0 1 0 
SPAC2E1P5.02c mug109 Rab GTPase binding protein upregulated 
in meiosis II (predicted) 
0 0 0 0 0 0 0 0 1 0 0 1 
SPBC31F10.14c hip3 HIRA interacting protein Hip3 0 0 0 1 0 1 0 0 0 0 0 0 
SPCC737.04 
 
UPF0300 family protein 6 0 0 0 1 0 1 0 0 0 0 0 0 
SPCC737.05 
 
peroxin Pex28/29 (predicted) 0 0 0 1 0 1 0 0 0 0 0 0 
SPCC737.07c 
 
DNA polymerase alpha-associated DNA 
helicase A (predicted) 
0 0 0 1 0 1 0 0 0 0 0 0 
SPCC1223.03c gut2 glycerol-3-phosphate dehydrogenase 
Gut2 (predicted) 
0 0 0 1 0 1 0 0 0 0 0 0 
SPCC162.05 coq3 hexaprenyldihydroxybenzoate 
methyltransferase Coq3 
1 0 0 1 0 0 0 0 0 0 0 0 
SPCC285.05 
 
purine nucleoside transmembrane 
transporter (predicted) 
0 1 0 1 0 0 0 0 0 0 0 0 
SPCC1840.03 sal3 karyopherin Sal3 0 0 0 0 1 1 0 0 0 0 0 0 
SPAC22F8.05 
 
alpha,alpha-trehalose-phosphate 
synthase (predicted) 
0 0 0 0 1 1 0 0 0 0 0 0 
SPAC7D4.03c 
 
conserved fungal family 0 0 0 0 1 1 0 0 0 0 0 0 
SPCC736.06 dar2 mitochondrial aspartate-tRNA ligase Dar2 
(predicted) 
1 0 0 0 1 0 0 0 0 0 0 0 
SPAC4A8.03c ptc4 protein phosphatase 2C Ptc4 1 0 0 0 1 0 0 0 0 0 0 0 
SPAC1A6.04c plb1 phospholipase B homolog Plb1 1 0 0 0 1 0 0 0 0 0 0 0 
SPAC27E2.03c 
 
Obg-Like ATPase (predicted) 0 0 1 0 1 0 0 0 0 0 0 0 
SPCC1840.11 csl4 exosome subunit Csl4 0 0 0 0 1 0 0 0 0 0 1 0 
SPAC24B11.06c sty1 MAP kinase Sty1 0 0 0 0 1 0 0 0 0 0 1 0 
SPCC1450.06c grx3 monothiol glutaredoxin Grx3 0 0 0 0 1 0 0 0 0 0 0 1 
SPCC338.10c cox5 cytochrome c oxidase subunit V 
(predicted) 
1 0 0 0 0 1 0 0 0 0 0 0 
SPBC337.16 cho1 phosphatidyl-N-dimethylethanolamine N-
methyltransferase 
1 0 0 0 0 1 0 0 0 0 0 0 
SPAC1687.12c coq4 ubiquinone biosynthesis protein Coq4 
(predicted) 
0 1 0 0 0 1 0 0 0 0 0 0 
SPBC30B4.03c adn1 adhesion defective protein 0 1 0 0 0 1 0 0 0 0 0 0 
SPAC589.11 pth4 mitochondrial translation release factor 0 0 1 0 0 1 0 0 0 0 0 0 
SPBC4F6.15c swi10 DNA repair endonuclease non-catalytic 
subunit Swi10 
0 0 1 0 0 1 0 0 0 0 0 0 
SPCC162.06c 
 
vacuolar sorting protein Vps60 (predicted) 0 0 1 0 0 1 0 0 0 0 0 0 
SPAC8E11.01c 
 
beta-fructofuranosidase (predicted) 0 0 1 0 0 1 0 0 0 0 0 0 
SPBC660.07 ntp1 alpha,alpha-trehalase Ntp1 0 0 0 0 0 1 0 0 0 1 0 0 
SPAC13A11.03 mcp7 meiosis specific coiled-coil protein Mcp7 0 0 0 0 0 1 0 0 0 1 0 0 
SPBC2D10.19c alb1 pre-60S shuttling factor Alb1 (predicted) 0 0 0 0 0 1 0 0 0 0 1 0 
SPBC1709.12 rid1 GTPase binding protein Rid1 (predicted) 0 0 0 0 0 1 0 0 0 0 1 0 
SPBP4H10.05c spe2 S-adenosylmethionine decarboxylase 
proenzyme Spe2 
0 0 0 0 0 1 0 0 0 0 1 0 
SPCC18.11c sdc1 Dpy-30 domain protein Sdc1 0 0 0 0 0 1 0 0 0 0 1 0 
SPAC6F6.06c rax2 cell polarity factor Rax2 0 0 0 0 0 1 0 0 0 0 1 0 
SPAC1296.01c 
 
phosphoacetylglucosamine mutase 
(predicted) 
0 0 0 0 0 1 0 0 0 0 1 0 
SPAC694.04c 
 
conserved eukaryotic protein 0 0 0 0 0 1 0 0 0 0 1 0 
SPAC222.08c sno1 glutamine aminotransferase subunit Sno1 
(predicted) 
0 0 0 0 0 1 0 0 0 0 1 0 
SPAC31G5.18c sde2 silencing defective protein Sde2 0 0 0 0 0 1 0 0 0 0 1 0 
SPCC1620.02 wtf23 wtf element Wtf23 0 0 0 0 0 1 0 0 0 0 0 1 
SPAC1F5.10 
 
ATP-dependent RNA helicase (predicted) 1 1 0 0 0 0 0 0 0 0 0 0 
SPCC794.07 lat1 dihydrolipoamide S-acetyltransferase E2, 
Lat1 (predicted) 
1 1 0 0 0 0 0 0 0 0 0 0 
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SPAC821.11 pro1 gamma-glutamyl phosphate reductase 
Pro1 (predicted) 
1 1 0 0 0 0 0 0 0 0 0 0 
SPBC83.18c fic1 C2 domain protein Fic1 1 1 0 0 0 0 0 0 0 0 0 0 
SPBC19F8.08 rps401 40S ribosomal protein S4 (predicted) 1 1 0 0 0 0 0 0 0 0 0 0 
SPAC8C9.06c ppr4 mitochondrial translation regulator Ppr4 1 1 0 0 0 0 0 0 0 0 0 0 
SPAC56F8.04c ppt1 para-hydroxybenzoate--
polyprenyltransferase Ppt1 
1 1 0 0 0 0 0 0 0 0 0 0 
SPBC16A3.03c ppr7 mitochondrial PPR repeat protein Ppr7 1 1 0 0 0 0 0 0 0 0 0 0 
SPCC16C4.13c rpl1201 60S ribosomal protein L12.1/L12A 1 1 0 0 0 0 0 0 0 0 0 0 
SPBC337.08c ubi4 ubiquitin 1 0 1 0 0 0 0 0 0 0 0 0 
SPAC17G8.06c 
 
dihydroxy-acid dehydratase (predicted) 1 0 1 0 0 0 0 0 0 0 0 0 
SPBC146.12 coq6 monooxygenase Coq6 (predicted) 1 0 1 0 0 0 0 0 0 0 0 0 
SPAC19G12.11 coq9 ubiquinone biosynthesis protein Coq9 
(predicted) 
1 0 1 0 0 0 0 0 0 0 0 0 
SPCC320.12 atp23 mitochondrial inner membrane peptidase 
Atp23 (predicted) 
1 0 1 0 0 0 0 0 0 0 0 0 
SPAC19E9.03 pas1 cyclin Pas1 1 0 1 0 0 0 0 0 0 0 0 0 
SPBC31F10.10c 
 
zf-MYND type zinc finger protein 1 0 0 0 0 0 0 0 0 1 0 0 
SPAC1783.08c rpl1502 60S ribosomal protein L15b (predicted) 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC18B5.10c 
 
TREX complex subunit Tex1 (predicted) 1 0 0 0 0 0 0 0 0 1 0 0 
SPBC21.02 rtc5 TLDc domain protein 2 1 0 0 0 0 0 0 0 0 1 0 0 
SPBC660.11 tcg1 single-stranded telomeric binding protein 
Tgc1 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC17G8.05 med20 mediator complex subunit Med20 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC1827.02c pcy1 cholinephosphate cytidylyltransferase 
Pcy1 (predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC630.07c 
 
Schizosaccharomyces specific protein 1 0 0 0 0 0 0 0 0 1 0 0 
SPAC29E6.01 pof11 F-box protein Pof11 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC1020.06c tal1 transaldolase (predicted) 1 0 0 0 0 0 0 0 0 1 0 0 
SPBC16A3.16 coa5 mitochondrial inner membrane protein 
involved in cytochrome c oxidase 
assembly Coa5 (predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC513.03 mfm2 M-factor precursor Mfm2 1 0 0 0 0 0 0 0 0 1 0 0 
SPBC16A3.06 tad1 tRNA specific adenosine-37 deaminase 
Tad1 (predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPCC1393.08 
 
transcription factor, zf-GATA type 
(predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC637.03 
 
conserved fungal protein 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC338.05c mms2 ubiquitin conjugating enzyme Mms2 1 0 0 0 0 0 0 0 0 1 0 0 
SPBC609.02 ptn1 phosphatidylinositol-3,4,5-
trisphosphate3-phosphatase Ptn1 
1 0 0 0 0 0 0 0 0 1 0 0 
SPBC16C6.08c qcr6 ubiquinol-cytochrome-c reductase 
complex subunit 8, hinge protein 
(predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC1296.04 mug65 spore wall assembly protein Mug65 
(predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC1851.03 ckb1 CK2 family regulatory subunit Ckb1 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC162.11c 
 
uridine kinase/uracil 
phosphoribosyltransferase (predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPCC790.02 pep3 HOPS/CORVET complex subunit, 
ubiquitin-protein ligase E3 (predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC977.06 
 
S. pombe specific DUF999 family protein 3 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC622.15c 
 
Schizosaccharomyces specific protein 1 0 0 0 0 0 0 0 0 1 0 0 
SPAC26H5.10c tif51 translation elongation factor eIF5A 
(predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC22F3.08c rok1 ATP-dependent RNA helicase Rok1 
(predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC25B8.13c isp7 2-OG-Fe(II) oxygenase superfamily protein 1 0 0 0 0 0 0 0 0 1 0 0 
SPBC3E7.09 
 
Sad1-UNC-like protein involved protein 
folding in the ER (predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC29B12.05c 
 
mitochondrial S-adenosylmethionine-
dependent methyltransferase (predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPBC1271.05c 
 
zf-AN1 type zinc finger protein 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC18B5.06 dom34 peloto ortholog (predicted) 1 0 0 0 0 0 0 0 0 1 0 0 
SPAC5D6.04 
 
auxin family transmembrane transporter 
(predicted) 
1 0 0 0 0 0 0 0 0 1 0 0 
SPAC20G4.07c sts1 C-24(28) sterol reductase Sts1 1 0 0 0 0 0 0 0 0 1 0 0 
SPAC27E2.01 
 
alpha-amylase homolog (predicted) 1 0 0 0 0 0 0 0 0 1 0 0 
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SPAC27D7.09c 
 
But2 family protein 1 0 0 0 0 0 0 0 0 1 0 0 
SPAC1039.08 
 
serine acetyltransferase (predicted) 1 0 0 0 0 0 0 0 0 1 0 0 
SPCC188.07 ccq1 telomere maintenance protein Ccq1 1 0 0 0 0 0 0 0 0 1 0 0 
SPAC13C5.02 dre4 splicing associated factor Dre4 1 0 0 0 0 0 0 0 0 0 1 0 
SPBC106.04 ada1 adenosine deaminase Ada1 1 0 0 0 0 0 0 0 0 0 1 0 
SPBC16C6.03c 
 
ribosome assembly protein (predicted) 1 0 0 0 0 0 0 0 0 0 1 0 
SPAC24H6.07 rps901 40S ribosomal protein S9 1 0 0 0 0 0 0 0 0 0 1 0 
SPAC17A2.06c vps8 WD repeat protein Vps8 (predicted) 1 0 0 0 0 0 0 0 0 0 1 0 
SPAC630.10 bmt2 rRNA (adenine) methyltransferase activity 
Bmt2 (predicted) 
1 0 0 0 0 0 0 0 0 0 1 0 
SPBC15D4.03 slm9 hira protein Slm9 1 0 0 0 0 0 0 0 0 0 1 0 
SPCC1739.07 cti1 Cut3 interacting protein Cti1, predicted 
exosome subunit 
0 1 1 0 0 0 0 0 0 0 0 0 
SPBC18H10.16 can1 arginine transmembrane transporter 
Can1 
0 1 0 0 0 0 0 0 0 1 0 0 
SPBC27.02c ask1 DASH complex subunit Ask1 0 1 0 0 0 0 0 0 0 1 0 0 
SPCC16A11.10c oca8 cytochrome b5 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC550.07 
 
acetamidase (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC4G8.13c prz1 calcineurin responsive transcription factor 
Prz1 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC17A5.09c glc8 protein phosphatase regulatory subunit 
Glc8 (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC32H8.07 git5 heterotrimeric G protein beta subunit Git5 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1F7.09c 
 
allantoicase (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC12B10.09 pet801 mitochondrial S-adenosylmethionine 
transmembrane transporter (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC24B10.02c 
 
NAD/NADH kinase (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC336.05c 
 
small RNA 2'-O-methyltransferase activity 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC4G9.16c rpl901 60S ribosomal protein L9 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC830.10 ham1 nucleoside triphosphatase Ham1 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC4F6.12 pxl1 paxillin-like protein Pxl1 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC1685.09 rps29 40S ribosomal protein S29 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC8E4.04 
 
alditol NADP+ 1-oxidoreductase activity 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC4D7.10c spt20 SAGA complex subunit Spt20 0 1 0 0 0 0 0 0 0 0 1 0 
SPBP8B7.22 erd2 HDEL receptor (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC887.05c cwf29 RNA-binding protein Cwf29 0 1 0 0 0 0 0 0 0 0 1 0 
SPACUNK4.12c iph1 insulinase pombe homologue 1 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC725.02 mpr1 histidine-containing response regulator 
phosphotransferase Mpr1 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC649.04 uvi15 UV-induced protein Uvi15 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC3B9.13c rpp102 60S acidic ribosomal protein A3 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1442.05c mic26 MICOS complex subunit Mic26 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC15E1.04 hal3 thymidylate synthase/ flavoprotein fusion 
protein Hal3 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC338.16 pof3 F-box protein Pof3 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC16C6.02c vps1302 chorein homolog Vps1302 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1442.13c 
 
RNA-binding protein, G-patch type 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC9G1.07 
 
Schizosaccharomyces specific protein 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC21B10.15 
 
Schizosaccharomyces specific protein 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC1604.03c 
 
conserved fungal protein 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC553.12c 
 
transmembrane transporter (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAPB2B4.06 
 
conserved fungal protein 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC14C8.09c dbl3 IMPACT domain protein, possible 
chaperone (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC4D7.06c met8 siroheme synthase Met8 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC6B1.04 mde4 microtubule-site clamp monopolin 
complex subunit Mde4 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC6F6.19 
 
RNA-binding protein, G-patch type 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1039.07c 
 
aminotransferase class-III, possible 
transaminase, unknown specificity 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC460.02c 
 
eukaryotic translation elongation factor, 
glutathione S-transferase (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC4F10.04 ypa1 protein phosphatase type 2A regulator, 
PTPA family Ypa1 
0 1 0 0 0 0 0 0 0 0 1 0 
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SPBC1306.02 rtt10 WD repeat protein, human WDR6 family, 
involved in endocytic recycling 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC14F5.13c pho8 vacuolar membrane alkaline phosphatase 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC417.16 
 
cytochrome c oxidase subunit (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC25H1.05 meu29 calcium transport regulatory factor 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC1718.03 ker1 DNA-directed RNA polymerase I complex 
subunit Ker1 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1235.14 ght5 hexose transmembrane transporter Ght5 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC651.10 nse5 Smc5-6 complex non-SMC subunit Nse5 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC1778.02 rap1 telomere binding protein Rap1 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC644.15 rpp101 60S acidic ribosomal protein A1 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC31A2.09c apm4 AP-2 adaptor complex subunit Apm4 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC11E3.08c nse6 Smc5-6 complex non-SMC subunit Nse6 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC736.14 dis1 TOG/XMAP14 microtubule-associated 
protein Dis1 : defects -> spindle assembly 
checkpoint activation and mitotic arrest 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCP1E11.10 
 
ankyrin repeat protein, unknown 
biological role 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC13G7.02c ssa1 heat shock protein Ssa1 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC17A5.07c ulp2 SUMO deconjugating cysteine peptidase 
Ulp2 (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1851.04c ric1 Ypt/Rab-specific guanyl-nucleotide 
exchange factor (GEF) subunit Ric1 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC29B12.06c rcd1 RNA-binding protein, CCR4-NOT complex 
subunit Rcd1 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC3H1.06c 
 
transmembrane transporter (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC25H2.15 
 
SSU-rRNA maturation protein Tsr4 
homolog 1 (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC685.06 rps001 40S ribosomal protein S0A (p40) 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC622.12c gdh1 NADP-specific glutamate dehydrogenase 
Gdh1 (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC8F11.10c pvg1 pyruvyltransferase Pvg1 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1610.01 saf5 splicing factor Saf5 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC1778.06c fim1 fimbrin 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC13G7.03 upf3 up-frameshift suppressor 3 family protein 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC14C4.06c nab2 poly(A) binding protein Nab2 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC1778.03c 
 
NADH pyrophosphatase (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC61.05 
 
S. pombe specific multicopy membrane 
protein family 1 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC576.13 swc5 Swr1 complex subunit Swc5 0 1 0 0 0 0 0 0 0 0 1 0 
SPACUNK12.02c cmk1 calcium/calmodulin-dependent protein 
kinase Cmk1 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1F7.12 yak3 aldose reductase ARK13 family YakC 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC25G10.09c pan1 actin cortical patch component, with EF 
hand and WH2 motif Panl (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC63.06 
 
human WDR89 family WD repeat protein 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC1604.20c tea2 kinesin-like protein Tea2 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC4F11.02 ptc1 protein phosphatase 2C Ptc1 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1183.02 
 
glutathione S-transferase, translational 
elongation factor eEF1 (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC364.05 vps3 CORVET complex subunit, GTPase 
regulator Vps3 (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC191.01 
 
Schizosaccharomyces specific protein 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC895.09c ucp12 ATP-dependent RNA helicase Ucp12 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1039.01 
 
amino acid permease (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC17A5.08 erp2 COPII-coated vesicle component Erp2/3/4 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1840.12 opt3 OPT oligopeptide transmembrane 
transporter family protein Opt3 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC569.04 
 
Schizosaccharomyces pombe specific 
protein 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC660.10 
 
mitochondrial translation elongation 
factor G (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPBC839.03c 
 
neddylation protein Dcn1 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
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SPAC3A12.09c ure4 urease accessory protein UreD (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC14G10.03c ump1 proteasome maturation factor Ump1 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1F5.07c hem14 protoporphyrinogen oxidase Hem14 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC338.08 ctp1 CtIP-related endonuclease 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC126.12 
 
GTP cyclohydrolase (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC23H3.09c gly1 threonine aldolase Gly1 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1142.07c vps32 ESCRT III complex subunit Vps32 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC23B6.04c 
 
sec14 cytosolic factor family, 
glycerophospholipid-transfer protein 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1322.14c vtc4 vacuolar transporter chaperone (VTC) 
complex subunit (predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1620.04c mug55 Cdc20/Fizzy subfamily WD repeat protein 0 1 0 0 0 0 0 0 0 0 1 0 
SPAP14E8.02 tos4 FHA domain protein Tos4 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1A6.09c lag1 sphingosine N-acyltransferase Lag1 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1322.06 kap113 karyopherin Kap113 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC631.02 bdf2 BET family double bromodomain protein 
Bdf2 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC548.07c ght1 hexose transmembrane transporter Ght1 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC343.10 met11 methylenetetrahydrofolate reductase 
Met11 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1739.15 wtf21 wtf element Wtf21 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC25G10.06 rps2801 40S ribosomal protein S28 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC320.05 
 
sulfate transmembrane transporter 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC19G12.16c adg2 conserved fungal protein Adg2 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC25B8.19c loz1 transcription factor zf-C2H2 type 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC1739.09c cox13 cytochrome c oxidase subunit VIa 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPCC162.04c wtf13 wtf element Wtf13 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC584.13 
 
amino acid permease (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPBC577.02 rpl3801 60S ribosomal protein L38 (predicted) 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC594.07c bqt3 bouquet formation protein Bqt3 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC630.13c tsc2 tuberin 0 1 0 0 0 0 0 0 0 0 1 0 
SPCC188.13c dcr1 dicer 0 1 0 0 0 0 0 0 0 0 1 0 
SPAC144.06 apl5 AP-3 adaptor complex subunit Apl5 
(predicted) 
0 1 0 0 0 0 0 0 0 0 1 0 
SPAC1F7.14c tam6 mitochondrial conserved protein 0 1 0 0 0 0 0 0 0 0 0 1 
SPBC887.10 mcs4 response regulator Mcs4 0 0 1 0 0 0 0 0 0 1 0 0 
SPAC22E12.14c sck2 serine/threonine protein kinase Sck2 0 0 1 0 0 0 0 0 0 1 0 0 
SPCC663.12 cid12 poly(A) polymerase Cid12 0 0 1 0 0 0 0 0 0 1 0 0 
SPAC2G11.09 
 
calcium ion transmembrane transporter 
(predicted) 
0 0 1 0 0 0 0 0 0 1 0 0 
SPBC2D10.06 rep1 MBF transcription factor activator Rep1 0 0 1 0 0 0 0 0 0 0 1 0 
SPBC8D2.10c rmt3 type I ribosomal protein arginine N-
methyltransferase Rmt3 
0 0 1 0 0 0 0 0 0 0 1 0 
SPAC16E8.09 scd1 RhoGEF Scd1 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC3H5.07 rpl702 60S ribosomal protein L7 0 0 1 0 0 0 0 0 0 0 1 0 
SPCC338.07c naa15 NatA N-acetyltransferase complex 
regulatory subunit Naa15 (predicted) 
0 0 1 0 0 0 0 0 0 0 1 0 
SPAP7G5.06 per1 plasma membrane amino acid permease 
Per1 
0 0 1 0 0 0 0 0 0 0 1 0 
SPAC29A4.12c mug108 Schizosaccharomyces specific protein 
Mug108 
0 0 1 0 0 0 0 0 0 0 1 0 
SPAC6B12.07c 
 
ubiquitin-protein ligase E3 (predicted) 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC3G9.05 spa2 cell polarity protein Spa2 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC29A4.20 elp3 elongator complex subunit Elp3 
(predicted) 
0 0 1 0 0 0 0 0 0 0 1 0 
SPAC30D11.12 rpl3802 60S ribosomal protein L38 (predicted) 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC630.14c tup12 transcriptional corepressor Tup12 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC25B8.10 
 
trans-aconitate 3-methyltransferase 
(predicted) 
0 0 1 0 0 0 0 0 0 0 1 0 
SPCC1742.01 gsf2 galactose-specific flocculin Gsf2 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC5H10.05c 
 
FAD binding oxidoreductase (predicted) 0 0 1 0 0 0 0 0 0 0 1 0 
SPCC1494.01 
 
iron/ascorbate oxidoreductase family 0 0 1 0 0 0 0 0 0 0 1 0 
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SPAC3A11.07 nde2 mitochondrial NADH dehydrogenase 
(ubiquinone) Nde2 (predicted) 
0 0 1 0 0 0 0 0 0 0 1 0 
SPAC4H3.01 
 
DNAJ domain protein Caj1/Djp1 type 
(predicted) 
0 0 1 0 0 0 0 0 0 0 1 0 
SPCC18.20 
 
dubious 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC4A8.05c myp2 myosin II heavy chain Myo3 0 0 1 0 0 0 0 0 0 0 1 0 
SPBC12D12.02c cdm1 DNA polymerase delta subunit Cdm1 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC19G12.04 dal1 ureidoglycolate hydrolase (predicted) 0 0 1 0 0 0 0 0 0 0 1 0 
SPCC1259.04 iec3 Ino80 complex subunit Iec3 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC8E11.03c dmc1 RecA family ATPase Dmc1 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC56F8.16 esc1 transcription factor Esc1 (predicted) 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC6C3.04 cit1 citrate synthase Cit1 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC977.01 
 
S. pombe specific 5Tm protein family 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC29B12.02c set2 histone lysine methyltransferase Set2 0 0 1 0 0 0 0 0 0 0 1 0 
SPBC1778.01c zuo1 zuotin (predicted) 0 0 1 0 0 0 0 0 0 0 1 0 
SPBC2G2.13c dcd1 deoxycytidylate deaminase (predicted) 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC1952.05 gcn5 SAGA complex histone acetyltransferase 
catalytic subunit Gcn5 
0 0 1 0 0 0 0 0 0 0 1 0 
SPCC1259.07 rxt3 transcriptional regulatory protein Rxt3 0 0 1 0 0 0 0 0 0 0 1 0 
SPAC3G6.01 hrp3 ATP-dependent DNA helicase Hrp3 0 0 1 0 0 0 0 0 0 0 1 0 
SPBC2G2.07c mug178 mitochondrial ribosomal protein subunit 
L51-b (predicted) 
0 0 1 0 0 0 0 0 0 0 1 0 
SPBC947.15c nde1 mitochondrial NADH dehydrogenase 
(ubiquinone) Nde1 (predicted) 
0 0 1 0 0 0 0 0 0 0 1 0 
SPCC24B10.08c ada2 SAGA complex subunit Ada2 0 0 1 0 0 0 0 0 0 0 0 1 
SPBC56F2.05c 
 
transcription factor (predicted) 0 0 1 0 0 0 0 0 0 0 0 1 
SPCC1259.02c erm1 Endoplasmic Reticulum metallopeptidase 
Erm1 (predicted) 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC736.08 cbf11 CBF1/Su(H)/LAG-1 family transcription 
factor Cbf11 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC777.08c bit61 TORC2 subunit Bit61 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC1486.11 fmc1 mitochondrial matrix protein, F1F0 ATP 
synthase assembly factor Fmc1 
(predicted) 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC970.06 
 
cargo receptor for soluble proteins 
(predicted) 
0 0 1 0 0 0 0 0 0 0 0 1 
SPBC428.04 apq12 nuclear membrane organization protein 
Apq12 (predicted) 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC74.03c ssp2 AMP-activated protein serine/threonine 
kinase alpha subunit Ssp2 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC1450.12 
 
PXA domain protein 0 0 1 0 0 0 0 0 0 0 0 1 
SPCPJ732.02c xks1 xylulose kinase Xks1 (predicted) 0 0 1 0 0 0 0 0 0 0 0 1 
SPBC1921.03c mex67 mRNA export receptor, Tap, nucleoporin 
Mex67 
0 0 1 0 0 0 0 0 0 0 0 1 
SPAC24H6.04 hxk1 hexokinase 1 0 0 1 0 0 0 0 0 0 0 0 1 
SPCC4G3.10c rhp42 DNA repair protein Rhp42 0 0 1 0 0 0 0 0 0 0 0 1 
SPCC63.08c atg1 autophagy and CVT pathway 
serine/threonine protein kinase Atg1 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC794.09c tef101 translation elongation factor EF-1 alpha 
Ef1a-a 
0 0 1 0 0 0 0 0 0 0 0 1 
SPAC30.04c abc4 glutathione S-conjugate-exporting ATPase 
Abc4 
0 0 1 0 0 0 0 0 0 0 0 1 
SPAC4D7.14 new13 conserved fungal protein of unknown 
function 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC18.13 
 
tRNA (guanine-N7-)-methyltransferase 
subunit Trm82 (predicted) 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC70.03c 
 
proline dehydrogenase (predicted) 0 0 1 0 0 0 0 0 0 0 0 1 
SPBC3H7.08c 
 
conserved fungal protein 0 0 1 0 0 0 0 0 0 0 0 1 
SPCC777.12c 
 
thioredoxin family protein 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC630.09c mug58 GLYK family kinase of unknown specificity 
(predicted) 
0 0 1 0 0 0 0 0 0 0 0 1 
SPAC27D7.05c apc14 anaphase-promoting complex subunit 
Apc14 
0 0 1 0 0 0 0 0 0 0 0 1 
SPAC22G7.08 ppk8 serine/threonine protein kinase Ppk8 
(predicted) 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCP1E11.03 mug170 arrestin family Schizosaccharomyces 
specific protein Mug170 
0 0 1 0 0 0 0 0 0 0 0 1 
SPBC409.03 swi5 Swi5 protein 0 0 1 0 0 0 0 0 0 0 0 1 
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SPBC215.03c csn1 COP9/signalosome complex subunit Csn1 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC7D4.02c sfp47 Ubp4 interactor Sfp47 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC23G3.10c ssr3 SWI/SNF and RSC complex subunit Ssr3 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC22A12.11 dak1 dihydroxyacetone kinase Dak1 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC1A6.06c meu31 Schizosaccharomyces specific protein 
Meu31 
0 0 1 0 0 0 0 0 0 0 0 1 
SPCC1322.09 
 
conserved fungal protein 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC6F6.13c 
 
DUF726 family protein 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC4D7.07c csi2 mitotic chromosome segregation protein 
Csi2 
0 0 1 0 0 0 0 0 0 0 0 1 
SPAPB1A10.14 pof15 F-box protein (predicted) 0 0 1 0 0 0 0 0 0 0 0 1 
SPBC13G1.12 did2 ESCRT III complex subunit Did2 (predicted) 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC19D5.06c din1 Dhp1p-interacting protein Din1 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC607.07c 
 
Schizosaccharomyces specific protein 0 0 1 0 0 0 0 0 0 0 0 1 
SPCC1259.08 
 
conserved fungal protein, DUF2457 family 0 0 1 0 0 0 0 0 0 0 0 1 
SPAC4F10.08 mug126 Schizosaccharomyces pombe specific 
protein 
0 0 1 0 0 0 0 0 0 0 0 1 
SPBC18H10.15 cdk11 serine/threonine protein kinase cdk11 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC28E12.02 
 
RNA-binding protein 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC18H10.10c saf4 splicing associated factor Saf4 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC18H10.20c any1 arrestin-related endocytic adaptor Any1 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC1071.03c sil1 nucleotide exchange factor for the ER 
lumenal Hsp70 chaperone, Sil1 (predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC3H7.06c pof9 F-box protein Pof9 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC32F12.01c css1 inositol phosphosphingolipid 
phospholipase C, Css1 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC21.07c ppk24 serine/threonine protein kinase Ppk24 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC9B6.09c mdl1 mitochondrial peptide-transporting 
ATPase 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC3H7.13 far10 SIP/FAR complex FHA domain subunit 
Far10/Csc1 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC11G11.02c end3 actin cortical patch component End3 
(predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPCC16C4.20c hap2 HMG box protein (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPCC4B3.04c nte1 lysophospholipase (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC140.04 ctr1 conserved eukaryotic protein, human 
CCDC174 ortholog 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC32H8.13c mok12 alpha-1,3-glucan synthase Mok12 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC18H10.19 vps38 phophatidylinositol 3-kinase complex 
subunit Vps38 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC18B11.09c 
 
serine O-acetyltransferase activity 
(predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC18H10.18c 
 
Schizosaccharomyces specific protein 0 0 0 0 0 0 0 0 0 1 1 0 
SPCC1393.09c gir2 RWD domain protein, involved in 
cytoplasmic translation Gir2 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC18H10.05 
 
WD repeat protein, human WDR44 family 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC28E12.06c lvs1 beige protein homolog Lvs1 (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC27B12.09c 
 
mitochondrial FAD transmembrane 
transporter (predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC683.02c 
 
zf-CCHC type zinc finger protein 
(predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC1399.04c 
 
uracil phosphoribosyltransferase 
(predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC18G6.02c chp1 chromodomain protein Chp1 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC12B10.12c rhp41 DNA repair protein Rhp41 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC31G5.04 lys12 homoisocitrate dehydrogenase Lys12 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC1709.11c png2 ING family homolog Png2 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC6F6.01 cch1 calcium ion channel Cch1 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC28E12.03 rga4 Rho-type GTPase activating protein Rga4 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC8F11.08c 
 
esterase/lipase (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC31A2.14 bun107 WD repeat protein, human WDR48 family 
Bun107 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC365.13c hba1 Ran GTPase binding protein Hba1 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC30.02c 
 
elongator complex associated protein Kti2 
(predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC23H4.12 alp13 MRG family Clr6 histone deacetylase 
complex subunit Alp13 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC3H7.14 mug176 BRCT domain protein 0 0 0 0 0 0 0 0 0 1 1 0 
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SPAC17A5.16 ftp105 Ubp5 interacting protein Ftp105 0 0 0 0 0 0 0 0 0 1 1 0 
SPCC417.02 dad5 DASH complex subunit Dad5 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC1685.13 fhn1 plasma membrane organization protein 
Fhn1 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC1685.02c rps1202 40S ribosomal protein S12 (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC3H7.02 
 
sulfate transmembrane transporter 
(predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC12B10.11 exg2 glucan glucosidase Exg2, unknown 
specificity 
0 0 0 0 0 0 0 0 0 1 1 0 
SPCC188.08c ubp5 ubiquitin C-terminal hydrolase Ubp5 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC4F10.19c hit1 zf-HIT family C/D snoRNP assembly 
protein Hit1 (predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC13A11.06 
 
pyruvate decarboxylase (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC11G11.01 fis1 mitochondrial fission protein Fis1 
(predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC8E11.05c 
 
conserved fungal protein, associated with 
clathrin coated vesicles (predicted) 
0 0 0 0 0 0 0 0 0 1 1 0 
SPAC22H12.04c rps102 40S ribosomal protein S3a (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC13C5.04 
 
amidotransferase (predicted) 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC824.04 swd22 mRNA cleavage and polyadenylation 
specificity factor complex subunit, WD 
repeat protein Swd22 
0 0 0 0 0 0 0 0 0 1 1 0 
SPBC20F10.07 
 
GRAM domain protein 0 0 0 0 0 0 0 0 0 1 1 0 
SPAC17C9.05c pmc3 mediator complex subunit Med27 0 0 0 0 0 0 0 0 0 1 1 0 
SPBC336.01 fbh1 DNA helicase I, ubiquitin ligase F-box 
adaptor Fbh1 
0 0 0 0 0 0 0 0 0 1 0 1 
SPBC16H5.13 
 
WD repeat protein, human WDR7 
ortholog 
0 0 0 0 0 0 0 0 0 1 0 1 
SPAC823.13c 
 
mitochondrial inner membrane protein 
(predicted) 
0 0 0 0 0 0 0 0 0 1 0 1 
SPAC19A8.01c sec73 guanyl-nucleotide exchange factor Sec73 
(predicted) 
0 0 0 0 0 0 0 0 0 0 1 1 
SPBC4B4.08 ght2 hexose transmembrane transporter Ght2 0 0 0 0 0 0 0 0 0 0 1 1 
SPCC320.07c mde7 RNA-binding protein Mde7 0 0 0 0 0 0 0 0 0 0 1 1 
SPBC16E9.11c pub3 HECT-type ubiquitin-protein ligase E3 
Pub3 (predicted) 
0 0 0 0 0 0 0 0 0 0 1 1 
SPCC1259.09c pdx1 pyruvate dehydrogenase protein x 
component, Pdx1 (predicted) 
0 0 0 0 0 0 0 0 0 0 1 1 
SPAC977.15 
 
dienelactone hydrolase family 0 0 0 0 0 0 0 0 0 0 1 1 
SPAC29A4.17c 
 
mitochondrial FUN14 family protein 
involved in mitophagy 
0 0 0 0 0 0 0 0 0 0 1 1 
SPCC1682.12c ubp16 ubiquitin C-terminal hydrolase Ubp16 0 0 0 0 0 0 0 0 0 0 1 1 
SPBP35G2.05c cki2 serine/threonine protein kinase Cki2 0 0 0 0 0 0 0 0 0 0 1 1 
SPBP23A10.16 sdh4 TIM22 inner membrane protein import 
complex anchor subunit Tim18 
0 0 0 0 0 0 0 0 0 0 1 1 
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Appendix D: Variants identified in the strains used 
 
The Wildtype and mutant strains (all in Pem2 background) were sequenced and aligned to 
the reference S. pombe sequence, in replicates.  This table lists all the variants (INDELs and 
SNPs) that were identified. The alternate sequence refers to the sequence obtained that 
were different from the refence sequence.  Remarks section for most of the rows show the 
sequence at the region with the base-pairs at the position in bold. (* denotes that many of 
the apparent variants are in regions with long runs of the same residue where sequencing 
errors may be more common.)
Chr Position
Reference 
sequence
Alternate 
sequence Type
Pem2 
Replicate 1
Pem2 
Replicate 2
ell1Δ 
Replicate 
1
ell1Δ 
Replicate 2
eaf1Δ 
Replicate 1
eaf1Δ 
Replicate 
2
ebp1Δ 
Replicate 1
ebp1Δ 
Replicate 2 Remarks
I 440084 T TA INDEL TA T TA T TA T TA TA *TTTTTTAAAAAAAAAAAAA
I 453369 G GAA INDEL GAA . . GAA . GAA . GAA *GAAAAAAAAAAAAAAA
I 650099 C CAA INDEL CAA C CAA CAA . C CAA . *CAAAAAAAAAAAAAAA
I 660056 T TG INDEL TG TG TG T TG TG TG TG *TGGGGGGGGGG
I 960025 G GT INDEL GT GT GT GT GT GT GT GT *GTTTTTTTTTTTT
I 965438 C CA INDEL CA CA CA CA . C . CA *CAAAAAAAAAAAAAAA
I 1358794 C CAA INDEL CAA CAA CAA CAA CAA CAA CAA CAA *CCAAAAAAAAAAAAA
I 1595056 C CT INDEL CT CT C C . CT CT . *CTTTTTTTTTTTTTTTTT
I 1905525 T TG INDEL TG TG TG . T TG T TG *TTTTTTTTTGGGGGGGGG
I 1955853 T TA INDEL TA TA TA TA TA TA TA TA *TAAAAAAAAAAAAAAA
I 3166776 G GTTT INDEL G GTTT GTTT GTTT GTTT GTTT GTTT GTTT *GTTTTTTTTTTTTTTTTT
I 3659724 C CT INDEL CT C C C C CT CT CT *CTTTTTTTTTTTTTTTTT
I 4916623 C CA INDEL . C C . C CA CA C *CAAAAAAAAAAAAAAA
I 5176926 T TA INDEL TA TA T T TA TA TA T *TAAAAAAAAAAAAAAA
I 5426622 C CT INDEL CT CT CT CT CT CT C CT *CTTTTTTTTTTTT
II 889921 C CTTTT INDEL C C CTTTT CTTTT C C C CTTTT *CTTTTTTTTTTTTTTTTT
II 1266289 T TA INDEL . TA TA TA . TA . TA *TAAAAAAAAAAAAAAA
II 1555919 A ATTTATT INDEL ATTTATT ATTTATT ATTTATT ATTTATT ATTTATT ATTTATT . ATTTATT *ATTTATTTTTATTTTT
II 1716256 G GT INDEL G G G GT GT GT G GT *GTTTTTTTTTTTTTT
II 1867795 A AT INDEL AT AT . AT AT AT AT AT *ATTTTTTTTTT
II 1868122 G GTT INDEL GTT GTT GTT GTT G GTT GTT G *GTTTTTTTTTTTTTTTTT
II 2630607 C CA INDEL CA CA C CA CA CA CA CA *CAAAAAAAAAAAAAAA
II 2640785 T TA INDEL . TA TA TA T T TA T *TTAAAAAAAAAAAAAA
II 2755338 CAT C INDEL C C CAT C C C C C *CATATATATATATATATAT
II 3799350 G GA INDEL GA GA G GA GA G GA GA *GAAAAAAAAAAAAAAA
II 4233001 C CTA INDEL C C C C C C CTA CTA *CTATATATATATATA
II 4419921 T TA INDEL . TA . TA . T . TA *TTAAAAAAAAAAAAAA
III 107118 G C SNP G G G G G G G C SNP in only 1 of the 3 replicates
III 719971 G T SNP T T T T T T . T variant in all strains used
III 1168363 G A SNP A A G A A G G A *GGGAAAAAAAAAAAAA
III 1861945 A AC INDEL A A A A AC AC A A Eaf1 gene position
III 1861966 TA T INDEL TA TA TA TA T T TA TA Eaf1 gene position
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